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Background Lacunar ischaemic stroke accounts for around one quarter of all 
strokes, and is presumed to result from the occlusion of a single perforating artery 
supplying the deep subcortical areas of the brain.  The underlying arterial pathology 
is poorly understood, but is thought to differ from the atherothrombotic processes 
that occlude larger intra- and extracranial arteries causing most other ischaemic 
stroke subtypes.  Progress in understanding the aetiology of lacunar stroke has been 
limited by the lack of informative autopsy studies, and the difficulties in studying 
small blood vessels using brain imaging.  One alternative approach is to compare the 
epidemiology of ischaemic stroke subtypes, since differences in the epidemiology 
may reflect and inform about different underlying pathologies. 
Methods I performed two systematic literature reviews to identify studies presenting 
data on (1) the risk factors for, and (2) the outcome of, different ischaemic stroke 
subtypes.  I extracted relevant data from included studies and performed a series of 
meta-analyses comparing risk factor profiles, and risks of death, recurrent stroke and 
myocardial infarction (MI) in patients with lacunar versus non-lacunar ischaemic 
stroke.  To address some of the unanswered questions and controversies surrounding 
the causes of ischaemic stroke we set up the Edinburgh Stroke Study (ESS), which I 
co-ordinated.  We recruited patients with stroke and transient ischaemic attack seen 
at our hospital between 2002 and 2005, and followed them for 1-4 years for death, 
recurrent stroke and MI.  To overcome the methodological limitations of the studies 
included in my reviews and of my meta-analyses, I carried out a large collaborative 
individual patient data analysis in which I combined data from five stroke registries - 
including the ESS - that had used similar robust methodology, and performed a series 
 viii 
of analyses comparing the risk factor profiles of patients with lacunar versus non-
lacunar ischaemic stroke.  In an updated meta-analysis, I combined this data with 
existing published studies that had used an unbiased method of classifying ischaemic 
stroke subtypes.  Using the ESS data, I compared the risks of recurrent stroke and 
MI, and patterns of recurrent stroke subtypes in patients with lacunar versus non-
lacunar stroke. 
Results In my systematic review of risk factors I found evidence of classification 
bias in many studies, where systematic error was introduced through the use of 
classification methods that included risk factors in the definitions of stroke subtypes.  
This led to overestimation of some risk factor-stroke subtype associations and, in 
particular, to apparently stronger associations between hypertension and diabetes and 
lacunar compared with non-lacunar ischaemic stroke.  When I included only 
unbiased studies, I found a significantly reduced prevalence of atrial fibrillation (AF) 
and severe carotid stenosis and a trend towards a reduced prevalence of ischaemic 
heart disease (IHD) in lacunar patients.  I found a very slight excess of hypertension 
among lacunar patients, but no difference in the prevalence of diabetes, or any other 
risk factor studied.  In my collaborative individual patient data analysis, I confirmed 
a significantly lower prevalence of severe carotid stenosis, AF and previous IHD in 
patients with lacunar ischaemic stroke, but found no difference in the prevalence of 
hypertension, diabetes, or any other risk factor studied, even after adjusting for 
confounding factors.  These results were largely confirmed in my updated meta-
analysis, although there was a slight excess of hypertension among lacunar compared 
with non-lacunar ischaemic strokes. In my systematic review of outcome after 
lacunar versus non-lacunar ischaemic stroke, I found a lower risk of death following 
 ix
lacunar compared with non-lacunar stroke which attenuated but persisted long-term; 
a higher recurrent stroke risk in non-lacunar patients during the first month only; and 
limited data on recurrent stroke subtypes suggesting that ischaemic stroke subtypes 
may breed true to type.  Data on MI risk were extremely sparse.  My analyses of data 
from the ESS showed no difference overall in risk of recurrent stroke between 
patients with lacunar versus non-lacunar ischaemic stroke, but some evidence for a 
lower very early recurrence risk among lacunar patients.  There was evidence that 
recurrent stroke subtypes breed true, since patients with a lacunar stroke at baseline 
were much more likely to have a lacunar than a non-lacunar recurrence.  We 
identified five times as many MI events following stroke than have been previously 
reported in the published literature, and found a non-significantly reduced risk of MI 
in patients with lacunar compared with non-lacunar ischaemic stroke.  
Conclusions My comparisons of the epidemiology of lacunar versus non-lacunar 
ischaemic stroke subtypes revealed differences in the risk factor profiles and risks of 
recurrent stroke and myocardial infarction which suggest that a distinct, non-
atherothrombotic arteriopathy underlies many lacunar ischaemic strokes.  My 
analyses of recurrent stroke subtype patterns suggest that recurrent ischaemic strokes 
subtypes tend to breed true, providing further support for a distinct lacunar 
arteriopathy.  Contrary to widespread belief, hypertension and diabetes do not appear 
to be more important in the aetiology of lacunar stroke than in other types of 
ischaemic stroke. 
These findings support other lines of evidence for a distinct lacunar arteriopathy, and 
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A. Background and systematic literature review with meta-analyses 
Chapter 1. Epidemiology of stroke and classification of stroke 
subtypes 
 
1.1 Global impact of stroke 
1.1.1 Mortality 
Stroke, defined by the World Health Organisation as the clinical syndrome of rapid 
onset of focal cerebral deficit, lasting more than 24 hours or leading to death and 
with no apparent cause other than a vascular one (Aho et al. 1990), is a major public 
health burden.  It is the third most common cause of death worldwide, second to 
ischaemic heart disease and all cancers combined, and the second commonest cause 
of death when cancer is divided into its different types (Lopez et al. 2006).   Stroke is 
becoming a major health problem in middle- and low-income countries, where there 
has been a 50% increase in the burden of chronic diseases in the last decade (Strong 
et al. 2007).  In 2005, stroke caused an estimated 5.7 million deaths worldwide, 87% 
of which occurred in low- and middle-income countries (Strong et al. 2007).   
1.1.2 Incidence 
Stroke is largely a disease affecting older people, with the incidence risk increasing 
with each decade of life and three-quarters of all first strokes occurring after the age 
of 65 years (Feigin et al. 2003).  Most methodologically robust incidence studies 
have been performed in predominantly Caucasian populations in Europe, Australasia 
and the USA.  Among population-based incidence studies carried out since 1990, the 
 8 
age-adjusted incidence of total stroke for those aged more than 55 years ranged from 
about 4.2 to 11.7 per 1000 person-years (Feigin et al. 2003).   
Incidence data from the UK is in keeping with data from other high-income 
countries, with a handful of community-based incidence studies carried out in 
England after 1990 having reported age-standardised incidence rates for all stroke 
types that range from 1.3 to 1.6 per 1000 per year (Du et al. 1997; Rothwell et al. 
2004; Stewart et al. 1999).  For ischaemic stroke in particular, the most recent 
incidence study reported an age-standardised incidence rate of 1.4 per 1000 per year 
(Rothwell et al. 2004).  Similarly, the only study to have accurately measured stroke 
incidence within Scotland – the Scottish Borders Study – recently reported an age-
standardised ischaemic stroke incidence rate of 1.6 per 1000 per year (Syme et al. 
2005).  It is difficult to compare these two most recent stroke incidence studies in 
Scotland and England since different reference populations were used in the age 
standardisation.  There are, however, almost no reliable incidence data from low- and 
middle-income countries. 
1.1.3 Trends and projections 
Most studies have shown an overall decline in stroke incidence, particularly in the 
elderly population, in Western Europe, Australasia, Japan and the USA through the 
1970s and 1980s, with incidence generally stabilising in the 1990s.  Elsewhere, 
stroke incidence has risen in some Eastern European countries (Feigin et al. 2003, 
Truelsen et al. 2006).   
Routinely collected data suggest that mortality rates have similarly declined in many 
countries since the mid 1960s, particularly in Western Europe, North America, 
Australia and Japan (Sarti et al. 2000), but may have stabilised over the last ten 
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years.  However, with increasing life expectancy, the global population aged over 65 
years is increasing by 9 million per year, and the projections are that by 2025 there 
will be over 800 million people aged over 65 years in the world (Truelsen et al 
2001).  Despite stabilising incidence rates in many countries, these demographic 
changes will lead to a substantial increase in the number of stroke events, with the 
rate of death from stroke for all ages combined estimated to increase from 89 per 
100,000 in 2005 to 98 per 100,000 in 2030 (Strong et al. 2007). 
1.1.4 Disability  
Not only is stroke one of the leading causes of death worldwide, it is also responsible 
for a substantial proportion of the world’s disability burden.  Following a stroke, 
about one third of patients will die within a year, and of those who survive, almost 
half remain dependent (Warlow et al. 2003).  There are about 250,000 disabled 
stroke survivors in the UK alone (Rothwell 2001).  In 2001, stroke caused 4.5% of 
the total disability burden among low- and middle-income countries, and 3.6% of the 
disability burden among high-income countries (Lopez et al 2006).   
1.1.5 Economic burden 
Stroke is a major drain on health-care funding, through the costs of treatment, 
hospital care and the huge disability burden.  In the UK stroke accounts for about 6% 
of the National Health Service and Social Service expenditure, which equates to 
about £2.3 billion per year (Rothwell 2001).   
1.2 Pathological types and subtypes of stroke 
Stroke is a heterogeneous disorder: about 80% are ischaemic, resulting from 
occlusion of one or more arteries; 15% are caused by intracerebral haemorrhage, 
(bleeding within the brain tissue); and 5% are due to subarachnoid haemorrhage 
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(bleeding into the subarachnoid space – the area between the arachnoid and the pia 
mater) (Figure 1.1).  Ischaemic stroke can be sub-classified further: among 
Caucasian populations about 50% are due to atherothrombosis of the extracranial 
arteries, and - less commonly - of the intracranial arteries; 20% are due to emboli 
from the heart; 25% are lacunar strokes, presumed to be caused by an intrinsic small 
vessel disease; and the remainder are due to rare causes such as arterial dissection 
and monogenic disorders (Warlow et al. 2003).  There do appear to be ethnic 
differences in the incidence of ischaemic stroke subtypes, with the incidence of 
lacunar ischaemic stroke perhaps higher among Asian, Black and Hispanic 
populations compared with Caucasian populations (Feigin et al. 2006; White et al. 
2005). 
     
Figure 1.1 Estimates of the frequency of the pathological types and subtypes of stroke in 
Caucasian populations 
 
Reproduced from The Lancet, Vol 362, Warlow et al., pp 1211-1244, Copyright 2003, with 
permission from Elsevier. 
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1.3 Classification of ischaemic stroke subtypes 
Correct diagnosis of stroke and its pathological types and subtypes is based on a 
patient’s clinical signs and symptoms, usually (but not always) accompanied by brain 
imaging findings.  A diagnosis of stroke versus not stroke is primarily made based on 
clinical symptoms and signs, with brain imaging findings used to rule out occasional 
non-stroke diagnosis (e.g. brain tumour).  Assignment of pathological type of stroke 
requires appropriately timed brain imaging to correctly distinguish between 
ischaemic and haemorrhagic stroke.  Once a stroke is diagnosed as being ischaemic, 
a specific ischaemic stroke subtype can then be assigned, using one of a number of 
methods, as described below.  Although brain imaging may visualise an acute infarct 
which can help in assigning an ischaemic stroke subtype, brain imaging is normal 
(i.e. there is no visible relevant lesion) in up to about one third of patients with a 
clinical stroke (Mead et al. 2000), although this proportion varies depending on type 
and timing of brain scan.  An infarct may not be visible because the scan is 
performed too soon after stroke onset or the lesion is too small to be visualised. 
In epidemiological studies, and in clinical practice, ischaemic stroke subtypes are 
generally assigned using one of two main classification methods: the Oxfordshire 
Community Stroke Projection (OCSP) classification (Bamford et al. 1991) or the 
Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification (Adams et al. 
1993).  
1.3.1 Oxfordshire Community Stroke Project classification 
The OCSP classification defines ischaemic stroke subtypes according to the arterial 
territory of the brain that is affected, and the likely size of the stroke lesion, with the 
four clinical syndromes being: total anterior circulation stroke (TACS); partial 
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anterior circulation stroke; (PACS); lacunar stroke (LACS) and posterior circulation 
stroke (POCS).  This classification therefore relies on the clinical presentation, with 
the assigned clinical syndrome based on the patients’ symptoms and signs, which 
reflect the territory of brain affected (Appendix 1).  The OCSP classification predicts 
early death, long-term disability and recurrent stroke (Bamford et al. 1991), and 
relates to the presumed pattern of vascular pathology of each subtype (Wardlaw et al. 
1996).  The inter-observer reliability of the clinical OCSP classification was 
moderate to good when assessed in a hospital-based setting by neurologists (Lindley 
et al. 1993) and in a community-based setting by both neurologists and trained 
research nurses (Dewey et al. 2001).  In both studies poor inter-observer agreement 
was related to differences in the neurological signs elicited by the observers, 
particularly the assessment of speech dysfunction and the presence or absence of 
hemianopia (visual field defect).  All or some of a patient’s neurological symptoms 
may have resolved by the time a clinical assessment is made by a doctor, in which 
case an accurate clinical diagnosis depends heavily on obtaining a thorough clinical 
history from the patient and/or witnesses.  Distinguishing between symptoms such as 
dysphasia (disorder of the production and/or comprehension of speech) and 
dysarthria (disorder of the articulation of sounds, i.e. slurred speech) for example can 
be especially difficult when relying on clinical history alone, and may lead to 
misclassification between lacunar and mild cortical stroke (Lindley et al. 1993).  
Assessment of acutely ill stroke patients is particularly difficult, since patients can be 
confused, dysphasic and/or drowsy.   
In a clinical and brain imaging-based classification, the clinical classification can be 
modified.  For example, if a patient presents with a lacunar syndrome, but has a 
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small cortical infarct on brain imaging that would explain the patient’s symptoms, 
the classification can be altered from LACI to PACI, thus reducing the proportion of 
ischaemic stroke subtypes misclassified.  The disadvantage of the OCSP is the 
potential for misclassification when no brain imaging is performed, or brain imaging 
is performed but reveals no visible acute lesion, in which case the classification is 
based solely on the clinical symptoms and signs.  When CT brain imaging is used, a 
visible relevant lesion is present in about two thirds of patients, and reliability studies 
have shown that in the remaining one third of patients who have no visible lesion, the 
clinical OCSP classification correctly predicts site and size of lesion in about three 
quarters of patients (Mead et al. 2000).   
1.3.2 Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification 
Other classification methods classify ischaemic stroke subtypes according to the 
presumed aetiological mechanism.  The most commonly used is the TOAST 
classification, in which an ischaemic stroke is classified as being due to: small vessel 
disease; atherothrombosis (or large vessel disease); cardioembolism; an 
undetermined cause (due to incomplete investigation, the existence of more than one 
potential cause, or no evident cause despite complete investigation); and “other 
causes” (which includes unusual causes such as arterial dissection and monogenic 
disorders) (Appendix 2).  The inter-observor reliability of this classification method 
is similar to that of the OCSP, with two studies reporting moderate agreement 
between assessing neurologists (Adams et al. 1993; Gordon et al. 1993).  The 
TOAST classification is heavily dependent on clinical investigations such as carotid 
doppler ultrasound and echocardiogram, and in centres where these investigations are 
less readily available or are not performed routinely because they are unavailable or 
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deemed not to change clinical management, the undetermined category of the 
TOAST classification can include up to about 40% of patients.  Even in centres 
where these types of investigations are carried out the proportion categorised as 
undetermined can be quite large, because patients often have no detectable 
aetiological reason for their stroke occurring, or have more than one potential cause.  
Furthermore, definitions of ischaemic stroke subtypes within the TOAST 
classification are also risk factor-dependent, with the presence or absence of 
particular risk factors, such as hypertension, diabetes, cardioembolic source and 
carotid stenosis influencing classification.  This is an important source of potential 
bias in research studies of the associations between ischaemic stroke subtypes and 
risk factors. 
1.4 Lacunar ischaemic stroke is not a benign disorder 
As described, lacunar stroke accounts for about a quarter of all ischaemic strokes in 
Caucasian populations, and it may be more prevalent in some other ethnic groups.  In 
the past lacunar ischaemic stroke was considered to have a relatively benign 
prognosis, in comparison to other types of ischaemic stroke.  However, that view is 
changing, as although the short term outcome - in terms of case-fatality - of patients 
with lacunar ischaemic stroke may be more favourable than that of other subtypes of 
stroke, in the long term lacunar stroke carries a greater risk of death, morbidity, 
recurrent stroke and cognitive decline than was previously realised (Norrving 2008), 
although the differences in outcome between patients with lacunar versus other 
ischaemic stroke subtypes remain to be clearly established.  Given that lacunar 
ischaemic stroke accounts for such a large proportion of stroke, and carries a 
substantially worse prognosis than was once thought, a better understanding of the 
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underlying arterial pathology is clearly needed.  At present, acute treatment and 
secondary prevention of ischaemic stroke is essentially similar across all subtypes of 
ischaemic stroke.  This is largely because the evidence base is randomised controlled 
clinical trials that do not have the power to investigate differences in treatment 
effects between ischaemic stroke subtypes.  Furthermore, ischaemic stroke subtypes 
in such trials have often not been well characterised.  However, if lacunar ischaemic 
stroke is caused by a distinct intrinsic small vessel disease, then unravelling the 
nature of this arteriopathy could lead to more targeted and effective therapeutic 
options for acute treatment of lacunar ischaemic stroke, prevention of recurrent 
stroke, and improvement in long-term morbidity and cognitive function.                                                                                                                  
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Chapter 2. Unravelling the arterial pathology of lacunar ischaemic 
stroke  
 
2.1 Lacunar ischaemic stroke 
Most lacunar ischaemic stroke manifests clinically as one of five main clinical 
lacunar syndromes: pure sensory; pure motor; sensorimotor stroke; clumsy-hand 
dysarthria and ataxic hemiparesis (Norrving 2008).  These symptoms result from 
infarction in the deep subcortical areas of the brain which, when visible on CT brain 
imaging, appears as a small focal area of hypointensity ≤ 20 mm in diameter (Figure 
2.1a).   
 
Figure 2.1 Computed tomography brain imaging, demonstrating (a) a typical lacunar infarct 





This small area of infarction is thought to result from the occlusion, or perhaps 
leakiness (Wardlaw et al. 2009), of a single perforating artery supplying the deep 
subcortical areas of the brain.  These arteries include the lenticulostriate arteries, 
which arise from the mainstem of the middle cerebral artery (Figure 2.2).  The 
arterial processes leading to lacunar infarction are thought by many to differ from the 
atherothrombotic processes that occlude larger intra- and extra-cranial arteries 
causing most other types of ischaemic stroke (Figures 2.1 and 2.2). However, the 
location and small size of the perforating arteries make investigation of the vascular 














Figure 2.2 Pictorial depictions of (a) presumed occlusion of lenticulostriate arteries resulting 
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2.2 Pathological evidence for a distinct lacunar arteriopathy  
Much of our current understanding of the arterial pathology of lacunar ischaemic 
stroke is based on Miller Fisher’s meticulous clinicopathological studies from the 
1960s and 1970s.  During this time he serially dissected the vascular supply of 68 
lacunar infarcts in 18 postmortem brains of patients who had had either a clinical 
lacunar stroke or a posterior circulation stroke thought to be due to infarction in the 
territory supplied by the perforating pontine arteries that arise from the basilar artery 
(Fisher 1968; Fisher 1971; Fisher 1977; Fisher 1978; Fisher 1979; Fisher & Tapia 
1987).  He reported that most symptomatic lacunar infarcts were associated with the 
narrowing or sometimes occlusion of perforating arteries 200-800 µm in diameter by 
atheromatous plaques - sometimes largely composed of lipid-containing 
macrophages - with or without complicating thrombus.  This small vessel 
atherosclerosis was found particularly in the basilar artery and its pontine perforating 
branches (Fisher 1977; Fisher 1987; Fisher 1971).  He also reported that most 
asymptomatic lacunar infarcts - caused by disruption of the blood flow in small 
perforating arteries of about 40-200 µm in diameter - were associated with 
lipohyalinosis.  This destructive small vessel lesion is characterised in the acute 
phase by fibrinoid necrosis and in the healed phase by arterial wall disorganisation, 






Figure 2.3 Pathological cross-section of a lenticulostriate artery with lipohyalinosis, 
showing an asymmetric, disorganised arterial wall with fibrinoid material (*) and mural 
foam cells (arrow)  
   
Reproduced from Lammie GA, Hypertensive cerebral small vessel disease and stroke, Brain Pathology 2002 vol 
12, pp 358-370, by permission of Oxford University Press. 
 
Miller Fisher’s pathological observations without doubt made an important 
contribution to our understanding of the arteriopathy of lacunar ischaemic stroke.  
However, a number of limitations make it difficult to draw firm conclusions from 
these pathological studies.  The number of patients included was small (18 patients in 
total), most of the lacunar infarcts were asymptomatic, and infarcts related to stroke 
symptoms were studied months or even years after the acute event.  Furthermore, in 
the study in which the majority of infarcts were described (50 lacunes in four 
patients), all patients had hypertension, three of whom had severe hypertension.  
Indeed, it is likely that the presence of hypertension was the reason for their inclusion 
in the study.  Miller Fisher’s findings are therefore based largely on the study of a 




lacunar ischaemic stroke, particularly in the present day when severe hypertension is 
far less common. 
2.3 Theories and controversies surrounding lacunar stroke arteriopathy 
Since Miller Fisher’s studies, further progress in understanding the arteriopathy of 
lacunar ischaemic stroke has been limited, for three main reasons.  First, direct 
evidence from pathological studies is limited.  Lacunar ischaemic stroke has a low 
early case fatality rate (Bamford et al. 1987), and thus autopsies soon after stroke are 
rarely carried out.  This is compounded by the overall decline in autopsy rates during 
the last 30 to 40 years (Burton et al. 2007).  In addition, tracing the vascular supply 
of areas of subcortical infarction is technically demanding, time consuming and 
expensive.  Second, informative brain imaging studies are scarce due to the 
difficulties of directly visualising in vivo the small perforating arteries.  Third, there 
is a lack of suitable, informative animal models for lacunar ischaemic stroke, 
although the spontaneous hypertensive stroke-prone rat is perhaps a good model for 
some aspects of the disease (Bailey et al. 2009).   
In the absence of informative modern autopsy data, the relative importance of 
lipohyalinosis and atherosclerosis to the cause of lacunar infarction therefore remains 
unclear, and the initiating arterial changes leading to infarction and these 
pathological features observed at autopsy are still unknown.  Furthermore, a 
particular limitation of autopsy studies is that it is difficult to distinguish between 
pathological changes that actually caused the brain injury from those that represent a 
response to brain injury.   
Given that lipohyalinosis and intracranial atherosclerosis were found by Miller 
Fisher and others to be associated with thickening of the small vessel wall and 
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narrowing of the lumen, the assumption was that this narrowing led to vessel 
occlusion, resulting in lacunar infarction.  However, whether lacunar infarction is 
actually caused by occlusion has recently been questioned, and it has been suggested 
that specific small vessel arterial changes may initiate the cascade of events leading 
to lacunar infarction (Wardlaw et al. 2003).  One hypothesis is that endothelial 
dysfunction may lead to alteration of the permeability of the blood-brain barrier, 
extravasation of plasma components into the vessel wall and surrounding brain 
tissues, and ultimately neuronal damage and infarction (Wardlaw et al. 2003).  
Although there are reports that patients with lacunar ischaemic stroke have elevated 
levels of markers of endothelial activation and damage (Hassan et al. 2003; Hassan 
et al. 2004), and reduced endothelial function (Pretnar-Oblak et al. 2006), a major 
limitation is the lack of a cortical ischaemic stroke control group in these studies to 
demonstrate that endothelial dysfunction is a specific characteristic of lacunar 
ischaemic stroke, and not ischaemic stroke in general.  One recent study of blood-
brain barrier leakiness in patients with lacunar ischaemic stroke did include a control 
group of patients with cortical ischaemic stroke, and found that increased leakiness in 
arteries of the brain was present in patients with lacunar stroke (Wardlaw et al. 
2009).  It has also been suggested that lacunar infarction may be one manifestation of 
a spectrum of consequences of small vessel disease, supported in part by the 
observed association between lacunar infarction and cerebral white matter lesions 
(which are associated with vascular dementia) (Inzitari 2003) and 
microhaemorrhages (Kato et al. 2002; Wardlaw et al. 2006).  However, although 
blood brain barrier leakage may be consistent with causing diffuse, widespread white 
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matter lesions, there is some doubt as to whether such processes could cause the 
focal, well demarcated lesions that result in lacunar ischaemic stroke (Kalimo 2003).   
The aetiology of lacunar ischaemic stroke is still controversial, and there is an 
ongoing debate as to whether an intrinsic small vessel disease is indeed responsible 
for most lacunar stroke (Futrell 2004; Millikan & Futrell 1990; Norrving 2004).  The 
extent to which cardiac or carotid emboli cause lacunar ischaemic stroke is one 
particular area of controversy (Futrell 2004; Millikan & Futrell 1990; Norrving 
2004).  Many believe that embolism is the cause of only a minority of strokes, with 
the majority due to intrinsic small vessel disease (Norrving 2004), whereas others 
propose that the importance of embolism as a causal mechanism is underestimated 
(Futrell 2004).  The advent of new neuroimaging techniques, particularly diffusion 
weighted magnetic resonance imaging (which is very sensitive to small lesions, 
especially in the very acute period), has perhaps re-ignited this debate.  Multiple 
acute infarction patterns on diffusion weighted magnetic resonance imaging have 
been associated with cardiac or carotid sources of emboli, and some have suggested 
that when embolic patterns of infarction on advanced brain imaging are taken into 
account, 30-40% of lacunar strokes may be considered to be attributed to 
atherothromboembolism (Caso et al. 2005; Wessels et al. 2005).  However, these 
results contrast with those from another recent study in which the frequency of such 
embolic patterns was much lower, and the prevalence of definite embolic 
mechanisms (such as atrial fibrillation) similar to that reported in patients with single 
lacunar infarcts (Chowdhury et al. 2004).  Such ischaemic lesion patterns may be in 
keeping with an embolic mechanism of stroke, but as argued by some, may also 
reflect an underlying diffuse small vessel disease (Chowdhury et al 2004).   
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The difficulty of studying the aetiology of lacunar stroke is compounded by the co-
existence of multiple risk factors for stroke, and sometimes more than one possible 
mechanism of stroke.  In elderly patients the existence of coincidental abnormalities 
is to be expected and the contribution of various risk factors, including some cardiac 
abnormalities, to ischaemic stroke, and to lacunar stroke in particular, remains 
uncertain.   
2.4 An epidemiological approach to studying the aetiology of lacunar stroke 
Given the difficulties and limitations of the more direct approaches to investigating 
the arterial pathology of lacunar stroke, one indirect approach is to use observational 
studies to compare the epidemiological features of patients with lacunar versus non-
lacunar ischaemic stroke, since differences might provide evidence for, and 
information about, a distinct underlying lacunar arteriopathy.  There may be 
differences in the risk factor profiles, and in the risks of vascular outcomes including 
recurrent stroke and myocardial infarction.  To date, many such observational studies 
have been limited by methodological shortcomings, the potential effects of which 
have often been overlooked.  We aimed to address many of these methodological 
shortcomings in the Edinburgh Stroke Study, a cohort study of patients recruited 
from our hospital and followed for up to four years for death and recurrent vascular 
events.  Through systematic review of the literature and analysis of data from the 
Edinburgh Stroke Study and from other similar stroke registers, I addressed the 
following aim and objectives in this thesis:     
2.4.1 Aim and objectives of thesis 
My aim was to compare the epidemiological features of patients with lacunar 
ischaemic stroke versus those with non-lacunar ischaemic stroke, with the hypothesis 
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that differences in epidemiology may reflect and inform about the underlying 
arteriopathy of lacunar ischaemic stroke. 
My specific objectives were: 
1. to systematically review and synthesise (using meta-analysis where 
appropriate) the existing published data on the risk factor profiles of patients 
with lacunar compared with non-lacunar ischaemic stroke; 
2. to systematically review and synthesise (using meta-analysis where 
appropriate) the existing published data on outcome, in terms of death and 
recurrent vascular events, among patients with lacunar compared with non-
lacunar ischaemic stroke; 
3. to carry out an individual patient data analysis of ischaemic stroke subtype-
risk factor associations by pooling data from the Edinburgh Stroke Study with 
individual patient data from stroke registers from around the world that used 
a similar methodology; 
4. to determine and compare the outcome, in terms of death, recurrent stroke 
and myocardial infarction, of patients with lacunar versus non-lacunar 
ischaemic stroke using data from the Edinburgh Stroke Study.           
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Chapter 3. Risk factor profiles of lacunar versus non-lacunar 
ischaemic stroke: a systematic review and meta-analysis 
 
3.1 Aim 
In this chapter I will present the results of my systematic review and meta-analysis of 
studies comparing risk factor profiles of lacunar versus non-lacunar ischaemic stroke. 
3.2 Introduction 
Various classical risk factors, including vascular risk factors such as hypertension, 
diabetes mellitus and atrial fibrillation (Burchfiel et al. 1994; MacMahon et al. 1990; 
Prospective Studies Collaboration 2002; Rodgers et al. 1998; Wolf et al. 1991), and 
lifestyle risk factors such as cigarette smoking and alcohol excess (Hankey 1999; 
Reynolds et al. 2003), are known independently to increase the risk of ischaemic 
stroke.  What is less clear is how the risk factor profiles of different subtypes of 
ischaemic stroke differ.  Prospective studies of healthy individuals in whom risk 
factors were measured at baseline and stroke outcome data were collected have 
rarely distinguished between pathological types or subtypes of stroke (Prospective 
Studies Collaboration 2002; Rodgers et al. 1998).  Comparison of the risk factor 
profiles of lacunar versus non-lacunar ischaemic stroke may however reveal 
important differences that may suggest that there is a distinct lacunar arteriopathy.  
Hypertension and diabetes, for example, are major risk factors for all types of stroke, 
but are commonly believed to be particularly important in the causation of lacunar 
ischaemic stroke (Mohr & Stein 1998).  As described in the previous chapters, much 
of the current knowledge of the arterial pathology of lacunar ischaemic stroke is 
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based largely on Miller Fisher’s meticulous clinicopathological studies (Fisher 1968; 
Fisher 1977; Fisher 1978; Fisher 1979; Fisher & Tapia 1987).  These studies also led 
Miller Fisher to hypothesise that hypertension is a major causative factor in the 
pathogenesis of lacunar ischaemic stroke.  In an autopsy study of 1042 patients from 
a general medical ward, he identified one or more lacunes in 114 patients.  Since 111 
of these patients were found retrospectively to have a history of hypertension, Miller 
Fisher concluded that hypertension was a central causative factor for lacunar 
ischaemic stroke (Fisher 1965).  However, in only eight patients did the lacunes 
identified at autopsy correlate with the patient’s clinical presentation, indicating that 
the vast majority of the infarcts Miller Fisher studied were in fact asymptomatic.  
Diabetes has perhaps been considered to play a particular role in lacunar ischaemic 
stroke because it is known to be a risk factor for small artery occlusive disease 
affecting distal extremities and organs such as the kidney and retina.  The 
clinicopathological correlation between diabetes and lacunar ischaemic stroke is 
uncertain, with autopsy studies reporting conflicting results (Fisher CM 1965; 
Tuszynski et al. 1989).  Yet, as with hypertension, the belief that diabetes is 
particularly important in lacunar stroke has become entrenched in the literature and 
clinical teaching (Mohr & Stein 1998; Weisberg 1988). 
Since Miller Fisher’s clinico-pathological studies, further support for the particular 
role of hypertension in the pathogenesis of lacunar ischaemic stroke has stemmed 
from cross-sectional epidemiological studies comparing the risk factors of patients 
with lacunar and non-lacunar ischaemic stroke.  However, the findings from these 
studies have been inconsistent, and much controversy persists, particularly with 
respect to the relative importance of hypertension and diabetes in lacunar compared 
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with non-lacunar stroke.  While some researchers have found that these risk factors 
predispose more to lacunar than non-lacunar ischaemic stroke, others suggest that 
they are no more common in patients with lacunar than non-lacunar ischaemic 
stroke.  Several methodological problems limit the interpretation of the results of 
these epidemiological studies.  Perhaps most importantly, studies have used a variety 
of different classification methods to define lacunar and other ischaemic stroke 
subtypes.  Some used a classification primarily based on the clinical features of the 
stroke syndrome, which was usually refined by the results of brain imaging – i.e. if a 
patient’s computed tomography (CT) and / or magnetic resonance (MR) brain scan 
showed an infarct that was relevant to the presenting syndrome but whose site and 
size suggested a different stroke subtype classification from the clinical features 
alone, the patient was re-classified in line with the imaging findings.  Other studies, 
however, have included potential risk factors such as hypertension in their stroke 
subtype definitions, which could clearly bias the results of a comparison of the 
prevalence of such risk factors between subtypes.  Some studies have relied on 
imaging findings alone to classify stroke subtypes, regardless of the patients’ 
symptoms.  Some patients in these studies may have been classified on the basis of 
asymptomatic or remotely symptomatic visible infarcts.  Furthermore, patients with a 
definite ischaemic stroke but no visible infarct would not have been included. 
To critically appraise and summarise the existing published data in this area, I 
performed a systematic review and a series of meta-analyses of studies comparing 
the prevalence of risk factors in patients with lacunar versus non-lacunar ischaemic 
stroke.  In my meta-analyses I focused in particular on investigating the effect of the 
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method of classifying subtypes of ischaemic stroke subtypes on risk factor-stroke 
subtype associations. 
3.3 Methods 
3.3.1 Study identification 
I sought studies comparing the prevalence of risk factors among patients with stroke 
attributable to lacunar versus non-lacunar cerebral infarction and published in 
English up to and including November 2006.  I identified studies by a comprehensive 
text word and MeSH-based electronic search of Medline and Embase, which was 
designed to identify articles relating to ischaemic stroke subtypes, especially lacunar 
strokes (Appendices 3 and 4);  perusal of the reference lists of relevant articles 
identified; searching within books on cortical and subcortical strokes; and through 
discussions with colleagues. 
I selected potentially relevant studies from those identified in the search strategy, and 
discussed inclusion or exclusion of each study with a second reviewer (CLMS).  
Following these discussions, we decided that only studies published from 1985 
onwards should be included because the few earlier studies had very limited access 
to brain imaging, which was often restricted to younger patients.  I excluded studies 
that included highly selected groups of patients such as randomised controlled trials, 
studies in which the method used to classify ischaemic stroke subtypes was unclear, 
and studies where there were data inconsistencies or the data were in a non-
extractable format. 
3.3.2 Data extraction 
From each included study, I extracted data on: 
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• the population studied (community-based or hospital-based; inpatients or 
outpatients; consecutive recruitment or not) 
• the method of classifying ischaemic stroke subtypes 
• the proportion of males overall and in lacunar and non-lacunar groups 
• the mean (or median) age of patients overall and in lacunar and non-lacunar 
groups 
• the proportion of the study population with CT and/or MR brain imaging; 
• the definitions of risk factors 
• and the numbers of lacunar and non-lacunar patients with each of the 
following risk factors: hypertension; diabetes; ischaemic heart disease; atrial 
fibrillation; carotid stenosis; smoking; previous transient ischaemic attack 
(TIA); alcohol excess; and raised cholesterol.   
The second reviewer also independently extracted data on risk factor frequency from 
each study, and we resolved any discrepancies by discussion.    
I included in the non-lacunar comparison group all patients with non-lacunar 
ischaemic stroke apart from the small number of patients with “unusual” causes of 
stroke (e.g. arterial dissections, non-atherosclerotic vasculopathies or haematological 
disorders) for studies where these were categorised separately.  I included patients 
with posterior circulation ischaemic stroke (where these patients were presented as a 
separate group), and patients who were categorised as having an “undetermined” 
cause of stroke (in studies that used an aetiological classification of ischaemic stroke 
subtypes) in the non-lacunar comparison group. 
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3.3.3 Statistical analyses 
I stratified studies according to whether the classification used to define ischaemic 
stroke subtypes included the risk factor under study; included other risk factors, but 
not specifically the risk factor under study; was based on brain imaging alone; was 
based on clinical features of the stroke syndrome alone, but not including risk 
factors, or was based on clinical features of the stroke syndrome refined by brain 
imaging findings (but not dependent on the presence or absence of risk factors).  For 
each risk factor, I determined study-specific and pooled fixed effects odds ratios 
(ORs) with 95% confidence intervals (CIs) for lacunar versus non-lacunar ischaemic 
stroke using Cochrane RevMan software (Cochrane Collaboration 2003), and 
assessed heterogeneity using the I2 statistic, which describes the proportion of total 
variation in study estimates that is due to heterogeneity (Higgins & Thompson 2002).  
Heterogeneity can be described loosely as mild (I2 < 30), moderate (30 > I2 < 50) or 
substantial (I2 > 50) (Higgins & Thompson 2002).  I determined between-group 
heterogeneity by subtracting the subgroup χ2 values from the total χ2 value.   
In a pre-defined sensitivity analysis, I repeated the analyses but excluded patients 
with a cardioembolic stroke (excluding studies where it was not possible to separate 
cardioembolic strokes from other aetiological types).  In doing so, I was able to make 
a comparison, albeit crude, between patients with ischaemic stroke caused by 
presumed small vessel disease versus large vessel disease.  The distribution of risk 
factors and of ischaemic stroke subtypes may differ between hospitalised and non-
hospitalised patients.  Therefore, to test the robustness of the results of my primary 
analyses, in a second, post-hoc sensitivity analysis I confined my analyses to 
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community-based studies, or studies that had recruited consecutive patients from 
hospital admissions and outpatient clinics.           
3.4 Results 
From a total of 4939 studies identified from the electronic search strategy, 65 
presented risk factor data for ischaemic stroke subtypes and were potentially eligible 
for inclusion.  From these, I excluded 24 studies: two studies published prior to 1985 
(Mohr et al. 1978; Pullicino et al. 1980); 7 studies where the method of classifying 
ischaemic stroke subtypes was very unclear (Al-Shammri et al. 2003; Cupini et al. 
2002; Dulli et al. 1998; Jeng et al. 1994; Loeb 1986; Spolveri et al. 1998; Yokota et 
al. 2004); one study with data inconsistencies (Falcone et al. 2000); one study where 
the data were presented in a non-extractable format (Tanizaki et al. 2000); 10 studies 
that included highly selected groups of patients (Adams et al. 1989; Boiten et al. 
1996b; Cerrato et al. 2002a; Cerrato et al. 2002b; Halkes et al. 2006; Hupperts et al. 
1994; Inzitari et al. 2000; Lee et al. 2002; Nagai et al. 2001; Slowik et al. 2003); and 
three studies where there was probable overlap with patient populations in other 
included studies (Di et al. 2006; Iso et al. 2004; Loeb 1986; Mannami et al. 2004) 
(Figure 3.1).  Where there was definite overlap between patient populations in 
separately published studies, I included the study with the larger patient population.  
This left 40 studies (Table 3.1), including 43,989 patients, of whom 13,571 had a 
lacunar ischaemic stroke and 30,418 a non-lacunar ischaemic stroke.   





Figure 3.1 Flow diagram of included studies 
 
 
65 studies presented data on risk 
factors amongst stroke subtypes and 
were potentially eligible for inclusion  
(N = 54,780) 
24 studies 
excluded 
(N = 10,499) 
In 7 studies the method of 
classifying ischaemic stroke 
subtypes was unclear (N = 2765) 
10 studies included selected 
groups of patients (N = 3935) 
2 studies contained data 
inconsistencies or data in a non-
extractable format  
(N = 221) 
2 studies were published before 
1985 (N = 782) 
3 studies potentially overlapped 
with other studies (N = 2796) 
40 studies were included in the meta-
analysis  
(N = 43,989; 13,571 lacunar and 30,418 
non-lacunar patients)  
 
4939 studies identified from systematic 
review search strategy 
507 studies were potentially relevant based 
on initial review of titles and abstracts 
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ischaemic strokes ‡ 




Athens2 2000 Consecutive 
admissions 
71 
67 : 72 
58 





ischaemic strokes ‡ 





Barcelona3 1999 Consecutive 
admissions 
66 
67 : 68 
57 





ischaemic strokes ‡ 




Besançon4 2000 Consecutive 
admissions 
69 
68 : 69 
57 
NR : NR 
100 Imaging-based All non-lacunar 
ischaemic strokes 
with a single visible 
infarct on CT/MRI 






Boston5 2000 Consecutive 
admissions 
69 
NR : NR 
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Buenos Aires6 2001 Consecutive 
admissions 
64 
62 : 66 
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ischaemic strokes ‡ 
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Germany11 2001 Admissions 
(multicentre) 
68 
NR : NR 
58 













Grenoble12 2006 Admissions 
(multicentre) 
within a week 
of onset  
66** 
68 : 66 
62 
63 : 60 
100 Imaging-based All non-lacunar 
ischaemic strokes 








NR : NR 
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(136) 
Istanbul14 2005 Consecutive 
admissions  
64** 
NR : NR 
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admissions 
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London20  2001 Community-
based 
72 
NR : NR 
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admissions  
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67 : 71 
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CE strokes for all 
comparisons except 
AF)‡ 








1996 NR NR 
NR : NR 
NR 








BP, DM, IHD 869 
(287) 
Manchester25 1998 Acute stroke 
admissions 
NR 
NR : NR 
NR 

















Nanjing26 2006 Admissions 
within 7 days 
of symptom 
onset, minus 
patients lost to 
follow-up 
68 
67 : 69 
66 







BP, DM, IHD, 
TIA, AF, 
smoking, 





































Oxford (a)27 1990 Community-
based  
73 
72 : 41 
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Oxford (b)28 2003 Community-
based 
NR 
NR : NR 
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61 : 62 
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hours of stroke 
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67 
67 : 68 
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Seoul (a)35 1999 Admissions 
who had a CT 




61 : 61 
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Seoul (b)36 2001 Admissions 
within 7 days 














Taiwan37 1997 Consecutive 
admissions 
66 
66 : 66 
57 



















61 : 61 
75 








excluding CE  and 
unclassified infarcts 







USA (a)39 1987 Admissions 
(multicentre) 
68 
66 : 69 
47 
46 : 48 

















































56 : NR 
57 











* of publication  
† Total of 40 studies with 43,989 ischaemic stroke patients included in the lacunar versus non-lacunar comparisons, and 13571 patients with lacunar ischaemic stroke 
‡ Ischaemic strokes with unusual causes excluded - generally < 5% of ischaemic stroke patients studied 
§ Siriraj score or Guy's Hospital Stroke Diagnostic Scale was used to distinguish between ischaemic and haemorrhagic stroke in the absence of brain imaging 
¶ % of the total number of ischaemic stroke patients included (shown in final column) except where otherwise stated 
# % of total cohort studied (all ischaemic strokes ± haemorrhagic strokes) 
**median 
TOAST = Trial of Org 10172 in Acute Stroke Treatment; NINDS = National Institute of Neurological Disorders and Stroke; OCSP = Oxford Community Stroke Project; TACI = total 
anterior circulation infarction; POCI = posterior circulation infarction; BP = blood pressure; DM = diabetes mellitus; AF = atrial fibrillation; HC = hypercholesterolaemia; IHD = 
ischaemic heart disease; CS = carotid stenosis; NR = not reported; MRI = magnetic resonance imaging; CE = cardioembolic; ECG = electrocardiogram. 
 
1Murat & Erturk 2002; 2Vemmos et al. 2000; 3Marti-Vilalta & Arbroix 1999; 4Moulin et al. 2000; 5Saposnick et al. 2000; 6Saposnick et al. 2001; 7Woo et al. 1999; 8Pittock et al. 2002; 
9Mead et al. 1999; 10Kolominsky-Rabas et al. 2001; 11Grau et al. 2001; 12Amarenco et al. 2006.; 13Aszalos et al. 2002; 14Somay et al. 2006; 15Kumral et al. 1998; 16Kimura et al. 2004; 
17Bahou et al. 2004 ; 18Sacco et al. 2006; 19Tejada et al. 2003; 20Hajat et al. 2001; 21Norrving & Cronqvist 1989; 22Lindgren et al. 1994; 23Boiten & Lodder, 1991; 24Boiten et al. 1996; 
25Mead et al. 1998; 26Liu et al. 2006; 27Lodder et al. 1990; 28Schulz et al. 2003; 29Pinto et al. 2006; 30Silvestrelli et al. 2006; 31Awada & Rajeh, 1999; 32Petty et al. 1999; 33Toni et al. 
1995; 34Rothrock et al. 1993; 35Kim & Choi-Kwon 1999; 36Lee et al. 2001; 37Yip et al. 1997; 38Tegeler et al. 1997; 39Foulkes et al. 1998; 40Ohira et al. 2006; 
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Descriptions of the main types of classification methods used are given in Table 3.2.  
Twenty-three studies (34,165 patients) used classification methods that included risk 
factors in the definitions of ischaemic stroke subtypes (Aszalos et al. 2002; Awada & 
Al 1999 ; Bahou et al. 2004; Foulkes et al. 1988; Grau et al. 2001; Kim & Choi-
Kwon 1999; Kimura et al. 2004; Kolominsky-Rabas et al. 1998; Kumral et al. 1998; 
Lee et al. 2001; Liu et al. 2006; Marti-Vilalta & Arboix 1999; Murat & Erturk 2002; 
Petty et al. 1999; Pinto et al. 2006; Rothrock et al. 1993; Saposnik et al. 2000; 
Saposnik et al. 2001; Schulz & Rothwell 2003; Silvestrelli et al. 2002; Vemmos et 
al. 2000; Woo et al. 1999; Yip et al. 1997).  Eleven of these used the original 
TOAST classification (Bahou et al. 2004; Kolominsky-Rabas et al. 1998; Kumral et 
al. 1998; Lee et al. 2001; Murat & Erturk 2002; Rothrock et al. 1993; Saposnik et al. 
2000; Saposnik et al. 2001; Silvestrelli et al. 2002; Vemmos et al. 2000; Yip et al. 
1997), in which the presence of hypertension and diabetes favours a diagnosis of 
lacunar infarction, and carotid stenosis of > 50% and potential sources of cardiac 
embolism precludes a diagnosis of lacunar infarction. (Table 3.2). 
In 5 studies, most of which were published more recently, the authors stated that they 
used a “modified” TOAST classification (Grau et al. 2001; Kim & Choi-Kwon 1999;  
Liu et al. 2006; Pinto et al. 2006; Schulz & Rothwell 2003).  This appears to be 
similar to the original TOAST classification, but does not consider the presence of 
hypertension and diabetes to favour a diagnosis of lacunar infarction, although a 
“modified” TOAST classification has not been formally described in the literature. 
The remaining 8 studies that used a risk factor-based classification method used the 
National Institute of Neurological Disorders and Stroke (NINDS) classification 
method (Table 3.2), or similar.    
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Based on risk 
factors as well as 





















Ischaemic stroke classified into one of 5 categories: 
Large artery atherosclerosis: Clinical findings include cortical, cerebellar, or brain stem dysfunction and on brain 
imaging cortical, cerebellar, brain stem or subcortical lesions > 1.5 cm are considered to be of potential large artery 
atherosclerotic origin.  Diagnosis requires supportive evidence by duplex imaging or arteriography of > 50% stenosis 
of an appropriate intracranial or extracranial artery.  Potential sources of cardiogenic embolism, such as AF should be 
excluded, and history of TIAs in the same vascular territory supports the clinical diagnosis. 
Cardioembolism:Clinical and brain imaging findings are similar to those described for large artery atherosclerosis.  At 
least 1 cardiac source of embolism, such as AF, must be identified.  Previous TIAs in > 1 vascular territory supports 
the diagnosis.  Potential large artery atherosclerotic sources of thrombosis or embolism should be absent.   
Lacunar: Clinical findings of one of the lacunar syndromes should be present.  Brain imaging should be normal or 
show a relevant brain stem or subcortical hemispheric lesion of diameter < 1.5 cm.  A history of diabetes mellitus or 
hypertension supports the diagnosis.  Potential cardiac sources of embolism, such as AF, should be absent, and the 
large extracranial arteries should not demonstrate > 50% stenosis. 
Undetermined aetiology: Includes patients with ≥ 2 potential causes of stroke (e.g., AF and > 50% stenosis of 
extracranial arteries) and patients with an unidentified cause of stroke (following either complete or incomplete 
investigation 
Other determined aetiology: Includes patients with rare causes of stroke (e.g., non-atherosclerotic vasculopathies and 
haematologic disorders). 
 
Large artery atherosclerosis: Clinical and brain imaging findings as described in TOAST.  A history of TIAs is 
considered more common than among those with other types of stroke.  Clinical diagnosis rests on finding evidence of 
arterial stenosis or occlusion at ≥ 1 sites. 
Cardioembolism: Clinical and brain imaging findings as described in TOAST.  The basis for the clinical diagnosis is 
the demonstration of a cardiac-transcardiac source of embolism (such as AF) and no evidence of other causes of stroke. 
Lacunar: Clinical findings of a lacunar syndrome with normal brain imaging or relevant lesion.  No mention of risk 
factors that specifically support a lacunar diagnosis. 
Undetermined aetiology: Cerebral infarction in the absence of stenosis or occlusion of extracranial or intracranial 
arteries, cardiac sources of embolism, or other demonstrable mechanism. 
Other determined aetiology: As in TOAST classification. 
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Based on brain 
imaging only 
 
Site and size of visible infarction on CT or MRI scan used to classify stroke subtypes irrespective of patient’s symptoms.   
Patients with a definite ischaemic stroke but no visible lesion excluded. 
Based on clinical 
features only 
eg, OCSP (not 
modified by 
imaging) 
Clinical stroke syndrome (eg TACI, PACI, LACI and POCI) used to assign stroke subtype. 
Syndromes are not revised in light of brain imaging findings. 
Based on clinical 





Clinical stroke syndrome (eg TACI, PACI, LACI and POCI) assigned to each patients, which is then revised in light of site 
and size of any relevant infarct seen on CT or MRI scan. 
 
 
TOAST = Trial of Org 10172 in Acute Stroke Treatment; NINDS = National institute of Neurological Disorders and Stroke: Classification of Cerebrovascular 
Diseases III; AF = atrial fibrillation; TIA = transient ischaemic attack; OCSP = Oxfordshire Community Stroke Project classification; TACI = total anterior circulation 
stroke; PACI = partial anterior circulation stroke; LACI = lacunar infarction; POCI = posterior circulation infarction. 
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Four studies (2530 patients) defined ischaemic stroke subtypes on the basis of size 
and location of infarction on imaging alone (Amarenco et al. 2006; Moulin et al. 
2000; Ohira et al. 2006; Tejada et al. 2003).  In 10 studies (6706 patients), ischaemic 
subtypes were defined according to the clinical features of the stroke syndrome (but 
not including risk factors), refined where appropriate by the site and size of any 
relevant lesion seen on brain imaging (Boiten et al. 1996a;  Boiten & Lodder 1991; 
Hajat et al. 2001; Lodder et al. 1990; Mead et al. 1999b; Norrving & Cronqvist 
1989; Sacco et al. 2006; Somay G et al. 2006; Tegeler et al. 1991; Toni et al. 1995) 
(Table 3.1).  Three studies (588 patients) defined ischaemic subtypes on the basis of 
clinical features of stroke syndrome but not modified by brain imaging findings 
(Lindgren et al. 1994b; Mead et al. 1998; Pittock et al. 2003), and in my analyses I 
grouped these with clinical and imaging-based studies, since the study populations 
were very small, and excluding them from this category did not affect the summary 
odds ratio for any risk factor.   
7 studies (5406 patients) were community-based, whereas 33 (38,583 patients) were 
hospital-based, mostly recruiting hospital admissions (Table 3.1).  The mean age of 
the patients was higher in the community- than in the hospital-based studies 
(weighted mean age 72 versus 68 years), and the proportion of males was lower in 
the community-based studies (48% versus 58%).  
Just over half of all studies included presented the mean ages of lacunar and non-
lacunar patients, which were similar (weighted mean 69 versus 70 years).  The 
proportion of males among lacunar patients was slightly higher than among non-
lacunar patients (58% versus 54%).  Thirty four studies provided data on the number 
of patients who had brain imaging performed, with 27 studies reporting that 100% of 
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patients had brain imaging.  The non-lacunar comparison group varied across studies, 
due to the differing methods used to classify ischaemic stroke subtypes and the 
additional exclusion criteria employed in some studies.  Presumed cardioembolic 
strokes were excluded from the study population in six studies, posterior circulation 
strokes were excluded in two studies, and total anterior circulation and posterior 
circulation strokes were excluded in one study (Table 3.1).  The definitions of risk 
factors used by each study are given in Table 3.3. 
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Table 3.3 Definitions of risk factors in included studies* 
 Hypertension Diabetes†   
 





















Ankara1 Pre or 
post 








within 5 years 
ND > 5.7 ND ND 
Athens2 Pre 160/90 Pre  Fasting > 
6.0 




ND > 6.5 ND ND 
Barcelona3 Pre or 
post 













Besançon4 NR NR NR NR NR NR NR NR ND ND 
Boston5  Pre or 
post 

















> 5.7 ND ND 
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Table 3.3 (continued) 
 
 Hypertension Diabetes†   
 





















Cincinnati7 Pre NR Pre NR ND Current 
smoking 
ND ND ND ND 
Dublin8 NR NR NR NR History of 
MI or angina 
Current or ex-
smoking 
ND ND ND ND 
Edinburgh9 ND ND ND ND ND ND ND ND > 70% Ultrasound 
Erlangen10 Pre or 
post 















ND ND ND ND 
Germany11 Pre 160/90 Pre or 
post 





> 5.7 before 
stroke or on 
lipid-lowering 
medication 
ND ND  
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Table 3.3 (continued) 
 
 Hypertension Diabetes†   
 





















Grenoble12 Pre - Pre NR ND Current 
smoking 




Hungary13 Pre or 
post 




ND ND ND ND ND 
Istanbul14 Pre or 
post 





angina or MI 
Current 
smoking 
within the last 
12 months 
NR Fasting 













Japan16 Pre 160/95 Pre or 
post 
NR ND Current 
smoking 





Table 3.3 (continued) 
 Hypertension Diabetes†   
 





















Jordan17 NR NR NR NR NR NR ND NR ND ND 
L'Aquila18 Pre or 
post 
150/90 Pre Fasting > 
7.8 
NR Daily smoking 
within at least 







> 5.7 > 50% Ultrasound 
Leon19 Pre or 
post 








type signs on 
ECG 
Current 
smokers of at 
least 10 
cigarettes/day 
in the previous 
6 months and 
ex-smokers 
with a similar 
consumption 
for 6 months 





NR NR NR 
London20 Pre 160/95 Pre Fasting > 
7.8 
History of 
MI or angina 
Ever smoked ND ND ND ND 
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Table 3.3 (continued) 
 
 Hypertension Diabetes†   
 





















Lund (a)21 Pre or 
post 







NR ≥ 50% Catheter 
angiography 





160/90 Pre or 
post 
NR NR ND ND  ND ≥ 50% Ultrasound 
Maastricht 
(b)24 
NR NR NR NR NR ND ND ND ND ND 
Manchester25 ND ND ND ND ND ND ND ND > 70% Ultrasound 
Nanjing26 Pre or 
post 















Table 3.3 (continued) 
 
 Hypertension Diabetes†   
 






























Ever smoked ND ND ND ND 
Oxford (b)28 Pre 160/95  Pre NR ND Current 
smoking 
ND ND ND ND 
Palermo29 Pre NR NR NR ND NR ND NR ND ND 
Perugia30 NR NR NR NR ND Current 
smoking 
NR NR ND ND 
Riyadh31 Pre or 
post 












Table 3.3 (continued) 
 
 Hypertension Diabetes†   
 





















Rochester32 NR NR NR NR History of 
MI or angina 
NR ND ND ND ND 
Rome33 NR NR NR NR ND NR ND ND ND ND 
San Diego34 NR NR NR NR NR ≥ 5 
cigarettes/day 
at time of 
stroke 
ND ND ND ND  




ND ND ND 
Seoul (b)36 Pre or 
post 






ND > 5.7 ND ND 




Texas38 NR NR NR NR ND NR ND ND ≥ 50% Ultrasound 
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USA (a)39 Pre NR Pre NR History of 
MI or angina 
ND ND ND ND ND 









*Definitions for prior transient ischaemic attack and atrial fibrillation not shown. 
† Values converted from mg/dl to mmol by multiplying by 0.055 
‡ Values converted from grams into UK units where necessary (1unit = 8g) 
¶ Values converted from mg/dl to mmol by multiplying by 0.02586 
# Cut-off used when diabetes is defined according to blood glucose measurements post-stroke 
ND = not determined; the risk factor concerned was either not studied or extractable data were not given in the publication(s); NR = not reported, even though the risk factor concerned 
was studied; MRA = magnetic resonance angiography 
 
1Murat & Erturk 2002; 2Vemmos et al. 2000; 3Marti-Vilalta & Arbroix 1999; 4Moulin et al. 2000; 5Saposnick et al. 2000; 6Saposnick et al. 2001; 7Woo et al. 1999; 8Pittock et al. 2002; 
9Mead et al. 1999; 10Kolominsky-Rabas et al. 2001; 11Grau et al. 2001; 12Amarenco et al. 2006; 13Aszalos et al. 2002; 14Somay et al. 2006; 15Kumral et al. 1998; 16Kimura et al. 2004; 
17Bahou et al. 2004 ; 18Sacco et al. 2006; 19Tejada et al. 2003; 20Hajat et al. 2001; 21Norrving & Cronqvist 1989; 22Lindgren et al. 1994; 23Boiten & Lodder 1991; 24Boiten et al. 1996; 
25Mead et al. 1998; 26Liu et al. 2006; 27Lodder et al. 1990; 28Schulz et al. 2003; 29Pinto et al. 2006; 30Silvestrelli et al. 2006; 31Awada & Rajeh 1999; 32Petty et al. 1999; 33Toni et al. 
1995; 34Rothrock et al. 1993; 35Kim & Choi-Kwon 1999; 36Lee et al. 2001; 37Yip et al. 1997; 38Tegeler et al. 1997; 39Foulkes et al. 1998; 40Ohira et al. 2006; 
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3.4.1 Hypertension 
A total of 37 studies (42,760 patients, 13,227 with lacunar ischaemic stroke) 
presented data on hypertension.  Of the 30 studies that reported a definition of 
hypertension, most defined it on the basis of raised blood pressure before or after the 
stroke (Table 3.3). 
Overall, hypertension was commoner among patients with lacunar then non-lacunar 
ischaemic stroke (pooled OR 1.60, 95% CI 1.53 to 1.68).  However, there was 
substantial heterogeneity between individual studies (I2 = 73%), partly arising from 
the different methods used to define ischaemic stroke subtypes (Figure 3.2). 
The excess of hypertension in patients with lacunar as compared with non-lacunar 
ischaemic stroke was most noticeable among studies in which the presence of 
hypertension favoured a diagnosis of lacunar ischaemic stroke, with an almost two-
fold increase in the prevalence of hypertension among lacunar compared with non-
lacunar patients (OR 1.98, 95% CI 1.76 to 2.23).  Interestingly, this excess of 
hypertension was also present among studies that included risk factors other than 
hypertension when defining ischaemic stroke subtypes (OR 1.66, 95% CI 1.57 to 
1.76).  The increased prevalence of hypertension among those with lacunar 
ischaemic stroke was much less extreme (OR 1.26, 95% CI 1.12 to 1.41; Figure 3.2) 
in studies that used a clinical and imaging-based risk factor-free classification. 
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 Figure 3.2 Odds ratios for hypertension (lacunar versus non-lacunar) 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
†This study defined subtypes according to clinical syndrome only (not modified by brain imaging).   
The diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with hypertension; OR = 
Odds ratio; CI = confidence interval.  Heterogeneity between four groups: χ23df












































OR (95% CI) Study* 
Lacunar Non-lacunar 
52 / 66 
142 / 177 
90 / 109 
81 / 105 
86 / 120 
158 / 198 
87 / 103 
444 / 642 
89 / 133 
154 / 215 
166 / 195 
1549 / 2063 
101 / 198 
435 / 673 
171 / 301 
97 / 129 
218 / 402 
941 / 1331 
32 / 40 
574 / 1007 
156 / 315 
479 / 754 
254 / 442 
3458 / 5592 
305 / 399 
33 / 39 
806 / 1028 
112 / 136 
4143 / 6146 
64 / 123 
12 / 20 
30 / 38 
141 / 248 
54 / 72 
33 / 49 
253 / 337 
1179 / 2321 
82 / 128 
2421 / 3814 
217 / 299 
5027 / 8718 
216 / 487 
45 / 81 
66 / 109 
269 / 370 
70 / 104 
608 / 936 
5986 / 8635 10429 / 17875 
153 / 243 
49 / 105 
42 / 105 
369 / 658 
580 / 1019 
163 / 302 
146 / 326 
949 / 1772 
27 / 48 29 / 69 
166 / 272 
335 / 491 
173 / 282 
32 / 61 
51 / 103 
138 / 287 
45 / 102 
95 / 170 
33 / 55 
1095 / 1871 
84 / 152 
1383 / 2153 
310 / 580 
27 / 61 
35 / 94 
260 / 582 
161 / 347 
30 / 54 
2414 / 4294 
8999 / 13227 17250 / 29533 
3.57 (1.86 to 6.85) 
2.22 (1.48 to 3.32) 
3.60 (2.09 to 6.21) 
1.11 (0.61 to 2.04) 
2.13 (1.37 to 3.32) 
1.64 (1.13 to 2.36) 
1.36 (0.53 to 3.48) 
1.69 (1.37 to 2.08) 
2.06 (1.35 to 3.15) 
1.45 (1.04 to 2.02) 
4.24 (2.74 to 6.56) 
1.98 (1.76 to 2.23) 
3.14 (2.46 to 4.02) 
3.09 (1.20 to 7.91) 
2.09 (1.78 to 2.46) 
1.76 (1.06 to 2.93) 
1.52 (1.42 to 1.63) 
1.36 (0.92 to 2.02) 
1.20 (0.44 to 3.25) 
2.44 (1.02 to 5.83) 
1.61 (1.18 to 2.18) 
1.13 (0.63 to 2.01) 
1.00 (0.49 to 2.07) 
229 / 508 
1.62 (1.23 to 2.15) 
1.66 (1.57 to 1.75) 
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3.4.2 Diabetes mellitus 
Thirty-six studies (42,325 patients, 13,091 with lacunar ischaemic stroke) presented 
data on diabetes mellitus.  Half of the studies gave a clear definition of diabetes, 
generally comprising a history of diabetes before or after the stroke or raised fasting 
blood glucose during admission (Table 3.3).  Overall, diabetes appeared to be almost 
one fifth more common in patients with lacunar than non-lacunar ischaemic stroke 
(OR 1.18, 95% CI 1.13 to 1.24), but there was moderate heterogeneity between 
studies (Figure 3.3).  However, when stratified by ischaemic stroke subtype 
classification method, this association was confined to those studies that used a 
classification method where diabetes favoured a definition of lacunar ischaemic 
stroke (OR 1.38, 95% CI 1.23 to 1.55), and among studies that included risk factors 
other than diabetes in the ischaemic subtype definitions (OR 1.18, 95% CI 1.11 to 
1.25).  Among studies using a risk factor-free classification, there was no difference 
in the prevalence of diabetes in patients with lacunar versus non-lacunar ischaemic 












Figure 3.3 Odds ratios for diabetes (lacunar versus non-lacunar) 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
†This study defined subtypes according to clinical syndrome only (not modified by brain imaging).  
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with diabetes; CI = 
confidence interval.  Heterogeneity between four groups: χ23df = 17.0; p < 0.001.  
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3.4.3 Ischaemic heart disease 
24 studies (19,062 patients, 4779 with lacunar ischaemic stroke) presented data on 
IHD.  Twelve studies gave a definition of IHD, most commonly defined as a history 
of myocardial infarction or angina.  Overall IHD was significantly less frequent in 
lacunar than non-lacunar ischaemic stroke (pooled OR 0.73, 95% CI 0.67 to 0.79; 
Figure 3.4), although there was substantial heterogeneity between studies.  The 
association was more extreme among studies that used a risk factor-based 
classification method (OR 0.64, 95% CI 0.57 to 0.72).  However, among studies that 
used a factor-free classification method, the association was marginal, with an upper 
confidence limit compatible with no difference in prevalence of IHD between 
lacunar and non-lacunar ischaemic stroke (OR 0.87, 95% CI 0.76 to 1.00; Figure 
3.4). 
3.4.4 Atrial fibrillation 
19 studies (27,971 patients, 9716 with lacunar ischaemic stroke), reported on 
prevalence of AF.  Overall, AF was less common among patients with lacunar than 
non-lacunar ischaemic stroke (OR 0.14; 95% CI 0.13 to 0.16; Figure 3.5), but with 
substantial heterogeneity between studies.  The association between AF and non-
lacunar ischaemic stroke was particularly strong among studies in which the presence 
of AF favoured a diagnosis of non-lacunar ischaemic stroke (pooled OR 0.09, 95% 
CI 0.08 to 0.10), although there was substantial heterogeneity between studies (I2 = 
82%).  The association was less extreme among studies using a clinical and imaging-
based risk factor-free classification (OR 0.43, 95% CI 0.36 to 0.51), with moderate 
heterogeneity between studies. 
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Figure 3.4 Odds ratios for ischaemic heart disease (lacunar versus non-lacunar) 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
†This study defined subtypes according to clinical syndrome only (not modified by brain imaging).   
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with IHD;  
CI = confidence interval; IHD = ischaemic heart disease.   
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Figure 3.5 Odds ratios for atrial fibrillation (lacunar versus non-lacunar) 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
†These studies defined subtypes according to clinical syndrome only (not modified by brain imaging). 
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with AF; OR = odds 
ratio; CI = confidence interval; AF = atrial fibrillation.   
Heterogeneity between 2 groups: χ21df
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3.4.5 Carotid stenosis 
Nine studies (3850 patients, 1074 with lacunar ischaemic stroke) reported data on 
ipsilateral internal carotid artery (ICA) stenosis among stroke subtypes.  Definitions 
of severe stenosis varied, but > 50% or > 70% ICA stenosis on ultrasound were the 
commonest (Table 3.3).  Four of the studies also gave data on contralateral ICA 
stenosis.  Overall there was a lower prevalence of ipsilateral carotid stenosis in 
patients with lacunar compared with non-lacunar ischaemic stroke (OR 0.22, 95% CI 
0.17 to 0.29; Figure 3.6).  However, this association was again more extreme among 
studies where severe stenosis favoured a definition of non-lacunar ischaemic stroke 
(pooled OR 0.07, 95% CI 0.02 to 0.22) and less pronounced among studies using 
clinical and imaging-based risk factor-free ischaemic subtype definitions (OR 0.26, 
95% CI 0.19 to 0.34).  The findings were similar for contralateral stenosis, where all 
studies were clinical and imaging-based (OR 0.18, 95% CI 0.09 to 0.37). 
3.4.6 Smoking 
Thirty-three studies (39,986 patients, 12,364 with lacunar ischaemic stroke) reported 
data on smoking.  Overall, smoking was significantly more common among lacunar 
as compared with non-lacunar ischaemic stroke (pooled OR 1.21, 95% CI 1.15 to 
1.28), although there was moderate heterogeneity between studies (Figure 3.7).  This 
is a little surprising if the hypothesis that lacunar stroke is largely not due to 
atherosclerosis is indeed true, given the presumed pro-atherosclerotic properties of 
tobacco.  I observed a similar result when I included only studies that used a clinical 
and imaging-based risk factor free classification method (pooled OR 1.12, 95% CI 
0.98 to 1.28), although there was substantial heterogeneity between studies which 
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appeared to be mainly due to the results of one outlying study based in Texas 
(Tegeler et al. 1991). 
   
Figure 3.6 Odds ratios for (a) ipsilateral carotid stenosis and (b) contralateral carotid 




*For study references, refer to Table 3.1 (references included in footnotes to table) 
†These studies defined subtypes according to clinical syndrome only (not modified by brain imaging). 
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with carotid stenosis; 
OR = odds ratio; CI = confidence interval; CS = carotid stenosis.   
Heterogeneity between 2 groups for ipsilateral stenosis: χ21df = 5.35; p < 0.01   
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Figure 3.7 Odds ratios for smoking (lacunar versus non-lacunar) 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
†This study defined subtypes according to clinical syndrome only (not modified by brain imaging). 
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients exposed to smoking; 
OR = odds ratio; CI = confidence interval 
Heterogeneity between 3 groups: χ22df = 1.6; p = 0.1 
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3.4.7 Raised cholesterol 
Twenty studies (35,158 patients, 10,821 with lacunar ischaemic stroke) presented 
data on raised cholesterol.  Overall raised cholesterol appeared to be more strongly 
associated with lacunar than non-lacunar ischaemic stroke (pooled OR 1.34, 95% CI 
1.27 to 1.42; Figure 3.8), with substantial heterogeneity between studies (I2 = 56%).  
When only clinical and imaging-based studies were considered, there was a non-
significant trend towards raised cholesterol being more common in lacunar ischaemic 
stroke (pooled OR 1.21, 95% CI 1.00 to 1.46).  
3.4.8 Previous TIA  
Twenty-one studies (18,799 patients, 4628 with lacunar ischaemic stroke) presented 
data on previous TIA.  There was no clear stronger association between previous 
TIA and either lacunar or non-lacunar ischaemic stroke, irrespective of the method 
used to classify ischaemic strokes subtypes (overall pooled OR 0.92, 95% CI 0.83 to 
1.02; Figure 3.9).  There was however moderate heterogeneity between studies that 
included TIA in the definition of ischaemic stroke subtypes, and substantial 
heterogeneity between studies that used risk factor-free clinical and imaging-based 
classification methods.    
3.4.9 Alcohol Excess 
Thirteen studies (11,966 patients, 3419 with lacunar ischaemic stroke) presented data 
on alcohol excess.  As with previous TIA, excess alcohol consumption did not appear 
to be more strongly associated with either lacunar or non-lacunar ischaemic stroke, 
irrespective of ischaemic stroke subtype classification method, with very little 
heterogeneity between studies overall (overall pooled OR 1.11, 95% CI 0.98 to 1.26; 
Figure 3.10). 
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Figure 3.8 Odds ratios for raised cholesterol (lacunar versus non-lacunar) 
 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with raised 
cholesterol; OR = odds ratio; CI = confidence interval 
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Figure 3.9 Odds ratios for prior TIA (lacunar versus non-lacunar) 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
†TIA included in definition of some non-lacunar ischaemic stroke subtypes 
‡This study defined subtypes according to clinical syndrome only (not modified by brain imaging) 
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with prior TIA;  
OR = odds ratio; CI = confidence interval; TIA = transient ischaemic attack 
Heterogeneity between 3 groups: χ22df = 1.65; p < 0.1 
 
 



























TIA included in definition† 
Clinical & Imaging-based 
Study* 
Lacunar Non-lacunar 
13 / 177 90 / 673 
36 / 399 245 / 2321 
128 / 1028 464 / 3814 
30 / 198 247 / 1331 
20 / 123 69 / 487 
3 / 20 15 / 81 
18 / 38 27 / 109 
49 / 642 78 / 1007 
12 / 72 63 / 370 
16 / 133 39 / 315 
9 / 214 37 / 754 
42 / 324 148 / 840 
n / N n / N 
382 / 3472 1530 / 12142 
47 / 243 178 / 1019 
29 / 205 31 / 125 
76 / 448 209 / 1144 
11 / 48 19 / 69 
11 / 272 16 / 152 
15 / 61 20 / 61 
18 / 102 37 / 202 
39 / 170 42 / 347 
4 / 55 3 / 54 
98 / 708 137 / 885 
556 / 4628 1876 / 14171 
6 / 103 8 / 40 
0.51 (0.28 to 0.94) 
0.84 (0.58 to 1.21) 
1.03 (0.83 to 1.27) 
0.78 (0.52 to 1.18) 
1.18 (0.68 to 2.02) 
0.78 (0.20 to 2.99) 
2.73 (1.26 to 5.91) 
0.98 (0.68 to 1.43) 
0.97 (0.50 to 1.92) 
0.97 (0.52 to 1.80) 
0.85 (0.40 to 1.78) 
0.70 (0.48 to 1.01) 
0.90 (0.80 to 1.02) 
1.13 (0.79 to 1.62) 
0.50 (0.28 to 0.88) 
0.90 (0.66 to 1.22) 
0.78 (0.33 to 1.84) 
0.36 (0.16 to 0.79) 
0.96 (0.51 to 1.78) 
2.16 (1.34 to 3.50) 
1.33 (0.28 to 6.26) 
1.05 (0.79 to 1.40) 
0.92 (0.83 to 1.02) 
0.25 (0.08 to 0.77) 
 0.67 (0.30 to 1.47) 
χ212df = 21.5; p = 0.04 
I2 = 44% 
Prior TIA more common 
in non-lacunar stroke 
Prior TIA more common 
in lacunar stroke 
OR (95% CI) OR  
χ21df = 5.8; p = 0.02 
I2 = 83% 
χ25df = 17.6; p < 0.01 
I2 = 72% 
χ220df = 45.8; p < 0.01 
I2 = 56% 
Heterogeneity 
between studies  
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Figure 3.10 Odds ratios for excess alcohol (lacunar versus non-lacunar) 
 
*For study references, refer to Table 3.1 (references included in footnotes to table) 
The open diamond represents the overall pooled OR.  N = total number of patients, n = number of patients with history of 
excess alcohol; OR = odds ratio; CI = confidence interval 
Heterogeneity between 3 groups: χ22df = 0.98; p < 0.1 
0.1 1 10 
Study* 
Lacunar Non-lacunar 
n / N n / N OR (95% CI) 
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Other risk factors included in definitions 
7 / 109 24 / 301 
39 / 105 33 / 129 
111 / 1028 352 / 3814 
30 / 123 100 / 487 
20 / 49 45 / 104 
34 / 195 45 / 442 
287 / 2251 697 / 6284 





33 / 243 98 / 1019 
53 / 205 40 / 125 
1 / 105 11 / 326 






30 / 272 16 / 152 
3 / 61 2 / 61 
72 / 615 104 / 793 
446 / 3419 950 / 8547 
39 / 282 86 / 580 
Clinical & imaging-based 
0.79 (0.33 to 1.89) 
1.72 (0.98 to 3.01) 
1.19 (0.95 to 1.49) 
1.25 (0.78 to 1.99) 
0.90 (0.45 to 1.80) 
0.90 (0.58 to 1.40) 
1.16 (1.00 to 1.36) 
1.24 (0.83 to 1.85) 
1.48 (0.97 to 2.25) 
0.74 (0.45 to 1.21) 
0.28 (0.04 to 2.16) 
1.03 (0.75 to 1.41) 
1.05 (0.55 to 2.00) 
0.53 (0.25 to 9.47) 
0.97 (0.70 to 1.36) 
1.11 (0.98 to 1.26) 
0.92 (0.61 to 1.39) 
χ26df = 4.7; p = 0.59 
I2 = 0% 
Excess alcohol more 
common in non-
lacunar stroke 
Excess alcohol  
more common in 
lacunar stroke 
OR 
χ22df = 6.1; p = 0.05 
I2 = 67% 
χ22df = 0.4; p = 0.8 
I2 = 0% 
χ212df = 12.1; p = 0.44 
I2 = 1% 
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3.4.10 Sensitivity Analyses 
When I excluded patients from the non-lacunar comparison group whose stroke was 
thought to be due to a cardiac source of emboli the results were generally similar to 
those of the primary analysis, although the summary odds ratio for each sub-group of 
studies was generally less extreme (Table 3.4).  This may have been partly a 
consequence of reduced power, since fewer studies were included in the sensitivity 
analyses.       
When I included only community-based studies and hospital-based studies that 
recruited from both inpatients and outpatients, the results were similar to those 
















Table 3.4 Sensitivity analyses showing summary odds ratios (lacunar vs non-lacunar) for (1) studies where cardioembolic strokes could be excluded 
from the non-lacunar comparison group and (2) only studies that are community-based, or hospital-based including both inpatients and outpatients 
Primary analysis 
Cardioembolic strokes excluded from non-
lacunar comparison group 
Community-based studies or those 




No. of studies / 
total patients / 
lacunar patients OR (95% CI) 
No. of studies /     
total patients / 
lacunar patients OR (95% CI) 
No. of studies / 
total patients / 
lacunar patients OR (95% CI) 
Hypertension HT included in 
definitions 
11 / 7655 / 2063 1.98 (1.76 to 2.23) 11 / 5542 / 2063 1.80 (1.58 to 2.04) 2 / 970 / 253 2.10 (1.54 to 2.85) 
 Other risk factors 
included 
12 / 26510 / 8635 1.66 (1.57 to 1.75) 9 / 18892 / 1828 1.31 (1.22 to 1.39) 2 / 543 / 92 1.14 (0.69 to 1.89) 
 Imaging-based 4 / 2430 / 658 1.12 (0.93 to 1.36) 1 / 431 / 105 2.05 (0.53 to 1.29) 2 / 761 / 310 1.17 (0.86 to 1.61) 
 Clinical and 
imaging-based 
10 / 6165 / 1871 1.26 (1.12 to 1.41) 3 / 428 / 219 1.45 (0.99 to 2.13) 4 / 3919 / 930 1.21 (1.03 to 1.41) 
 Total 37 / 42760 / 13227 1.60 (1.53 to 1.68) 24 / 25293 / 10515 1.39 (1.31 to 1.47) 10 / 6193 / 1585 1.32 (1.16 to 1.41) 
Diabetes Diabetes included 
in definitions 
11 / 7655 / 2063 1.38 (1.23 to 1.55) 11 / 5542 / 2063 1.13 (1.00 to 1.28) 2 / 970 / 253 1.44 (1.05 to 1.98) 
 Other risk factors 
included 
11 / 26075 / 8499 1.18 (1.11 to 1.25) 10 / 19342 / 8251 0.95 (0.89 to 1.02) 2 / 543 / 92 1.04 (0.59 to 1.85) 
 Imaging-based 4 / 2430 / 658 1.21 (0.96 to 1.52) 2 / 756 / 210 1.27 (0.85 to 1.90) 2 / 761 / 310 1.29 (0.89 to 1.87) 
 Clinical and 
imaging-based 
10 / 6165 / 1871 0.95 (0.82 to 1.10) 3 / 428 / 219 1.06 (0.67 to 1.69) 3 / 3810 / 875 0.93 (0.77 to 1.12) 





Table 3.4 continued 
Primary analysis 
Cardioembolic strokes excluded from non-
lacunar comparison group 
Community-based studies or those 




No. of studies / 
total patients / 
lacunar patients OR (95% CI) 
No. of studies /    
total patients / 
lacunar patients OR (95% CI) 
No. of studies / 
total patients / 
lacunar patients OR (95% CI) 
Ischaemic 
heart disease 
Other risk factors 
included 
13 / 11830 / 2785 0.64 (0.57 to 0.72) 12 / 8540 / 2599 0.78 (0.69 to 0.88) 3 / 1280 / 325 0.60 (0.46 to 0.80) 
 Imaging-based 3 / 2023 / 553 0.78 (0.58 to 1.04) 1 / 431 / 105 0.43 (0.12 to 1.46) 2 / 761 / 310 0.72 (0.41 to 1.27) 
 Clinical and 
imaging-based 
8 / 5539 / 1646 0.87 (0.76 to 1.00) 3 / 623 / 266 0.58 (0.40 to 0.82) 3 / 3810 / 875 0.88 (0.74 to 1.05) 
 Total 24 / 19062 / 4779 0.73 (0.67 to 0.79) 16 / 9594 / 2970 0.75 (0.67 to 0.84) 8 / 5851 / 1510 0.78 (0.68 to 0.91) 
Atrial 
fibrillation 
AF included in 
definitions 
9 / 20791 / 7900 0.09 (0.08 to 0.10) 8 / 15628 / 7834 0.58 (0.51 to 0.67) - - 
 Other risk factors 
included in 
definitions 
1 / 756 / 248 0.10 (0.04 to 0.25) - - - - 
 Clinical and 
imaging-based 
8 / 4860 / 1023 0.43 (0.36 to 0.51) - - 3 / 3810 / 875 0.47 (0.38 to 0.58) 









Table 3.4 continued 
Primary analysis 
Cardioembolic strokes excluded from non-
lacunar comparison group 
Community-based studies or those 




No. of studies / 
total patients / 
lacunar patients OR (95% CI) 
No. of studies /    
total patients / 
lacunar patients OR (95% CI) 
No. of studies / 
total patients / 





2 / 2166 / 393 0.07 (0.02 to 0.22) 2 / 2642 / 393 0.12 (0.04 to 0.36) - - 
 Clinical and 
imaging-based 
7 / 3850 / 1074 0.26 (0.19 to 0.34) - - 3 / 930 / 405 0.32 (0.22 to 0.46) 





4 / 661 / 279 0.18 (0.09 to 0.37) - - 1 / 109 / 55 0.11 (0.02 to 0.50) 
 Total 4 / 661 / 279 0.18 (0.09 to 0.37) - - 1 / 109 / 55 0.11 (0.02 to 0.50) 
Smoking Other risk factors 
included 
21 / 32457 / 10225 1.23 (1.16 to 1.31) 20 / 23857 / 9977 0.97 (0.91 to 1.03) 4 / 1513 / 345 1.76 (1.35 to 2.30) 
 Imaging-based 4 / 2430 / 658 1.23 (1.01 to 1.49) - - - - 
 Clinical and 
imaging-based 
8 / 5099 / 1481 1.12 (0.98 to 1.28) 2 / 231 / 116 1.98 (0.32 to 0.89) - - 








Table 3.4 continued 
Primary analysis 
Cardioembolic strokes excluded from non-
lacunar comparison group 
Community-based studies or those 




No. of studies / 
total patients / 
lacunar patients OR (95% CI) 
No. of studies / total 
patients / lacunar 
patients OR (95% CI) 
No. of studies / 
total patients / 
lacunar patients OR (95% CI) 
Raised 
cholesterol 
Other risk factors 
included 
14 / 29868 / 9544 1.36 (1.28 to 1.45) 13 / 20372 / 8145 1.08 (1.01 to 1.15) - - 
 Imaging-based 3 / 410 / 109 1.24 (0.94 to 1.63) - - 1 / 431 / 105 0.30 (0.04 to 2.40) 
 Clinical and 
imaging-based 
3 / 3190 / 824 1.21 (1.00 to 1.46) - - 1 / 2644 / 491 1.25 (1.01 to 1.55) 
 Total 20 / 35158 / 10821 1.34 (1.27 to 1.42) 13 / 20372 / 8145 1.08 (1.01 to 1.15) 1 / 431 / 105 0.30 (0.04 to 2.40) 
Prior TIA Prior TIA 
included in 
definitions 
13 / 15614 / 3472 0.90 (0.80 to 1.02) 13 / 11767 / 3435 0.79 (0.70 to 0.90) 3 / 991 / 225 0.95 (0.61 to 1.46) 
 Imaging-based 2 / 1592 / 448 0.90 (0.66 to 1.22) - - 1 / 330 / 205 0.50 (0.28 to 0.88) 
 Clinical and 
imaging-based 
6 / 1593 / 708 1.05 (0.79 to 1.40) 2 / 231 / 116 0.82 (0.49 to 1.40) 2 / 413 / 157 1.00 (0.56 to 1.78) 
 Total 21 / 18799 / 4628 0.92 (0.83 to 1.02) 15 / 11998 / 3551 0.82 (0.74 to 0.91) 6 / 1734 / 587 0.81 (0.60 to 1.09) 
Alcohol 
excess 
Other risk factors 
included 
7 / 8535 / 2251 1.16 (1.00 to 1.36) 7 / 6248 / 2251 1.03 (0.88 to 1.21) - - 
 Imaging-based 3 / 2023 / 553 1.03 (0.75 to 1.41) - - 2 / 761 / 310 0.68 (0.43 to 1.09) 
 Clinical and 
imaging-based 
3 / 1408 / 615 0.97 (0.70 to 1.36) 1 / 122 / 61 1.53 (0.25 to 9.47) 1 / 862 / 282 0.92 (0.61 to 1.39) 
 Total 13 / 11966 / 3419 1.11 (0.98 to 1.26) 8 / 6370 / 2312 1.03 (0.88 to 1.21) 3 / 1623 / 592 0.81 (0.59 to 1.10) 




Many studies have examined the association of risk factors with different ischaemic 
stroke subtypes.  Their pooled results must be interpreted with some caution, with 
careful consideration of the potential sources of heterogeneity between studies. 
3.5.1 Ischaemic stroke subtype classification bias 
The most important and striking difference between studies identified in my 
systematic review was the classification method used to assign ischaemic stroke 
subtypes.  Many studies included the risk factors under investigation in their 
definitions of ischaemic stroke subtypes, which may have led to bias (hereafter 
referred to as “classification bias”) when assessing differences in risk factor profiles 
of lacunar versus non-lacunar ischaemic stroke.  The subtype classification method 
used when investigating risk factor-ischaemic stroke subtype associations should be 
free of aetiological assumptions about risk factors, and so ideally should be based 
solely on the clinical features of the stroke syndrome along with the site and size of 
any relevant lesion on brain imaging. 
Classification bias was of particular importance in the results for hypertension and  
diabetes.  The apparently stronger association between hypertension and lacunar as 
compared with non-lacunar ischaemic stroke was considerably attenuated when only 
studies using risk factor-free classification methods were considered, whilst the 
apparent excess of diabetes among patients with lacunar versus non-lacunar 
ischaemic stroke disappeared entirely.  
Classification bias also affected the results for AF, carotid stenosis and IHD.  The 
excess of AF and carotid stenosis among non-lacunar patients was (unsurprisingly) 
more extreme among studies in which the presence of AF or carotid stenosis 
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precluded or discouraged a diagnosis of lacunar ischaemic stroke.  Emboli from the 
heart can occasionally occlude small, perforating cerebral vessels, and so it may be 
difficult to ascertain whether AF is causal or simply a manifestation of generalised 
vascular disease.  Similarly, although carotid stenosis is much more prevalent among 
patients with non-lacunar ischaemic stroke, it does occur in association with some 
lacunar ischaemic strokes.  IHD was overall significantly less common among 
patients with lacunar than non-lacunar ischaemic stroke, although, again this 
association was attenuated (and not quite statistically significant) when only studies 
using a risk factor-free classification method were considered.  A history of IHD is 
generally not included in definitions of ischaemic stroke subtypes where the 
classification takes into account risk factors, although a history of myocardial 
infarction within four weeks prior to the stroke occurrence may allow a patient to be 
categorised under “cardioembolic stroke” in aetiological classifications (Adams et al. 
1993; Whisnant et al. 1990). 
It is interesting that classification methods that do not include the risk factor being 
studied in their ischaemic stroke subtype definitions but do include other risk factors 
in those definitions, also yield more extreme estimates of the association between the 
risk factor and lacunar versus non-lacunar ischaemic stroke.  This could reflect 
associations between risk factors. 
3.5.2 Variation between studies in stroke population studied   
Another potential source of variability between studies is in the population of 
patients studied.  Most studies identified were hospital-based.  An ideal study would 
include all strokes that occurred in the community in a defined geographical area, 
irrespective of whether or not they attended hospital.  One meta-analysis of 
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community-based studies comparing risk factor profiles of different ischaemic stroke 
subtypes found just four such studies (Schulz & Rothwell 2003), all of which have 
been included in this review.  Such community-based studies should avoid spurious 
differences in risk factor profiles between ischaemic stroke subtypes arising because 
of hospital admission selection bias.  However, such studies will be prone to other 
potential biases.  Diagnosis of ischaemic stroke depends on appropriately timed brain 
imaging to exclude intracerebral haemorrhage, and patients managed entirely outwith 
hospital are unlikely to access such imaging.  Additionally, subtyping of ischaemic 
stroke patients is less accurate in the absence of brain imaging.  Thus, a series of 
patients recruited from outpatients as well as hospital admissions is unlikely to be 
any more biased than a community-based register.  Indeed, the results of my primary 
analyses were essentially unchanged in a sensitivity analysis restricted to only those 
studies that were based in the community or included both inpatient admissions and 
outpatients. 
3.5.3 Variable misclassification of ischaemic stroke subtypes      
A further potential source of variation between studies using risk factor-based 
classification methods such as TOAST is the reliance on a number of investigations 
(such as carotid ultrasound, transcranial doppler, echocardiography etc) apart from 
brain imaging, access to which will vary considerably between countries and centres, 
and according to patient characteristics such as age.  Furthermore, the TOAST 
classification does not allow assignment of an ischaemic stroke subtype when there 
is more than one potential cause of stroke, which in one large hospital-based stroke 
register occurred in 7% of all ischaemic strokes (Moncayo et al. 2000).  In this case, 
or in the case of incomplete investigation or complete investigation without detection 
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of cause, patients are categorised as “undetermined aetiology”.  In the studies that 
used the TOAST classification, the proportion of patients in this category varied 
widely from 8% to 41% (Lee et al. 2001; Saposnik et al. 2001).  This must be partly 
due to variability in access to diagnostic investigations but probably also reflects 
inconsistent application of the TOAST criteria (Goldstein et al. 2001).  The large and 
variable proportion of patients in the “undetermined” subtype category (some of 
which will be lacunar, and others non-lacunar, in unknown proportions) introduces 
heterogeneity between studies.  A classification that can assign a stroke subtype to all 
(or almost all) ischaemic stroke patients in the study population will be less prone to 
such variability, favouring classifications based mainly on clinical features of stroke 
syndrome, preferably refined by brain imaging findings.   
However, even if all ischaemic strokes are assigned a subtype, there will still 
inevitably be some misclassification.  Although combining the findings on brain 
imaging with clinical features of the stroke syndrome will help to minimise this 
misclassification, a proportion of ischaemic strokes will remain misclassified.  In 
particular, about 10-20% of lacunar infarcts will be misclassified as small cortical 
infarcts and vice versa (Mead et al. 1999a) because the clinical features of the stroke 
syndrome alone are sometimes of limited accuracy in distinguishing between these 
subtypes, and sometimes the relevant infarct is not visible on CT or MR brain scan.  
The extent of the misclassification in the studies included in this analysis will depend 
partly on the proportion of patients with brain imaging and the type and timing of 
imaging used, which varied between the included studies.  Small recent infarcts are 
more likely to be seen with diffusion-weighted MR brain imaging, but none of the 
studies I identified reported using this technique.  The effects of misclassification of 
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subtypes on the risk factor associations in my meta-analysis are difficult to predict, 
and will depend on whether misclassification is independent of exposure status.   
Some studies have demonstrated that up to around one third of stroke patients with 
lacunar syndromes have patterns of multiple areas of infarction on DW MR brain 
imaging, which is perhaps suggestive of some lacunar strokes being due to an 
underlying atherothromboembolic pathology, as opposed to a distinct small vessel 
pathology (Caso et al. 2005; Wessels et al. 2005; Ay et al. 1999).  However, given 
that it is difficult to distinguish between acute and subacute lesions on DW MR 
imaging (Caso et al. 2005), we cannot be sure whether the multiple infarcts observed 
in these studies occurred at the same time rather than within a few weeks of each 
other.  Nonetheless, it is possible that some lacunar strokes may be caused by 
atherothromboembolism.  I therefore addressed this issue in my systematic review by 
performing a sensitivity analysis where I excluded those patients with presumed 
cardioembolic stroke from the comparison groups.  Interestingly, the results did not 
differ from those in the primary analyses.  As discussed in chapter 7, I was able to 
explore this issue further in my analyses of individual patient data from various 
stroke registers, by further refining the classification of the lacunar comparison group 
to take into account the presence of severe carotid stenosis as well as cardiac sources 
of emboli. 
3.5.4 Variable definitions of risk factors      
Variability in the definitions used for the risk factors studied could also account for 
some of the heterogeneity between results of different studies.  For some risk factors, 
such as hypertension, whether or not the definition is dependent on pre-stroke or 
post-stroke criteria will impact on the proportion of patients classed as having been 
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exposed to that risk factor.  This in turn may lead to differences in risk factor-
ischaemic stroke subtype associations, although the precise effect of particular 
definitions on risk factor associations is, again, unpredictable. 
Also, misclassification of risk factors through dichotomisation of continuous 
variables, such as hypertension, may have biased risk factor-ischaemic stroke 
subtype relationships.  The precise effect of this bias will depend on whether this 
misclassification is independent of outcome status.  In addition, the use of “crude” 
definitions, which fail to distinguish between subcategories of exposure, may have 
obscured any true associations between such subcategories and ischaemic stroke 
subtype.  Also, the duration and severity of exposure to risk factors, particularly 
hypertension and diabetes, as well as the effect of combined exposure to multiple 
risk factors may all impact on each risk factor-ischaemic stroke subtype relationship. 
One of the limitations of my meta-analysis is that I was able to determine univariate 
associations only, since individual patient data would be needed for multivariate 
modelling.  I was therefore unable to adjust for the confounding effects of age, sex 
and other risk factors.   
3.5.5 Conclusion 
The results of my systematic review and meta-analysis suggest that the apparent 
stronger association between diabetes and lacunar compared with non-lacunar 
ischaemic stroke may arise almost entirely from classification bias.  Similarly, the 
stronger association between hypertension and lacunar versus non-lacunar ischaemic 
stroke was largely due to effects of classification bias, although a marginal excess of 
hypertension amongst patients with lacunar ischaemic stroke was still observed in 
studies free from such bias.  Although important risk factors for ischaemic stroke in 
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general, the presence of diabetes, and probably hypertension, do not help to 
distinguish the ischaemic stroke subtype.  In addition, although AF and carotid 
stenosis are associated more with non-lacunar than lacunar ischaemic stroke, this 
association is less extreme in studies free from classification bias than in studies 
using risk factor-based classification methods.  IHD may similarly be slightly less 
common in lacunar than non-lacunar ischaemic stroke, whereas smoking and raised 
cholesterol may be more common in lacunar than non-lacunar ischaemic stroke.  
However as described, these findings are limited by the various shortcomings of 
many of the included studies and a lack of control for the confounding effects of age, 
sex and other vascular risk factors.  These issues are addressed in chapter 7, where I 
report the results of my analysis of risk factor-ischaemic stroke subtype associations 
in a large collaborative individual patient data pooling project.  I will therefore 
discuss the implications of the differences in risk factor profiles of different 
ischaemic stroke subtypes on our understanding of the arteriopathy of lacunar 
ischaemic stroke in more detail in this later chapter.  
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Chapter 4. Risks of death and recurrent vascular events in patients 




In this chapter I will present the findings from my systematic review and meta-
analysis of published studies reporting on risks of death, recurrent stroke and/or 
myocardial infarction, and on recurrent stroke subtype patterns, among patients with 
lacunar as compared with non-lacunar ischaemic stroke, to determine whether 
differences in prognosis provide evidence for a distinct lacunar arteriopathy. 
4.2 Introduction 
Lacunar ischaemic stroke is often thought to have a more favourable outcome than 
other ischaemic stroke subtypes.  Short term prognosis for death and disability is 
better among patients with lacunar compared with non-lacunar ischaemic stroke 
(Norrving 2003), but this may reflect smaller infarct size and a low early recurrence 
rate rather than a fundamentally different arterial pathology.  In the longer term, 
patients with lacunar ischaemic stroke have a significantly higher risk of death than 
the general population (Norrving 2003), but less is known about the difference in risk 
of death between patients with lacunar and non-lacunar stroke. 
Similarly, early recurrent stroke risk is lower in patients with lacunar ischaemic 
stroke compared with other ischaemic stroke subtypes (Lovett 2004).  This early 
difference probably reflects different arterial occlusive mechanisms, with non-
lacunar ischaemic stroke more likely to be caused by emboli from an active 
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thrombotic source, such as the carotid bifurcation or the heart.  However, it does not 
necessarily imply fundamentally different arterial pathologies, since 
atherothrombotic mechanisms in situ could still cause most lacunar stroke.  Reports 
on recurrent stroke risk in the longer term are conflicting.  Some studies have found 
that the risk of recurrence is greater among patients with non-lacunar than lacunar 
ischaemic stroke while others suggest that stroke subtype is not a predictor of stroke 
recurrence (Norrving 2003).  These inconsistencies may arise from differences in 
study methodology and small study size (specifically small numbers of recurrent 
events).  Furthermore, the definition of recurrent stroke differs markedly between 
studies, particularly with respect to the minimum time required to have passed 
between the index stroke and the recurrence.  This makes comparing studies difficult, 
and may explain why estimates of the early recurrence risk differ so much between 
studies (Coull & Rothwell 2004).     
It is often assumed that ischaemic stroke subtypes "breed true", in that the subtype of 
recurrent stroke is generally of the same subtype as the index event.  If true, this may 
support the hypothesis of a distinct underlying arterial pathology in lacunar 
ischaemic stroke.  If most lacunar ischaemic stroke is due to a non-atherosclerotic 
pathology, we might also expect the risk of myocardial infarction (MI), a marker of 
systemic atherothrombotic disease, to be lower among patients with lacunar stroke.   
I therefore carried out a systematic review and series of meta-analyses of cohort 
studies that followed patients with lacunar and non-lacunar ischaemic stroke for 
death, recurrent stroke and / or MI.  I compared risks of death and recurrent stroke 
and examined data on recurrent stroke subtype patterns and MI risk following 
lacunar compared with non-lacunar ischaemic stroke.   
 86 
4.3 Methods  
4.3.1 Study identification 
I sought cohort studies that had followed both lacunar and non-lacunar ischaemic 
stroke patients for at least one month for death, recurrent stroke and/or MI.  I 
identified relevant studies published in English language journals between January 
1966 and September 2007 inclusive through a comprehensive electronic search 
strategy using Medline and Embase (Appendices 3 and 4); perusing reference lists of 
all relevant primary and review articles identified; searching within books on cortical 
and subcortical stroke; and discussions with colleagues.  I included inception cohort 
studies that were either community or hospital-based, but excluded studies among 
highly selected groups of patients (e.g. clinical trials or studies of young patients 
only) and studies that were not inception cohorts.  I also excluded studies that met 
the initial inclusion criteria but were found to have irresolvable data inconsistencies.  
4.3.2 Data extraction 
From each study identified, I extracted data on:  
• the population studied (i.e. community or hospital-based, hospital admissions 
only or including outpatients, consecutive recruitment or not) 
• the numbers of patients with lacunar and non-lacunar ischaemic stroke  
(excluding those with unusual causes of ischaemic stroke, e.g. arterial 
dissection, hereditary causes of stroke such as CADASIL, etc) 
• the demographic characteristics of the study population 
• the definition of recurrent stroke  
• the stroke subtype classification method 
• the duration of follow up 
 87 
• the proportion of patients with brain imaging following index and recurrent 
stroke 
• the numbers of lacunar and non-lacunar ischaemic stroke patients who were 
dead or had a recurrent stroke at one month, from 1-12 months, and from 1-5 
years after the index stroke 
• the numbers of lacunar and non-lacunar patients who had an MI 
• the numbers and subtypes of recurrences among patients with lacunar and non-
lacunar stroke at baseline.   
I chose one month, 1-12 month, and 1-5 year time periods for death and recurrent 
stroke because this allowed separate assessment of the very early and longer term 
risks for these outcomes in the maximum number of studies.  It also eliminated the 
effects of varying definitions of early stroke recurrence in the assessment of longer 
term risk. 
4.3.3 Statistical analysis 
I calculated risks of death and recurrent stroke at 1 month, 1-12 months and 1-5 years 
with 95% confidence intervals (CIs) using Confidence Interval Analysis software  
(Bryant 2000).  
For studies with data on death and recurrent stroke I calculated study-specific and 
summary Peto odds ratios (non-lacunar versus lacunar ischaemic stroke) with 95% 
CIs for each of death and recurrent stroke at 1 month, 1-12 months and 1-5 years, 
using Cochrane Review Manager software (Cochrane Collaboration 2003).  I 
assessed heterogeneity between studies using the I2 statistic which loosely describes 
heterogeneity as mild (I2 < 30), moderate (30 > I2 < 50) or substantial (I2 > 50) 
(Higgins  & Thompson 2002).   
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4.3.3.1 Sensitivity analyses 
In sensitivity analyses, I repeated the analyses for death and recurrent stroke 
including community-based studies (or studies that had recruited from both 
inpatients and outpatients) only. 
4.3.3.2 Recurrent stroke subtype patterns 
I analysed data on recurrent stroke subtypes using three different methods:   
1)  I pooled data from all relevant studies to determine the proportions of patients 
with lacunar and non-lacunar ischaemic stroke (at baseline) with each type of 
recurrent stroke 
2)  I pooled data from all studies providing information on recurrent stroke 
subtypes, and calculated study-specific and summary odds ratios (ORs) of 
having a lacunar recurrence or of having a non-lacunar recurrence (for lacunar 
versus non-lacunar ischaemic stroke at baseline) 
3)  I determined the ratio of the observed proportion of lacunar recurrences 
following a lacunar index event to the proportion expected (24%), and the 
ratio of the observed to the expected proportion (54%) of non-lacunar 
recurrences following a non-lacunar index event (with expected proportions 
based on two community-based studies of first-ever stroke incidence 
(Bamford et al. 1991; Hillen et al. 2003)). 
4.4 Results  
My search initially identified 5267 abstracts.  Reading these revealed 126 potentially 
relevant studies, of which 28 were actually relevant.  Data on one or more outcome 
were extractable from 17 (9145 patients, 2387 lacunar ischaemic stroke) of these 28 
studies (Figure 4.1).   
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Figure 4.1 Flow diagram detailing number of studies with extractable data for each outcome 
 
*Details of excluded studies and their main findings are given in Table 4.1.   
†Some studies included data on both death and recurrent stroke, so overlap means that the number of studies in the first three boxes below this level do not add up to 17 
17 studies included† 
(9145 patients)  
2387 lacunar patients, 6758 non-lacunar patients 
28 relevant studies identified  
Recurrent stroke subtype patterns 
4 studies 
966 lacunar patients 
1708 non-lacunar patients 
Death at one month 
12 studies 
1388 lacunar patients 
4933 non-lacunar patients 
Recurrent stroke at one month 
7 studies 
596 lacunar patients 
1827 non-lacunar patients 
Death at 1-12 months 
8 studies 
1035 lacunar patients 
4247 non-lacunar patients 
Recurrent stroke at 1-12 months 
6 studies 
563 lacunar patients 
1710 non-lacunar patients 
Death at 1-5 years 
4 studies 
282 lacunar patients 
1369 non-lacunar patients 
Recurrent stroke at 1-5 years 
3 studies 
235 lacunar patients 
1107 non-lacunar patients 
11 studies excluded*  
(11,126 patients (2820 lacunar)) 
4 studies presented data on death only 
 6431 patients (1423 lacunar) 
3 studies presented data on recurrent  
stroke risks only 
2952 patients (965 lacunar) 
4 studies presented data on death and  
recurrent stroke risks 
1743 patients (432 lacunar) 
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4.4.1 Details of excluded studies 
I was unable to extract and include data from 11 studies (11,126, 2820 lacunar 
ischaemic stroke) (Figure 4.1).  Of these 11 studies, four (6431 patients, 1423 lacunar 
strokes) reported data on death only, and contributed over half of the total number of 
patients in all excluded studies.  One of these studies was particularly large (4842 
patients), but followed patients for just 3 months and did not report on death at one 
month (Grau et al. 2001).   Two studies followed patients for 1 year, but there were 
irresolvable data inconsistences in one (Brainin et al. 1992), and data were not 
extractable from the other (Liu et al. 2005).  In the fourth study, patients were 
followed for two years, but again data were not extractable (Giroud et al. 1991) 
(Table 4.1).  Four studies presented data on both death and recurrent stroke (1743 
patients, 432 lacunar strokes).  In two of these studies patients were followed for just 
6 months, and data at one month were not reported (Murat & Erturk 2002; Pittock et 
al. 2003).  Data were not extractable from the other two studies, in which patients 
were followed for 2 years (Kolominsky-Rabas et al. 1998) and 1 year (Soda et al. 
2004).   
Three studies reported data on recurrent stroke only (2952 patients, 965 lacunar 
ischaemic strokes).  One of these studies followed patients for only 3 months, and 
did not present any data at one month post-stroke (Moroney et al. 1998), one study 
followed patients for two years, but presented the data in an unextractable format 
(Hier et al. 1991), and one study followed patients for 10 years, but also presented 
the data in an unextractable format (Yokota et al. 2004).    
Of the 7 studies that reported data on recurrent stroke, one was community-based 
(Kolominsky-Rabas et al. 1998) and the remainder were hospital-based.  
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reported Key findings reported 
Austria1 1992 Admissions to 
hospital (first-
ever stroke)  





Death • Patients with a lacunar ischaemic stroke had a lower 1-year 








Death • Patients with a lacunar ischaemic stroke had a lower 2-year 
mortality rate compared with other ischaemic stroke subtypes 







at 3 months 
only 
Death • Proportion of patients dead at 3 months was lowest in the 
lacunar group, compared with all other ischaemic stroke 
subtypes 
Nanjing4 2006 Admissions to 
hospital (first-
ever stroke) 
12 610  
(123) 
Did not report 
one month 
outcome data 
Death • There was a statistically significant difference in mortality rate 
between ischaemic stroke subtypes, with the mortality rate 
lowest in patients with lacunar ischaemic stroke 
Death • Proportion of patients dead at 6 months was greater in the non-
lacunar than lacunar group 







at 3 weeks and 






• A greater proportion of patients with non-lacunar than lacunar 
ischaemic stroke had a  “stroke extension” at two weeks, but 
there was no difference in risk at six months† 
• There was no difference in the proportion of patients with 
stroke/TIA between ischaemic stroke subtypes at 2 weeks, but 
a greater proportion of non-lacunar than lacunar patients had a 
stroke/TIA at 6 months† 
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reported Key findings reported 
Death • Ischaemic stroke subtype significantly predicted death at 
two years, with the lowest rate of death amongst patients 
with lacunar ischaemic stroke 
Erlangen6 2001 Community-
based 






• Ischaemic stroke subtype was not found to be a predictor of 
long-term recurrence at 2 years 
Death • The proportion of patients who died during follow-up was 
lowest in the lacunar group compared with other ischaemic 
stroke subtype groups 
Japan7 2004 Admissions to 
hospital 
(multicentre) 






• There was no difference in rate of recurrent stroke at 1 year 
between ischaemic stroke subtypes 
Death • Mortality rate at 6 months was lower among lacunar 
compared with other ischaemic stroke subtypes 












• There was no statistically significant difference in risk of 

























reported Key findings reported 
Osaka9 2004 Consecutive 
admissions to 
stroke unit  
(first-ever 
stroke) 






• The rate of recurrence was statistically significantly higher 
among cardioembolic stroke patients than lacunar patients 
during the first year.  The recurrence rate also appeared to 
be higher among patients with atherothrombotic strokes 
compared with lacunar stroke, but the statistical significance 
of this was not reported.  
• After the first year, the recurrence rate was not significantly 
different between stroke subtypes 







• The rate of recurrent stroke at 30-days was greater among 
patients with atherothrombotic compared with lacunar 
ischaemic stroke, but it is unclear from the author’s report 
whether there was a difference in recurrence rate thereafter   
USA (b)11 1998 Admissions to 
hospital 








• Recurrence risk at 3 months was statistically significantly 
lower among patients with lacunar ischaemic stroke 
compared with patients with atherothrombotic or 
cardioembolic strokes 
 
*of publication. †Authors of the Dublin study did not define what they meant by “stroke extension” and how this differed from the outcome of “stroke/TIA” 
TIA = transient ischaemic attack 
1Brainin et al. 1992; 2Giroud et al. 1991; 3Grau et al. 2001; 4Liu et al. 2005; 5Pittock et al. 2003; 6Kolominsky-Rabas et al. 2001; 7Soda et al. 2004; 8Murat & Erturk 
2002; 9Yokota et al. 2004; 10Hier et al. 1991; 11Moroney et al. 1998 
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4.4.2 Characteristics of included studies  
Characteristics of the remaining 17 studies contributing to the analyses are shown in 
Table 4.2 (Lavados et al. 2007; Hata et al. 2005; Sacco et al. 2006; Hillen et al. 
2003; Boiten & Lodder 1993; De Jong et al. 2004; Landi et al. 1992; Sacco et al. 
1994; Bamford et al. 1991; Lovett et al. 2004; Pinto et al. 2006; Anderson et al. 
1994; Sacco et al. 1991; Petty et al. 2000; Toni et al. 1995; Eriksson & Olsson 2001; 
Nadeau et al. 1993).  
In 14 of these 17 studies, the non-lacunar comparison group consisted of all non-
lacunar ischaemic strokes.  One study excluded patients with subtentorial ischaemic 
stroke from the non-lacunar group (Toni et al. 1995), one excluded patients with 
cardioembolic ischaemic stroke (Nadeau et al. 1993), and a third excluded patients 
with a posterior circulation stroke or a cardioembolic stroke (Boiten & Lodder 1993).   
Thirteen studies reported the proportion of patients with brain imaging after their 
baseline stroke, which ranged from 74% to 100%, with four studies using MR 
imaging in addition to CT brain imaging.  In one study, 37% of baseline strokes had 
CT or MR brain imaging, but many of the patients without brain imaging had an 
autopsy performed, resulting in 92% of baseline strokes having had brain imaging or 
autopsy (Hata et al. 2005).  
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Table 4.2 Description of included studies 
 
Mean age  Male (%) 
Patients with CT/MRI 
























Chile1 2007 Community-based 
(first-ever stroke) 
64 68 63 53 6 
(1) 
NR NA 184 
(57) 
D 
Hisayama2 2005 Population-based NR NR NR NR 120 
(0) 
37% had CT 
or MRI‡ 





L’Aquila3 2006 Community-based 
(first-ever stroke) 
73 75 51 46 60 
(0) 
100% had 




London4 2003 Community-based 
(first-ever stroke) 
NR NR NR NR 14 
(0) 
87% had CT 
or MRI 















67 70 55 63 Max 29 
(0) 
93% had CT 56% had CT 197 
(103) 
D, R  
Maastricht (b)6 2004 As in Maastricht 
(a) 




61% had CT 998 
(339) 
RSS 
Milan7 1992 Patients seen in 
ER within 72 hrs 
of first-ever stroke 
& admitted to 
neurology dept 










Table 4.2 (continued) 
 
Mean age  Male (%) 
Patients with CT/MRI 
























New York8 1994 Hospitalised first-
ever strokes who 
were residents of 
Northern 
Manhattan 
NR NR NR NR Mean 40 
(6) 
NR NR 306 
(85) 
D, R 
Oxford (a)9 1991 Community-based 
(first-ever strokes) 
 
72 73 40 54 12 
(0) 
93% had CT NR 543 
(137) 
D, R 
Oxford (b)10 2004 Community-based 
(first-ever strokes) 
NR NR NR NR 12 
(NR) 
NR NR 150 
(33) 
R 













Perth12 1994  Community-based 
(first-ever strokes) 
 









Rochester (a)13 1991 Community-based 
(first-ever strokes) 
NR NR NR NR 60 
(NR)  








Table 4.2 (continued) 
 
Mean age  Male (%) 
Patients with CT/MRI 
























Rochester (b)14 2000 Community-based 
(first-ever strokes) 
73 76 43 40 Mean 38 
(0) 
92% had 





Rome15 1995 Consecutive first-
ever stroke 
patients admitted 
within 12 hours of 
onset of event 







Sweden16 2001 Admissions to 
stroke unit 
71 73  55 43 168 
(0) 
74% had CT NA 309 
(47) 
D 
USA17 1993 Consecutive 













†D = data on death; R = data on recurrent stroke; RSS = data on recurrent stroke subtypes; MI = data on frequency of MI following ischaemic stroke subtypes; MRI = magnetic resonance 
imaging; CT = computed tomography   
‡In this study many of the patients had an autopsy and the authors report that 92% of index strokes and 94% of recurrences had either brain imaging or autopsy performed. 
#Number of patients recruited at baseline, and not necessarily equal to the number of patients included in later analyses. 
 
1Lavados et al. 2007; 2Hata et al. 2005; 3Sacco et al. 2006; 4 Hillen et al. 2003; 5 Boiten & Lodder, 1993; 6 De Jong et al. 2004; 7 Landi et al. 1992; 8 Sacco et al. 1994; 9 Bamford et al. 




Of the 8 studies (5282 patients, 1035 lacunar strokes) reporting on death in lacunar 
and non-lacunar patients at both 1 month and 1 year (Anderson et al. 1994; Bamford 
et al. 1991; Boiten & Lodder 1993; Eriksson & Olsson 2001; Petty et al. 2000; Sacco 
et al. 1994; Sacco et al. 2006; Sacco et al. 1991), all but one included first-ever 
strokes only and five were community-based.   
The risk of death among lacunar patients ranged from 0% to 4% at 1 month, 2% to 
14% at 1-12 months, and 13% to 33% at 1-5 years.  Among non-lacunar patients, the 
risk of death was higher at one month, ranging from 11% to 27%, while at 1-12 
months the risk ranged from 15% to 21% and at 1-5 years, 35% to 41% (Figure 4.2).     
At one month the odds of death were over three and a half-fold greater in non-
lacunar than lacunar patients (OR 3.68, 95% CI 3.05 to 4.44; Figure 4.3).  This 
difference attenuated thereafter, with the odds of death at 1-12 months just two-fold 
greater among non-lacunar patients (OR 2.14, 95% CI 1.76 to 2.61), and at 1-5 years 
less than two-fold greater among non-lacunar patients (OR 1.77, 95% CI 1.28 to 
2.45).  However, there was moderate heterogeneity between studies for the 1-5 year 
results.  Data for this later time period are less reliable, since they were only 
available for four studies (Eriksson & Olsson 2001; Petty et al. 2000; Sacco et al. 
1994; Sacco et al. 1991) in 1651 patients, and their extraction required assumptions 
to be made about losses to follow-up and the statistical methods used in the original 
studies.  In the studies included in these mortality analyses, the lacunar patients were 
very slightly younger than the non-lacunar patients (weighted mean age 72 versus 75 
years), but I was unable to control for the potential confounding effect of this age 
difference in my analyses.
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Figure 4.2 Risks of death with 95% CIs at (a) 1 month, (b) 1-12 months and (c) 1-5 years among lacunar and non-lacunar patients 
  




















Lacunar patients Non-lacunar patients 
(a) 
*For study references, see Table 4.1 (references to studies included in footnotes to table) 
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Figure 4.3 Odds ratios of death at 1 month, 1-12 months and 1-5 years, comparing non-
lacunar versus lacunar ischaemic stroke 
 
 
N = total number of patients; n = number of deaths.  OR = odds ratio; CI = confidence interval.   
Squares represent the individual study-specific odds ratio estimates (with size of square reflecting weighting) 
with the vertical lines representing the 95% CI.  Open diamonds represent the overall pooled ORs. 
 
1Sacco et al. 2006; 2Boiten & Lodder 1993; 3Sacco et al. 1994; 4Bamford et al. 1991; 5Anderson et al. 1994; 
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15 / 83 
40 / 191 
56 / 353 
30 / 195 
72 / 444 
51 / 301 
34 / 229 
591 / 3374 
43 / 470 
13 / 101 
2 / 84 
12 / 134 
3 / 22 
2 / 78 
1 / 72 
5 / 47 
81 / 1008 
575 / 2153 
11 / 94 
24 / 221 
53 / 406 
30 / 225 
72 / 516 
69 / 370 
33 / 262 
867 / 4247 
21 / 491 
2 / 103 
0 / 85 
3 / 137 
0 / 22 
0 / 78 
0 / 72 
0 / 47 
26 / 1035 
1.99 (1.50 to 2.62) 
1.49 (0.67 to 3.34) 
4.18 (2.05 to 8.51) 
1.78 (1.00 to 3.15) 
1.14 (0.34 to 3.89) 
3.06 (1.54 to 6.11) 
3.64 (1.74 to 7.65) 
1.41 (0.57 to 3.47) 
2.14 (1.76 to 2.61) 
3.61 (2.86 to 4.57) 
4.83 (1.57 to 14.86) 
4.47 (1.77 to 11.32) 
3.23 (1.71 to 6.10) 
3.47 (0.91 to 13.22) 
3.70 (1.78 to 7.67) 
4.11 (2.05 to 8.22) 
3.73 (1.37 to 10.17) 
3.68 (3.05 to 4.44) 
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As described earlier, I was unable to include data from 8 relevant studies that 
reported on risk of death, the follow-up time having ranged from 3-24 months.  
These studies reported on death for the entire period for which patients were 
followed up and found risk of death to be lower among patients with lacunar versus 
other ischaemic stroke subtypes (Table 4.1) (Brainin et al. 1992; Giroud et al. 1991; 
Grau et al. 2001; Liu et al. 2005; Pittock et al. 2003; Kolominsky-Rabas et al. 2001; 
Soda et al. 2004; Murat & Erturk) .  Although these studies did not distinguish 
between risk of death at early and later time periods, these results are not in 
disagreement with those from studies included in my meta-analysis.   
4.4.4 Recurrent stroke 
Of the 17 studies included in my analyses, 7 studies reported data on recurrent stroke 
risk at one month or more (2423 patients, 596 with lacunar strokes) (Bamford et al. 
1991; Boiten et al. 1993; Landi et al. 1992; Petty et al. 2000; Sacco et al. 1994; 
Sacco et al. 1991; Lovett et al. 2004).  Four of these studies were community-based 
and all included first-ever strokes only (Table 4.2).  In each study the proportion of 
index strokes with brain imaging was close to 100%.  The proportion of patients with 
a recurrent stroke with brain imaging performed was reported in only one study, in 
which 56% of recurrent stroke patients had a CT scan (Boiten et al. 1993).  Studies 
presenting data on recurrent stroke risk used either a risk factor-independent clinical 
and brain imaging-based method of classifying ischaemic stroke subtypes, or a 
classification method that took into account the presence or absence of some risk 
factors, but not hypertension or diabetes, (i.e. NINDS classification or a modified 
TOAST classification) (Table 4.3).   Three studies gave a definition of recurrent 
stroke (Bamford et al. 1991; Petty et al. 2000; Lovett et al. 2004), one study made no 
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distinction between their definition of index and recurrent stroke (Sacco et al. 1994), 
two studies gave no definition of a recurrent stroke (Landi et al. 1992; Sacco et al. 
1991), and one study gave no definition but reported no recurrent strokes in either 
group within the first month, suggesting that the authors may have used a definition 
of recurrent stroke that excluded events occurring within a month of the index event 
(Boiten et al. 1993) (Table 4.3). 
   
Table 4.3 Details of ischaemic stroke subtype classification method and definition of 
recurrent stroke in studies of recurrent stroke risk  
Study Ischaemic stroke 
subtype classification 
Definition of recurrent stroke 
Maastricht (a)1 Risk factor-free 
(clinical syndrome and 
brain imaging-based) 
Not reported 
Milan2 Unclear Not reported 
New York3  Risk factor-based 
(NINDS) 
Defined using standard definition of stroke 
Oxford (a)4 Risk factor-free 
(clinical syndrome, 
not modified by brain 
imaging) 
Standard stroke definition, with added criteria that 
side effects of drug therapy or  intercurrent illness 
were excluded as potential explanations for any new 
neurological worsening, and recurrences within 21 
days of the index stroke had to occur in a different 
part of the brain from the index event 
Oxford (b)5 Modified TOAST Standard stroke definition, with added critera that 
oedema, haemorrhagic transformation, intercurrent 
illness or iatrogenesis  were excluded as potential 
causes of any new neurological worsening, and 
recurrences defined as occurring after a period of 
neurological stability lasting at least 24 hours 
Rochester (a)6 Risk factor-free 
(clinical syndrome and 
brain imaging-based) 
Not reported 
Rochester (b)7  Risk factor-based 
(NINDS) 
Standard stroke definition, with added critera that 
oedema, haemorrhagic transformation, intercurrent 
illness or iatrogenesis  were excluded as potential 
causes of any new neurological worsening, and 
recurrences defined as occurring after a period of 
neurological stability lasting at least 24 hours 
 
1Boiten & Lodder; 2Landi et al. 1992; 3Sacco et al. 1994; 4Bamford et al. 1991; 5Lovett et al. 2004; 
6Sacco et al. 1991; 7Petty et al. 2000 
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Six of these seven studies reported data on recurrent stroke risk at both 1 month and 
12 months.  The risk of recurrence among lacunar patients during the first month 
ranged from 0% to 4% and at 1-12 months from 6% to 9%.  The risk of recurrence at 
1-5 years varied considerably between the three studies with long-term data, ranging 
from 7% to 22%.  Among non-lacunar patients the one month recurrence risk ranged 
from 0% to 7%, the 1-12 month risk ranged from 3% to 14% and the 1-5 year risk 
ranged from 21% to 25% (Figure 4.4).  
The odds of recurrent stroke in the first month were just over two times greater in 
non-lacunar compared with lacunar ischaemic stroke patients (OR 2.11, 95% CI 1.28 
to 3.50; Figure 4.5), with only mild heterogeneity between studies.  Thereafter, the 
difference in risk attenuated, with no statistically significant difference in the risk of 
recurrent stroke at 1-12 months (OR 1.24, 95% CI 0.85 to 1.83) or at 1-5 years (OR 
1.61, 95% CI 0.96 to 2.70), although, as for mortality, the 1-5 year data are less 
reliable and available in fewer studies.  Where provided, the mean age for lacunar 
and non-lacunar patients was the same in studies included in the analyses (weighted 
mean 73 years). 
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Figure 4.4 Recurrence stroke risks, with 95% CIs at (a) 1-month, (b) 1-12 months and (c) 1-5 years for lacunar and non-lacunar patients 
 
 










% % % 
Lacunar patients Non-lacunar patients 
0 5 10 15 20 25 30 35 
Study* (a) (b) (c) 
*For references to studies, see Table 4.1 (study references included in footnotes to table) 
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Figure 4.5 Odds ratios of recurrence at 1 month, 1-12 months and 1-5 years, comparing non-
lacunar with lacunar ischaemic stroke 
 
N = total number of patients; n = number of patients with a recurrent stroke.  OR = odds ratio; CI = confidence 
interval.   
Squares represent the individual study-specific odds ratio estimates (with size of square reflecting weighting) 
with the vertical lines representing the 95% CI.  Open diamonds represent the overall pooled ORs.    
 
1Boiten & Lodder 1991;2Landi et al. 1992; 3Sacco et al. 1994; 4Bamford et al. 1991; 5Sacco et al. 1991; 6Petty et 
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I was unable to include data from 7 relevant studies that reported on recurrent stroke 
risk.  These studies usually reported on the recurrence risk for the entire period for 
which patients were followed up, and did not generally distinguish between 
recurrence risk during the early and later time periods.  It is therefore difficult to 
ascertain to what extent the results of these studies agree with those from my meta-
analyses.  However, after assessing the results of these studies, I found that they do 
not, on the whole, disagree with those from the included studies (Table 4.1).  In two 
studies where patients were followed for at least 1 year, the authors found no 
difference in recurrent stroke risk between ischaemic stroke subtypes (Kolominsky-
Rabas et al. 2001; Soda et al. 2004).  In one study, the authors reported a lower risk 
of recurrence among lacunar compared with cardioembolic patients at one-year, but 
no difference thereafter.  However, it was difficult to determine from the report 
whether this lack of difference was statistically signficant or not, and whether there 
was any difference in risk of recurrence between patients with lacunar compared 
with other types of non-lacunar stroke (Yokota et al. 2004).   
Where data were reported on recurrent risk in the short term (generally given for 
between 1 and 6 months), the findings were in keeping with our results, with two 
studies reporting a lower recurrence risk among patients with lacunar ischaemic 
stroke at 1 month (Moroney et al. 1998; Hier et al. 1991) (Table 4.1). 
4.4.5 Sensitivity analysis for death and recurrent stroke 
I found very similar results to the primary analysis when I repeated the analyses for 
death and recurrent stroke including only community-based studies (Anderson et al. 
1994; Bamford et al. 1991; Petty et al. 2000; Sacco et al. 1991).  The odds of death 
at one month were over three and a half times greater in non-lacunar than lacunar 
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patients, and at 1-12 months, just over two times greater in non-lacunar patients.  
Two of these studies also provided data for the longer term (Petty et al. 2000; Sacco 
et al. 1991) which suggested a trend towards an increased risk of death among non-
lacunar patients at 1-5 years, but which was not, however, statistically significant 
(Figure 4.6) 
Three of the community-based studies also reported on recurrent stroke risk at one 
month and 1-12 months (Bamford et al. 1991; Petty et al. 2000; Sacco et al. 1991), 
two of which also reported data at 5 years (Petty et al. 2000; Sacco et al. 1991).  
Similar to the results of the primary analysis, the odds of recurrence at one month 
was two times greater among non-lacunar than lacunar patients, but there was no 















Figure 4.6 Sensitivity analyses for risks of death and recurrent stroke (non-lacunar versus 
lacunar) including data from only community-based studies or hospital-based studies 
recruiting from both inpatients and outpatients 
 
 
Diamonds represent pooled summary odds ratios, with the width of the diamond representing the 95% confidence 
interval 
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4.4.6 Recurrent stroke subtype patterns 
Four studies (2674 ischaemic strokes, 966 of which were lacunar ischaemic strokes) 
reported on the pattern of recurrent stroke subtypes following both lacunar and non-
lacunar ischaemic stroke patients at baseline (De Jong et al. 2004; Hata et al. 2005; 
Hillen et al. 2003; Nadeau et al. 1993) (Table 4.2).  Three studies used a clinical and 
imaging-based classification method to categorise ischaemic stroke subtypes, and 
one study used the NINDS classification, which includes some risk factors (but not 
diabetes or hypertension) in the definitions of ischaemic stroke subtypes.  All four 
studies used a slightly different definition of recurrent stroke (Table 4.4).  The main 
difference was the minimum necessary time interval between index event and 
recurrent stroke, which was given as 3 days in one study, 21 days in another and 
unspecified in two studies.   
 
Table 4.4 Details of ischaemic stroke subtype classification method and definition of 
recurrent stroke in studies of recurrent stroke subtype patterns 
Study Ischaemic stroke 
subtype classification 
Definition of recurrent stroke 
Hisayama1  Risk factor-based 
(NINDS) 
Standard stroke definition, with added criteria that oedema, 
haemorrhagic transformation, intercurrent illness or iatrogenesis were 
excluded as potential causes of any new neurological worsening.  
Period of neurological stability not specified 
London2 Risk factor-free 
(clinical syndrome and 
brain imaging-based) 
Standard stroke definition, with added criterion that oedema, 
haemorrhagic transformation, intercurrent illness or iatrogenesis were 
excluded as potential causes of any new neurological worsening, and 
recurrences within 21 days of the index stroke had to occur in a 
different part of the brain from the index event 
Maastricht (b)3  Risk factor-free 
(clinical syndrome and 
brain imaging-based) 
Standard stroke definition, with added criteria that side effects of 
drug therapy or intercurrent illness were excluded as potiential 
explanations for any neurological worsening, and recurrences defined 
as occurring at least 72 hours after the index stroke 
USA4  Risk factor-free 
(clinical syndrome and 
brain imaging-based) 
Standard stroke definition, following a period of neurological 
stability, the length of which was not specified 
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1Hata et al. 2005; 2Hillen et al. 2003; 3De Jong et al. 2004; 4Nadeau et al. 1993 
 
In all four studies the authors reported on the proportion of patients who underwent 
brain imaging following the baseline stroke, which ranged from 37% to 100% (Table 
4.5).  CT or MRI was used in two studies (Hata et al. 2005; Hillen et al. 2003), and 
CT alone was used in the other two studies (De Jong et al. 2004; Nadeau et al. 1993).   
One study did not report on whether patients with recurrent stroke underwent brain 
imaging (Nadeau et al. 1993).  One study reported use of CT in 61% of recurrent 
stroke patients (De Jong et al. 2004) and in the other two studies CT or MRI was 
used in 40% (Hata et al. 2005) and 65% (Hillen et al. 2003) of recurrent stroke 
patients, although neither of these studies specified to what extent MR brain imaging 
was used, or whether DW MRI was performed (Table 4.5).  One of these three 
studies did carry out detailed autopsy in patients who died during follow-up, so that 
94% of recurrent stroke patients had either an autopsy or brain imaging (Hata et al. 
2005).    
In these four studies there were a total of 147 recurrences following lacunar 
ischaemic stroke at baseline, and 238 recurrences following non-lacunar ischaemic 
stroke at baseline.  The proportion of recurrences that were lacunar again following a 
lacunar ischaemic stroke at baseline ranged from 32% to 55%, and the proportion of 
recurrences that were non-lacunar again following a non-lacunar stroke at baseline 
ranged from 56% to 88% (Table 4.5).  
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Table 4.5 Brain imaging and characteristics of recurrences among patients with a recurrent stroke following either lacunar or non-lacunar ischaemic 
stroke at baseline 
Brain imaging among 
recurrences 
 Type of recurrences following lacunar ischaemic 
stroke at baseline   
Type of recurrences following non-lacunar 






























Hisayama1  CT or MR 40  51 18 (35) 22 (43) 9 (18) 2 (4)  34 1 (3) 30 (88) 1 (3)  2 (6) 
London2  CT or MR 65  37 12 (32) 16 (43) 4 (11) 5 (14)  66 15 (23) 37 (56) 4 (6) 10 (15) 
Maastricht (b)3 CT 61  49 27 (55) 14 (29) 6 (12) 2 (4)  89 4 (4) 71 (80) 6 (7) 8 (9) 
USA4  NR NR  10 5 (50) 4 (40) NR 1 (10)  49 2 (4) 40 (82) NR 7 (14) 
All studies - -  147 62 56 19 10  238 22 178 11 27 
 
CT = computed tomography; MRI = magnetic resonance; NR = not reported; ICH = intracerebral haemorrhage; Other = undetermined stroke subtypes.   
N = total number of recurrences in each study; n = number of each type of recurrence in each study 
 
1Hata et al. 2005; 2Hillen et al. 2003; 3De Jong et al. 2004; 4Nadeau et al. 1993 
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When I pooled data from these studies, I found that following lacunar ischaemic 
stroke nearly half the recurrences were lacunar again, and just over one third were 
non-lacunar (Figure 4.7).  Following non-lacunar ischaemic stroke at baseline, three 
quarters of the recurrences were non-lacunar again, and just 9% were lacunar.  There 
appeared to be a greater proportion of intracerebral haemorrhages among the 
recurrent strokes following lacunar ischaemic stroke as compared with non-lacunar 
ischaemic stroke, but this was based on quite small numbers of haemorrhages (Figure 
4.7 and Table 4.5).   
 
Figure 4.7 Type of recurrent stroke following each of lacunar and non-lacunar ischaemic 
stroke at baseline 
Other = strokes due to unusual causes and uncertain ischaemic subtypes; ICH = intracerebral haemorrhage 
 
In a second analysis I pooled these data together to determine the odds of having a 
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lacunar recurrence following lacunar versus non-lacunar stroke at baseline.  The odds 
of a further lacunar recurrence among lacunar patients was over six times the odds of 
a lacunar recurrence among non-lacunar patients (OR 6.83, 95% CI 4.18 to 11.18; 
Figure 4.8).  However, there was substantial heterogeneity between these studies 
which could be explained by the results of one study in which the effect estimate was 
much less extreme (Hillen et al. 2003).  This was largely due to the noticeably higher 
proportion of recurrences that were lacunar following non-lacunar ischaemic stroke 
at baseline in this study (23%) compared with in the other three studies (3% to 4%).  
The odds of a non-lacunar recurrence was 80% lower following a lacunar compared 
with a non-lacunar stroke at baseline (OR 0.20, 95% CI 0.13 to 0.32; Figure 4.8), 
with substantial heterogeneity between studies again explained by the results of one 













Figure 4.8 Odds ratios for (a) lacunar recurrence and (b) non-lacunar recurrence following 





In (a), n = number of patients with a lacunar recurrence and N = total number of either lacunar or non-lacunar 
patients who had a recurrence.   
In (b), n = number of patients with a non-lacunar recurrence and N = total number of either lacunar or non-
lacunar patients who had a recurrence. 
Open diamond represents the pooled summary estimate 
OR = odds ratio; CI = confidence interval. 
   
1Hata et al. 2005; 2Hillen et al. 2003; 3De Jong et al. 2004; 4Nadeau et al. 1993 
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If recurrent ischaemic stroke subtypes do not breed true, and the type of recurrent 
stroke is not related to the index subtype, we would expect the distribution of 
subtypes to be similar to the distribution of ischaemic strokes generally observed in 
studies of first-ever strokes.  Thus we would expect about 24% of recurrences to be 
lacunar ischaemic strokes, and about 57% to be non-lacunar ischaemic strokes based 
on the frequency of these subtypes in two community-based studies (Bamford et al. 
1991; Hillen et al. 2003).  In my third and final analysis of recurrent stroke subtype 
patterns I compared the observed pattern of recurrences to the expected pattern.  In 
the four studies included in my meta-analysis, the proportion of recurrences that were 
lacunar again following a lacunar ischaemic stroke at baseline was 71% greater than 
expected (observed number of lacunar recurrences = 62; expected number of lacunar 
recurrences [0.24*147] = 36; RR observed to expected 1.71, 95% CI 1.31 to 2.19).  
The proportion of recurrences that were non-lacunar following a non-lacunar index 
event was 30% greater than expected (observed number of recurrences that were 
non-lacunar = 178; expected number of non-lacunar recurrences [0.57*238] = 135; 
RR observed to expected 1.31, 95% CI 1.13 to 1.52). 
4.4.7 Myocardial infarction  
My search identified just one study that prospectively followed both lacunar and 
non-lacunar patients for MI incidence, reporting just 6 MIs among 191 patients in 
total, during a median follow-up of 28 months (Landi et al. 1992).  There were an 
additional five small studies reporting on MI among lacunar patients (24 MIs among 
533 patients), but these studies did not include a non-lacunar group of patients, and 
often recorded fatal MI events only (Gandolfo et al. 1986; Kazui et al. 2001; Salgado 
et al. 1996; Samuelsson et al. 1996; Yamamoto et al. 2002).    
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4.5 Discussion    
In my systematic review and meta-analyses of existing published studies I found that 
the risk of death at one month was greater among patients with non-lacunar than 
lacunar ischaemic stroke.  However, when the early period (first month) was 
excluded, the difference in risk thereafter (between 1-12 months) attenuated.  This 
may suggest that much of the difference in one year death rates between lacunar and 
non-lacunar patients is accounted for by the early effects of infarct size, and early 
risk of recurrent stroke.  However, persistent differences in risk of death remained at 
1-12 months and also in the longer term at 1-5 years (although the latter result is less 
reliable).  This may reflect a true increased risk of death among non-lacunar patients 
in the early and in the late post-stroke period, or it may be the effect of confounding 
factors.  Stroke severity, for example has been shown to be a strong independent 
predictor of long-term survival (Eriksson et al. 2008; Slot et al. 2008).  Thus the 
differences in survival among patients with lacunar versus non-lacunar stroke may 
well reflect differences in stroke severity.   
After one month, I found no statistically significant difference in the risk of recurrent 
stroke between patients with lacunar and non-lacunar ischaemic stroke.  The higher 
early recurrence risk among patients with non-lacunar ischaemic stroke patients 
confirms previous work on early recurrence risk among ischaemic stroke subtypes 
(Lovett et al. 2004).  It also suggests that there is a greater prevalence of active 
sources of thrombotic emboli among patients with non-lacunar ischaemic stroke, 
which supports the results of my systematic review which showed that both a 
cardioembolic source and severe carotid stenosis are much more common in patients 
with non-lacunar compared with lacunar ischaemic stroke. 
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Interestingly, the difference in survival and recurrence in the long-term (at 1-5 years) 
beween patients with lacunar versus non-lacunar ischaemic stroke attenuated in the 
more recent studies, perhaps reflecting improvements in post-stroke care and 
secondary prevention (which may have had more impact on the outcome of more 
severe strokes).  
4.5.1 Limitations of death and recurrent stroke analyses 
A number of methodological limitations affect my death and recurrent stroke 
analyses.  First, relevant studies identified in my search reported on risks of outcome 
events at varying time points, making it impossible to include data in pooled analyses 
from every potentially relevant study identified.  Second, the total number of 
outcome events, particularly recurrent strokes, was relatively small, which reduced 
the precision of the effect estimates.  Third, I was only able to perform univariate 
analyses, and thus was unable to control for potential confounding factors such as 
age, sex and co-morbidity.  Other potential confounders include interventions such as 
carotid endarterectomy and anticoagulation, which are usually tailored to stroke 
subtype.  Both interventions are generally used more often following non-lacunar 
than lacunar ischaemic stroke.  Furthermore, there may be differential effects on 
recurrent stroke subtypes, since available evidence from randomised trials and 
observational studies of oral anticoagulation suggests that this treatment is more 
effective in the prevention of cardioembolic than other types of ischaemic stroke 
(Evans et al. 2000; Hart et al. 2000).  However, available data do not suggest a 
definite difference in the effectiveness of carotid endarterectomy between 
symptomatic patients presenting with non-lacunar versus lacunar ischaemic stroke 
(Inzitari et al. 2000).  Neither is there clear evidence to suggest that carotid 
 118 
endarterectomy prevents a greater proportion of subsequent non-lacunar than lacunar 
ischaemic strokes (Barnett et al. 2000).  Fourth, the clinical distinction between 
lacunar and non-lacunar ischaemic stroke is not perfect, as discussed in the previous 
chapter.  Around 10-20% of patients with a clinical lacunar syndrome actually have a 
recent relevant cortical infarct which explains the clinical symptoms on brain 
imaging, and vice-versa (Mead et al. 1999a).  When there is no lesion present on 
imaging (and stroke subtype is therefore determined by clinical syndrome), around 
one fifth of lacunar and small cortical ischaemic strokes may therefore be 
misclassified.  This proportion could be reduced in future studies by the more 
frequent use of advanced MR brain imaging, especially when the CT scan does not 
show a relevant infarct.  I did not have the individual patient data from the studies 
included in my analyses, and so could not estimate the degree of misclassification in 
these studies.  However, if the degree of misclassification was indeed similar 
between the lacunar and non-lacunar comparison groups, then the effect of this 
misclassification would be to reduce the apparent size of any real epidemiological 
differences between lacunar and non-lacunar ischaemic stroke. 
Finally, the data on very early risk of stroke should be interpreted with caution 
because of varying stroke recurrence definitions.  In some studies, the risk of 
recurrence within the first month may have been underestimated if early recurrences 
involving the same arterial territory, or resulting in similar symptoms to the index 
event, were not always considered as recurrent strokes. There may also have been 
some overlap between the definition of recurrent stroke and stroke-in-progression.  
Stroke-in-progression has been defined recently by one group, the European Stroke 
Database collaboration, as "neurological progression occurring within the first three 
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days" (Birschel et al. 2004).  Stroke-in-progression is thought to be particularly 
common in lacunar stroke (Nakamura et al. 1999), therefore very early recurrences 
among lacunar patients may not be counted as such and may instead be considered 
part of the evolution of the initial stroke.  It has been recommended by some that 
neurological worsening occurring at any time after the index event, following a 
period of stability of ≥ 24 hours should be considered a potential recurrent stroke.  
Otherwise the very early recurrence risk will be underestimated (Coull & Rothwell  
2004).   
4.5.2 Evidence for a distinct lacunar arteriopathy? 
Notwithstanding the methodological limitations outlined above, my findings on the 
longer term risks of recurrent stroke (which are less likely to be subject to stroke 
recurrence definition bias) do not provide support for fundamentally different arterial 
pathologies in lacunar and non-lacunar ischaemic stroke.  For, although the risk of 
death appears to be lower in lacunar patients, which may reflect a distinct lacunar 
pathology - perhaps due to patients with lacunar ischaemic stroke being less likely to 
have systemic atherosclerosis and thus having a reduced risk of MI - it may also be 
due to confounding by factors such as age, sex, infarct size and stroke severity.  
Comparison of risk of death is therefore potentially less informative in determining 
whether there is a distinct lacunar arteriopathy.  
My analyses on recurrent stroke subtypes do provide some evidence that recurrent 
stroke subtypes "breed true”, lending some support to the hypothesis of a different 
arterial pathology underlying lacunar ischaemic stroke.  However, as mentioned 
above, there will have been some misclassification of ischaemic stroke subtypes, 
both at baseline and following recurrent events.  Recurrent stroke subtypes in 
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particular may not have been very accurately classified since brain imaging rates 
among recurrences were generally quite low and no study reported use of DW MRI, 
which is particularly useful in differentiating between old and recent infarcts and in 
establishing the infarct subtype.  In patients with residual deficits from their first 
stroke, suspected recurrences in the same arterial territory as the index event can be 
particularly difficult to diagnose and classify without the help of advanced MR 
imaging.  It is difficult to predict the effect of such misclassification on the results, 
but it is possible that, in the face of uncertainty, the stroke subtype assigned is more 
likely to be the same as that of the first stroke.  In addition, in my analyses of 
recurrent stroke subtypes I could not assess or control for the differential use of 
secondary preventive interventions such as anticoagulation and carotid 
endarterectomy in different subtypes of ischaemic stroke, since these data were not 
reported.  The definition of recurrent stroke may also have impacted on the pattern of 
recurrent stroke subtypes obtained in some studies.  In one study reporting on 
recurrent stroke subtypes there was a trend towards evidence of recurrent subtypes 
breeding true, but the results were noticeably less extreme compared with those of 
the other three studies (Hillen et al. 2003).  The definition of recurrent stroke used in 
this study did differ markedly from that used in the other studies. The minimum 
necessary time period between index and recurrent stroke, was longer than in other 
studies, with recurrences occurring before 21 days in the same area of the brain as 
the index stroke excluded.   The use of this definition may therefore have 
underestimated the extent to which stroke subtypes breed true in this study, since 
early recurrences occurring in the same territory would not have been included.  The 
method of classifying ischaemic stroke subtypes may impact on patterns of recurrent 
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stroke subtypes, especially if risk factors are included in the definitions of ischaemic 
stroke subtypes, since risk factors are unlikely to have changed between the onset of 
first and recurrent stroke.  Thus, studies using such classification methods may 
overestimate the degree to which stroke subtypes breed true.  However, classification 
bias is unlikely to have substantially affected the patterns of recurrent stroke 
subtypes reported in these studies, since three of the four studies used risk factor-
independent clinical and brain imaging-based classification methods.  
There were very few available data on the risk of MI following different ischaemic 
stroke subtypes, making it impossible to draw any conclusions about the risk of MI 
across different ischaemic stroke subtypes.  
4.5.3 Conclusion 
In conclusion, risk of death in the short and long-term appears to be lower in patients 
with lacunar compared with non-lacunar ischaemic stroke, which may reflect 
differences in underlying arterial pathologies or simply differences in age, sex, 
infarct size and stroke severity.  While differences between lacunar and non-lacunar 
ischaemic stroke patients in the early risks of recurrent stroke suggest different 
predominant mechanisms in terms of the arterial occlusive source, available data on 
the longer term risks of recurrent stroke do not provide convincing support for 
fundamentally different arterial pathologies.  Recurrent stroke subtype patterns 
provide some evidence for different arterial pathologies, but existing studies have 
methodological limitations.  Data on long term risks of MI after lacunar versus non-
lacunar ischaemic stroke are too sparse to draw any conclusions.
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B. The Edinburgh Stroke Study: design and methodology 




In this chapter I will describe the rationale, aims, design and methodology of the 
Edinburgh Stroke Study, and will refer to these details in the succeeding section 
where I present results of analyses that include data from the Edinburgh Stroke 
Study. 
5.2 Rationale of the Edinburgh Stroke Study  
As I described in my introductory chapters, a better understanding of the aetiology of 
the ischaemic stroke subtypes should ultimately lead to improvement in the treatment 
of stroke.  I have also described the lack of knowledge surrounding the arteriopathy 
underlying most lacunar ischaemic stroke in particular, and identified the 
methodological limitations of existing epidemiological observational studies through 
systematic review and meta-analysis of published studies.  The Edinburgh Stroke 
Study (ESS) was set up to address some of the unanswered questions and areas of 
controversy relating to the causes and consequences of stroke, with a particular focus 
on lacunar ischaemic stroke. 
5.3 Aims  
In the ESS we recruited and followed up a large cohort of stroke patients, the three 
principal aims of the study being as follows: 
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1. to compare the risk factor profiles of patients with different ischaemic stroke 
subtypes, and in particular to determine whether hypertension and diabetes 
really are more common in lacunar patients; 
2. to determine whether the risks of vascular events (recurrent stroke and 
myocardial infarction) differ between ischaemic stroke subtypes, and to 
compare the pattern of recurrent strokes following different stroke subtypes; 
3. to obtain blood samples from patients for future analyses of genotypes and 
other biomarkers. 
5.4 Ethical approval 
We sought and obtained ethical approval for the study from the Lothian Research 
Ethics Committee and approval for the study to occur in an NHS facility from the 
Lothian NHS Research & Development department. 
5.5 Patient eligibility and consent 
We prospectively recruited consenting patients with stroke, transient cerebral or 
monocular ischaemic attack (TIA) or retinal artery occlusion, admitted to, or seen in 
outpatient clinics at, the Western General Hospital, Edinburgh between April 2002 
and May 2005.  Patients had to have been clinically assessed at the Western General 
Hospital within 6 months of the date of their cerebrovascular event.  Stroke was 
defined as the sudden onset of clinical signs of focal disturbance of cerebral function 
lasting more than 24 hours with no apparent cause other than that of vascular origin 
(Aho et al. 1980), and we recruited patients with ischaemic stroke or intracerebral 
haemorrhage but not those with subarachnoid haemorrhage.   
A clinical stroke specialist (consultant, registrar or clinical research fellow) assessed 
patients as soon after their stroke, TIA or retinal artery occlusion as possible.  
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Informed consent was required and sought from all patients.  Eligible patients (or 
their relatives) received a simple concise information leaflet explaining the details of 
the study (Appendix 5) and a short consent form, with time to read and consider 
these before the consultation with the doctor.  Patients who desired further time to 
consider whether to give their consent were given the option of returning the consent 
form to the study team by post.  The consent form consisted of four components 
(Appendix 6).  Patients could consent to any or all of the following:  
• use of their collected data for research purposes; 
• contact with their General Practitioner (GP) and access to their medical record; 
• further follow-up contact;  
• and collection of a blood sample to be stored for future analyses of genotypes 
and other biomarkers.   
A relative could provide assent when patients were unable to provide consent for 
themselves.  Where the patient was able to understand and to give verbal but not 
written consent, their clinician could provide signed witnessed consent.  Waiver of 
consent (for use where the patient was cognitively impaired – sometimes as a result 
of the stroke – and where there were no relatives or other substitute decision makers 
available to provide proxy consent) was originally approved for use by the Ethics 
Committee.  However, the introduction of the Adults with Incapacity (Scotland) Act 
2002 shortly after the start of patient recruitment meant that, for the remainder of the 
study, waiver of consent was not allowed to be used for living incapacitated patients 
with no available proxy.  We were however still able to include patients who died 
during admission to hospital, and were no longer covered by the UK Data Protection 
Act 1998.     
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5.6 Baseline data collection  
We obtained data prospectively using a standardised structured questionnaire, 
completed by the clinician at the time of assessment, using information from the 
patients and/or their relatives; the patient’s GP; and patient’s medical records.  The 
questionnaire used to collect data from inpatients is included in Appendix 7.  We 
used a slightly different form to collect data from patients assessed in outpatient 
clinics, in order to collect additional data required by the parallel running clinical 
stroke audit (Appendix 8).  Both forms were developed from existing data collection 
forms used in the ongoing clinical stroke audit, and were designed specifically to be 
used by clinicians who could complete them during the process of normal clinical 
assessment of patients.  The key data items collected are summarised in Table 5.1. 
The study team’s lead clinician (CLMS) reviewed the medical records of all patients 
reported to have an unusual cause of or risk factor for stroke to determine whether 
the potential unusual cause was definitely or probably the cause of the stroke, 
allowing us to classify and code these patients appropriately in the dataset.  Rare, 
unusual specific causes of stroke included those where there was clear evidence of a 
rare cause of stroke that could not be assigned to one or a combination of large artery 
atherothrombotic or atherothromboembolic disease, cardiac thrombotic embolism, 
small artery (lacunar) disease.  These rare causes included: bacterial endocarditis; 
atrial myxoma; giant cell arteritis and other vasculitides; arterial dissection; 
radiotherapy induced large or small vessel disease; monogenic disorders such as 




Table 5.1 List and description of key data items collected in the ESS 
Data item Details / definitions 
Consent for ESS Type of consent (patient, relative etc) and 
components of study consented to) 
Final diagnosis Stroke / TIA 
Clinical Assessment  
   NIHSS score At time of clinical assessment 
   Date of onset of symptoms - 
   Antiplatelet treatment at onset On aspirin or on other antiplatelet treatment 
   Anticoagulant treatment at onset On warfarin 
   Side of brain lesion Right / left / cerebellar or brainstem / bilateral / 
uncertain 
   Blood pressure at time of assessment - 
Risk factors  
   Previous stroke Previous clinically apparent stroke 
   Previous TIA Transient cerebral or monocular symptoms lasting 
≤24 hours 
   IHD Previous MI, angina, CABG, coronary angioplasty 
or stent 
   Hypertension History of treated hypertension 
   Diabetes mellitus History of type I or type II diabetes mellitus   
   Cardiac failure Clinical signs of heart failure or taking at least two 
drugs for its treatment 
   Atrial fibrillation History of paroxysmal or persistent atrial 
fibrillation 
Social and family history  
   Cigarette smoking Never / current / ex > 12 months / ex ≤ 12 months 
   Alcohol intake Units per week 
   1st degree relative with stroke Mother / father / sibling / children as reported by 
patient or relative 
   1st degree relative with IHD / PAD Mother / father / sibling / children as reported by 
patient or relative 
Clinical classification of stroke / TIA 
Syndrome 
OCSP classification (TACS, PACS, LACS, POCS, 
uncertain) 
Details of other risk factors or 
unusual causes 
Arterial dissection; hereditary conditions such as 





Table 5.1 continued 
Data item Details / definitions 
Clinical investigations  
   Blood tests  Full blood count (haemoglobin etc) and 
biochemistry (creatinine etc) 
   Cardiac investigation (ECG / ECHO)  Evidence of AF on ECG and LVH on ECG and 
ECHO 
   Carotid imaging results Type of carotid imaging performed; degree of 
internal carotid artery stenosis (%); post-stenotic 
collapse; plaque instability 
   Brain imaging Type of brain scan performed; evidence of new 
relevant lesion 
   Final OCSP classification subtype  OCSP syndrome modified by site and size of 
relevant lesion on brain imaging 
ESS = Edinburgh Stroke Study; NIHSS = National Institute for Health Stroke Scale; TIA = transient ischaemic 
attack; IHD = ischaemic heart disease; PAD = peripheral arterial disease; MI = myocardial infarction; CABG = 
coronary artery bypass graft; OCSP = Oxfordshire Community Stroke Project; TACS = total anterior circulation 
stroke; PACS = partial anterior circulation stroke; LACS = lacunar stroke; POCS = posterior circulation stroke; 
CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy;    




5.7 Ischaemic stroke subtype classification  
The clinician assessing the patient first assigned a clinical stroke syndrome according 
to the patients’ symptoms and signs at maximal deficit, using the OCSP classification 
(Bamford et al. 1991).  This classifies patients according to whether they had a total 
anterior circulation stroke (TACS), partial anterior circulation stroke (PACS), 
lacunar stroke (LACS), posterior circulation stroke (POCS), or an uncertain stroke 
syndrome.  We then assigned a final ischaemic stroke subtype classification based on 
the clinical syndrome modified where appropriate by the site and size of any visible 
relevant infarct(s) on brain imaging.  We classified a patient as having a lacunar 
ischaemic stroke (LACI) if they had a clinical lacunar syndrome with either no 
visible relevant infarct or a visible relevant subcortical infarct (located in the 
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thalamus, basal ganglia, internal or external capsule, or centrum semiovale) 
measuring ≤ 20mm on brain imaging, or if they had a cortical syndrome with a 
relevant subcortical lacunar infarct that accounted for their symptoms.  We classified 
a patient as having either a partial anterior circulation infarction (PACI) or a total 
anterior circulation infarction (TACI) (depending on the specific cortical symptoms), 
if they presented with a cortical-involving anterior circulation syndrome with or 
without an accompanying visible relevant cortical or striatocapsular infarct on brain 
imaging or if they presented with a clinical lacunar or posterior circulation syndrome 
but had a cortical-involving or striatocapsular infarct in the anterior circulation 
territory that was clearly relevant to the presenting stroke.  Thus a patient presenting 
with a partial anterior circulation syndrome, for example, but with a visible relevant 
lacunar infarct on brain imaging in a location which explained the stroke symptoms, 
was reclassified as having a lacunar ischaemic stroke.  We classified patients as 
having posterior circulation infarction (POCI) if they presented with a posterior 
circulation syndrome with or without an accompanying relevant infarct on brain 
imaging, or with an anterior lacunar or cortical syndrome but a visible relevant 
infarct in the posterior circulation.  We classified patients as having an uncertain 
syndrome when they presented with an unclassifiable clinical syndrome which also 
could not be classified from brain imaging findings.  
We discussed all inpatients and selected outpatients (those for whom the clinical 
diagnosis and/or stroke classification required further discussion) at a weekly stroke 
register meeting attended by expert stroke clinicians, neuroradiologists and stroke 
research fellows.  The assessing clinician presented the clinical details of each patient 
and we discussed these, and reviewed the brain imaging before agreeing on the final 
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diagnosis and stroke pathological type and subtype.  The stroke specialist consultant 
responsible for each of the remaining outpatients assigned their final diagnosis and 
subtype classification after review of all relevant clinical details and brain imaging 
findings.      
5.7.1 Definition of cardioembolic source 
We assigned patients as having a potential cardioembolic source of stroke or TIA if 
they had a problem of cardiac rhythm, structure or function that increased risk of 
cardiac embolism, including:  
• history of persistent or paroxysmal atrial fibrillation or flutter, or if they had atrial 
      fibrillation or flutter on their post-stroke or TIA ECG; 
• native cardiac valve disease or cardiac valve replacement causing an increased 
      risk of cardioembolic phenomena; 
• patent foramen ovale +/- atrial septal aneurysm with no other vascular risk 
      factors that may have provided an alternative cause for the stroke or TIA 
• active endocarditis at the time of their stroke (bacterial endocarditis also 
      considered rare, unusual cause) 
• recent myocardial infarction (within last few weeks; although visible 
     cardiac thrombus not necessary) 
• dilated cardiomyopathy 
• atrial myxoma (also considered rare, unusual cause) 
5.8 Method of follow-up 
We followed patients up for a minimum of one year and a maximum of four years.  
Our primary outcomes were death; recurrent stroke; myocardial infarction (MI); and 
disability as measured by a self-reported Modified Rankin score (van Swieten et al. 
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1998) at 6 months, one year and annually thereafter.  The outcomes that were of 
primary interest for my thesis were death, recurrent stroke and MI.  
In the follow-up component of our study we included all recruited patients diagnosed 
with a stroke from whom we had obtained consent for future contact and who were 
living in the Edinburgh area (i.e. had a postcode beginning “EH”). 
We used several overlapping methods of follow-up in an attempt to ensure as 
complete follow-up as possible for relevant outcomes.  Patients received postal 
questionnaires at 6 months from their stroke onset date, one year and annually 
thereafter for at least one year and for a maximum of four years (Appendix 9).  The 
postal questionnaire was modified from a previous follow-up questionnaire used in 
the Lothian Stroke Register, which recruited patients from the same target population 
during the 1990s (Wardlaw et al. 1998).  Questionnaires were completed by the 
patient (or a relative or carer) and returned by post to the study team.  In the 
questionnaire we enquired whether patients had had further vascular events since 
their stroke (or since we were last in contact with them, whichever was most recent).  
The brief questionnaire included questions on the following:  
• where and how the patient lived now (on their own, with relatives etc); 
• whether or not they had had further weakness in their face, arm or leg, or 
problems with vision or speech (since previous stroke or last contact); 
• whether a doctor had told them they had had a stroke (since previous stroke or 
last contact); 
• whether or not they had had chest pains (since previous stroke or last contact); 
• whether they had been told they had had a heart attack (since previous stroke 
or last contact); 
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• and their activities of daily living (through completion of a self-rated modified 
Rankin scale) (van Swieten et al. 1998). 
We sent patients a reminder questionnaire one month after the first questionnaire was 
sent if the first questionnaire had not been returned within that time.  If patients did 
not return the reminder postal questionnaire for a particular point in their follow-up, 
we interpreted this as implicit withdrawal from this aspect of the study and did not 
send any further questionnaires. 
We also provided patients with a stroke study contact card (Appendix 10) at time of 
recruitment, and asked them to contact the team should they have a further suspected 
stroke or a heart attack.  We informed GPs by letter when a patient was recruited into 
the study, providing them with an ESS alert sticker for their GP notes (Appendix 10), 
and asking them to contact the study team in the event of a further stroke or death of 
the patient.  We also added ESS alert stickers to the front of the patients’ hospital 
records to ask clinicians to contact us in the event of the patient being admitted to 
hospital with a further stroke or myocardial infarction.  In addition, at the end of 
follow-up we also contacted by post the GPs of patients who were still alive to 
enquire about the occurrence of any further vascular events during the entire follow-
up period (Appendix 11). 
In addition to these “hot-pursuit” methods, at the end of follow-up we also compared 
our cohort of patients with those included in a concurrent clinical stroke audit that 
prospectively and retrospectively collected data on patients diagnosed with a stroke 
either as an inpatient or outpatient at the Western General Hospital and the Royal 
Infirmary of Edinburgh (Edinburgh’s only other large general hospital admitting 
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patients with stroke), to identify any recurrent stroke events that we may have missed 
via our other methods. 
Finally, we arranged for all patients to be flagged at the General Register Office for 
Scotland (GRO), who routinely provided information on the date and place of death, 
whether or not an autopsy was performed, the certifying doctor, and the cause of 
death.     
5.9 Identification and definition of vascular outcomes 
5.9.1 Recurrent stroke 
We identified recurrent stroke events using the overlapping methods of 
ascertainment described above.   
We defined recurrent stroke using the same criteria as for index stroke, with the 
added criterion that there had to have been a period of neurological stability of at 
least 24 hours between the occurrence of index and recurrent stroke.  Alternative 
causes for neurological decline, such as intercurrent illness, haemorrhagic 
transformation of an infarct or cerebral oedema, also had to be excluded.   
A specialist stroke clinician assessed all patients who suffered an early recurrent 
stroke whilst still in the Western General hospital.  Wherever possible, a stroke 
clinician assessed in the outpatient clinic those patients who we had identified as 
having a possible or probable further stroke, but who had not been admitted to the 
Western General Hospital.  Where patients were unable to attend a face-to-face 
clinical assessment, we confirmed suspected recurrent strokes by independent review 
of all relevant medical records and results of clinical investigations, including brain 
imaging.  Where a patient had a recurrent stroke, we collected data on the clinical 
features of the stroke; antiplatelet and anticoagulant treatment at time of stroke; the 
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clinical stroke syndrome; details of any clinical investigations performed, including 
type of brain imaging and details of visible relevant brain lesions; and final stroke 
subtype classification.  As with the classification of the index strokes, we assigned 
recurrent stroke syndromes using a combination of clinical and brain imaging 
findings (where brain imaging was performed).  Where the patient was assessed at 
hospital and in particular where CT brain imaging showed no new relevant lesion, 
advanced MR imaging, including diffusion-weighted imaging was performed 
wherever possible.  
5.9.2 Myocardial infarction 
We identified MI events using the overlapping methods of ascertainment described 
above.  We confirmed MI events through review of all relevant medical records.  We 
recorded the date of MI and, where clinical assessment and investigations had been 
carried out, whether there were relevant ECG changes, chest pain or raised troponin.  
If the patient had died and an autopsy had been performed, we reviewed the autopsy 
report to confirm whether there was pathological evidence of acute MI.   
Diagnosis of a definite MI required either:  
(1) evidence of two of the following:  
• typical symptoms (e.g. chest pain) 
• enzymatic changes indicative of MI (generally raised troponin) 
• ECG changes suggestive of new ischaemia (new ST-T changes or left 
bundle branch block) 
or 
(2) pathological evidence of acute MI at autopsy  
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We assigned a diagnosis of probable MI when the patient died suddenly and 
unexpectedly, without evidence of a non-cardiac cause and with no subsequent 
autopsy examination. 
5.10 Death 
When we informed GPs of their patient’s involvement in the study, we asked them to 
inform us if the patient died.  We also checked survival status prior to contacting any 
patient directly during follow-up.  Every month we received copies of death 
certificates for patients in our study from the GRO.  Initially, we hoped to review 
hospital medical (and where necessary GP and nursing home) records for all patients 
who had died, but we had insufficient resources to do so.  Therefore, since 
identification of recurrent strokes and MI was a key priority, we prioritised for notes 
review all deaths for which stroke or MI appeared anywhere in part one or part two 
of the death certificate.  In addition, we reviewed the reports of all post-mortem 
examinations.  We also reviewed hospital medical records for the vast majority of in-
hospital deaths for which medical records were easy to obtain.  In total, we reviewed 
the medical records of over two-thirds of patients who had died (of any cause).     
Where we reviewed medical records for cause of death, we assigned our own cause 
of death separate to that detailed on the death certificate.  
5.10.1 Assigning cause of death 
We assigned each patient who had died a single cause of death, which was the 
disease that started the chain of events leading to death.  We used all the information 
available to us (death certificate, medical, nursing and GP records, autopsy reports) 
to make an assessment of this chain of events.  We were also guided by the simple 
rules for assigning cause of death after stroke in clinical research laid out in Halkes et 
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al., Stroke 2006.  In this study, 29 neurologists with an interest in stroke completed a 
questionnaire relating to classification of death after stroke and assigned cause of 
death to 5 case vignettes.  Stroke severity and post-stroke disability, together with 
length of time between stroke and death, were found to be key factors taken into 
consideration by neurologists.  On the basis of the responses to the questionnaire and 
case vignettes, the authors developed simple criteria for classifying death after 
stroke, a method which performed well in an interobservor study, with good 
agreement obtained.   
Taking these suggested criteria into consideration, we considered a death as being 
due to stroke wherever the factors leading to the patients’ death were clearly related 
to the stroke (e.g. aspiration pneumonia in a patient with pneumonia, deep vein 
thrombosis leading to pulmonary embolism in a patient with post stroke immobility).  
We assigned stroke as the single cause of death if death occurred within a month of a 
stroke, unless there was an undeniable other cause of death (e.g. myocardial 
infarction, malignancy, car accident).  When a patient died more than one month 
after stroke, and specific information about the chain of events leading to death was 
unavailable, we assigned stroke as the single cause of death if the patient’s best 
modified Rankin grade after the stroke had been greater than 3 (i.e. patient had quite 
severe symptoms and required help from other people, but did not need attention day 
and night, or had major symptoms and required attention day and night) or if other 
information (e.g. discharge to a nursing home) suggested that they had been left with 
significant long term disability after their stroke. 
We also categorised each single cause of death as vascular or non-vascular, including 
deaths due to haemorrhage in the vascular category when the haemorrhage had 
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occurred as a direct result of the vascular disease (e.g. ruptured aortic aneurysm), and 
in the non-vascular category when the haemorrhage was not due to underlying 
vascular disease (eg. upper gastrointestinal haemorrhage from peptic ulcer disease). 
5.11 Data checks and manipulation 
At the end of the study, we ran data checks to identify missing data in key fields, 
which I then sought to complete as far as possible through review of medical records, 
with input from a clinician (CLMS) where necessary.  Our computer programmer 
(AH) performed data manipulation and primary coding of variables. 
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Chapter 6. Assessing the impact of the requirement for explicit 
consent in the Edinburgh Stroke Study 
 
6.1 Aim 
As described in the previous chapter, we were required to obtain informed consent 
from patients or their relatives before they could be included in our study.  I aimed to 
assess the impact of this requirement for consent in the Edinburgh Stroke Study, by 
comparison with a contemporaneous clinical stroke audit that targeted the same 
population but did not require consent. 
6.2 Introduction 
As described in the previous chapter, ethics committee approval required that we 
obtain explicit consent from patients (or their relatives) before including them in the 
ESS.  Our aim was to include all stroke and TIA patients seen in outpatient clinics at, 
or admitted to, the Western General Hospital during the period of recruitment.  
However the need for consent from patients inevitably meant that not all eligible 
patients were included in the study.  Patients may not have been recruited because 
they either refused to participate in the study, or because they were missed for 
inclusion due to the logistical constraints of the consent process itself.  Obtaining 
consent from patients with stroke can be problematic because patients are sometimes 
unable to consent for themselves, as a result of dysphasia, cognitive impairment, or 
reduced conscious level due to stroke.  Research involving patients unable to consent 
for themselves is particularly constrained by current legislation and guidance.  The 
Adults with Incapacity (Scotland) Act 2000, introduced early in the recruitment 
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phase of the ESS, does not allow consent to participate in medical research to be 
given by an impartial medical representative (i.e. waiver of consent) in these 
situations.  We therefore had to rely on relatives, where available, of incapacitated 
patients to provide proxy consent.   
Since the ESS is a hospital-based study, it is of course subject to referral bias  
(whereby patients assessed at or admitted to hospital differ systematically from those 
who are not, in terms of their demographic characteristics, medical history and/or 
features of the disease under study).  This may affect the generalisability of results of 
some analyses, but it is possible to predict the type of patients likely to be 
underrepresented in a hospital-based study, and to consider the effect that this may 
have on the results of specific research questions.  However, it is also important to 
consider the impact that the requirement for consent may have had in our study, by 
determining, firstly, the proportion of all eligible patients who were actually included 
in the ESS, and secondly, whether participants differed in their characteristics from 
non-participants, to assess whether the requirement for explicit consent introduced 
response bias, or, as it has recently been termed, “consent bias” (Al-Shahi et al. 
2005). 
I assessed the impact of the consent process in the ESS through comparisons with a 
concurrent clinical stroke audit that targeted the same population but did not require 
explicit consent.  I determined patients’ willingness to participate in the various 
components of the ESS, and compared baseline characteristics of participants versus 
non-participants.    
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6.3 Methods 
6.3.1 Clinical stroke audit 
The ongoing clinical stroke audit collects data on process of care and key clinical 
variables on all patients with a stroke or TIA admitted to, or seen in outpatient clinics 
at, the Western General Hospital, with no requirement for explicit patient consent.  
Administrative and nursing staff in the audit team identify patients using 
comprehensive, multiple, overlapping, prospective and retrospective methods.  
Ethical approval for the audit was given by the Multicentre Research Ethics 
Committee (as part of a Scotland-wide stroke audit).   
6.3.2 Numbers of consenters, refusers, and participants 
We assessed participation during an 18-month period in the middle of the 
recruitment phase (October 2002 through March 2004) which we considered to be 
representative of the overall recruitment period.  We did not analyse data from the 
entire recruitment phase because firstly, we expected recruitment during the first few 
weeks of the study to be incomplete while we were piloting and refining our 
recruitment procedures, and secondly, we had not quite reached the end of the 
recruitment phase when we started analysing these data.   
The clinical audit and the ESS used a common data collection form for outpatients, 
and so the only reason for a patient who was assessed in outpatients to be in the audit 
and not in the ESS was lack of consent.  Data from inpatients were recorded 
separately for the audit and the ESS, and as a result the reason that an inpatient was 
included in the audit and not in the ESS was one of the following:  
• discrepancy between the final clinical diagnosis assigned by the audit and by 
the ESS;  
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• identification by the audit but not by the ESS; 
• identification by the audit and by the ESS but non-inclusion due to 
patient/relative refusal; 
• identification by the audit and the ESS but non-inclusion due to lack of 
consent for other reasons (e.g. patient discharged before consent could be 
sought or relatives not available to give consent). 
To identify the reasons for non-inclusion in the ESS, we gathered information from a 
variety of data sources, including a pre-inclusion administrative spreadsheet where 
we had logged all definite and possible stroke or TIA patients admitted to hospital 
and whether or not they had given consent to be included in the study; original data 
collection forms; and, where necessary, medical records of patients in order to 
confirm the diagnosis of patients identified by the audit but not the ESS.   
Where the stroke audit and the ESS had disagreed on whether or not a patient had 
had a probable or definite stroke, we considered the ESS diagnosis to be more 
accurate.  Although we considered the audit to be superior in terms of case 
ascertainment (because the latter used both prospective and retrospective methods of 
identification) we considered the ESS to be superior in terms of accuracy of 
diagnosis since all patients were assessed by a specialist stroke clinician and, as 
described in chapter 5, were discussed at our stroke register meeting.  In contrast, not 
all patients identified by the audit had been assessed by a specialist stroke clinician 
and the decision to include them in the audit as a stroke or TIA was based on review 
of medical records. 
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We obtained the total number of patients with a stroke or TIA included in the audit 
during this time (after excluding those patients where the ESS had assigned a non-
stroke/TIA diagnosis.  Of these, we determined the number who: 
• were approached and gave consent for inclusion in the ESS; 
• died in hospital before consent could be obtained, and were thus included in 
the study because their data was no longer covered by the UK Data Protection 
Act 1998; 
• refused consent to any part of the study; 
• were not included in the ESS because they were either not identified 
prospectively by the ESS, or were identified prospectively but not approached 
for consent for logistical reasons (which includes patients being discharged 
before being approached for consent or difficulties in obtaining consent from 
a relative).   
Among consenters, we calculated the proportion with consent given directly from the 
patient (either signed consent or verbal consent (witnessed by the clinician)) or from 
a relative.  Among those from whom we sought consent, we calculated the 
proportion giving consent to each of the four consent subcategories described in the 
previous chapter (use of data for research; contact with GP and access to medical 
records; follow-up; and collection of a blood sample).  We defined and enumerated 
‘participants’ as those included in the ESS (that is, those who gave consent and those 
who died in hospital before consent could be sought), and ‘non-participants’ as those 
not included in the ESS (those who refused consent and those from whom consent 
was not sought and who were discharged from hospital alive). 
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6.3.3 Characteristics of participants versus non-participants  
I assessed differences between participants and non-participants, comparing variables 
that had been collected by both the audit and the ESS, which included age; sex; event 
subtype (TIA, eye attack [transient monocular blindness or retinal artery occlusion], 
or stroke classified according to the Oxfordshire Community Stroke Project 
classification (Bamford et al. 1991) modified by site and size of relevant lesion(s) on 
brain imaging); socio-economic deprivation, using the Carstairs deprivation index 
which assigns a deprivation score based on postcode sector (McLoone 2002) and (for 
inpatients only) admission to stroke unit and length of stay.   
6.3.4 Statistical analyses 
I performed statistical analyses using STATA version 8.0 (StataCorp 2003).   
I analysed data for inpatients and outpatients separately, using the Mantel-Haenszel 
χ
2 test to compare categorical variables, Student’s t-test to compare continuous 
variables, and the χ2 test for trend to compare ordered categorical variables among 
participants versus non-participants.  I adjusted for potential confounding using 
logistic regression.  I modelled the data for inpatients and outpatients separately, 
including age, gender, event type (PACS, LACS, POCS, TACS, uncertain stroke 
type and TIA or eye attack) and socioeconomic status in both models, and length of 
hospital stay and admission to stroke unit in the inpatient model only.  I determined 
the statistical significance of the association between each included variable and 
participation by comparing a model with the variable to one without the variable 
using the likelihood ratio test (LRT), with a p-value of less than 0.05 denoting 
statistical significance.  I included age and socioeconomic status assuming a linear 
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association with participation, since inclusion of these as categorical variables did 
not improve the fit of the models, which I assessed using the LRT.    
6.4 Results 
6.4.1 Numbers of participants and non-participants 
Of 1521 patients included in the audit during the defined time period, 23 patients 
were diagnosed by the ESS study team as having had a possible stroke or TIA event 
only.  Of the remaining 1228 patients included in the audit and eligible for the ESS, 
we prospectively identified 1199 (98%), and 1075 of the 1228 (88%) eventually 
participated in the ESS (Figure 6.1).  1061 patients were approached for consent and 
we obtained consent from 1050 of these.  Twenty-five patients died in hospital 
before consent could be sought and were also included as participants.  Of the 1050 
from whom we obtained consent, 94% gave their own consent, with proxy consent 
from relatives accounting for the remaining 6%.   
There were 153 non-participants (12% of the 1228 patients included in the audit).  
Non-participants comprised 11 of 1228 eligible patients (1%) who refused consent, 
29 (2%) who were not identified prospectively by the ESS but were identified by the 
audit, and 113 (9%) identified by the ESS but from whom consent was not sought 
(Figure 6.1).  Reasons for not seeking consent from identified patients included 
discharge from hospital before consent could be sought by one of the ESS team, and 
inability to meet with and obtain signed consent from relatives of patients who were 
unable to consent for themselves. 
The proportion of patients assessed as outpatients in the ESS was greater than the proportion 
assessed as inpatients.  This reflects differences in the catchment area of the outpatient and 
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inpatient services of the Western General Hospital, with the catchment area being larger for 
outpatients.  
 
Figure 6.1 Flow diagram showing participation and non-participation of patients in the 
Edinburgh Stroke Study 
 
The proportion of patients from whom we sought and obtained consent was higher 
among outpatients than inpatients, resulting in higher participation rates among 
outpatients than inpatients (95% vs 76%, p<0.001) (Figure 6.2). 
 
Figure 6.2 Participation in the Edinburgh Stroke Study  
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Of the 1061 patients approached for consent: 
 1050 (99%) consented to use of their clinical data for research 
 1048 (99%) consented to contact with their family doctor 
 1031 (97%) consented to future direct contact for follow-up purposes 
 1021 (96%) consented to storage of a blood sample 
6.4.2 Characteristics of participants versus non-participants  
The characteristics of the 1075 participants and 153 non-participants are presented 
separately for inpatients and outpatients (Tables 6.1 and 6.2).  There were no 
significant differences between participants and non-participants in age or gender 
among inpatients and outpatients.  However, there were differences in other 
characteristics, particularly for inpatients, among whom participants were 
significantly more likely than non-participants to be admitted to a stroke unit (77% 
versus 45%, adjusted p value < 0.001), and to be more affluent (adjusted χ2 test for 
trend, p = 0.01).  The unadjusted distribution of event type among inpatients also 
differed significantly between participants and non-participants (p = 0.001): 
participants had a smaller proportion of TIAs and eye attacks, a greater proportion of 
mild (lacunar or partial anterior circulation) strokes, and a slightly greater proportion 
of the most severe (total anterior circulation) strokes (Figure 6.3).  However, the 
relationship became non-significant (p = 0.08) after adjusting for the other variables 
(Table 6.2).   
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Table 6.1 Characteristics of participants and non-participants amongst inpatients 
Characteristic 
All patients 
(N = 497) 
n (%) 
Participants* 
(N = 378) 
n (%) 
Non-participants† 




Adjusted OR participants vs non-
participants (95% CI)‡ 
Adjusted      
p-value 
(LRT)¶ 
Mean age in years (± SD) 74 (± 13) 74 (± 13) 73 (± 14) 0.38 1.00 (0.98 to 1.01) 0.63 
Male 226 (45) 176 (47) 50 (42) 0.39 1.00 0.24 
Female 271 (55) 202 (53) 69 (58)  0.73 (0.46 to 1.16)  
Event type       
 PACS 177 (35.6) 142 (37.6) 35 (29.4) 1.00 
 LACS 86 (17.3) 71 (18.8) 15 (12.6) 1.15 (0.57 to 2.32) 
 POCS 81 (16.3) 54 (14.3) 27 (22.7) 0.63 (0.33 to 1.20) 
 TACS 90 (18.1) 72 (19.1) 18 (15.1) 0.96 (0.49 to 1.89) 
 Uncertain 22 (4.4) 17 (4.5) 5 (4.2)  1.07 (0.35 to 3.28) 








Socio-economic Deprivation score (N = 495)       
 1 (most affluent) 46 (9.3) 37 (9.8) 9 (7.6) 
 2 102 (20.6) 84 (22.3) 18 (15.1) 
 3 93 (18.8) 71 (18.9) 22 (18.5) 
 4 118 (23.8) 87 (23.1) 31 (26.1) 
 5 85 (17.2) 62 (16.5) 23 (19.3) 
 6 19 (3.8) 13 (3.5) 6 (5.0) 
 7 (least affluent) 32 (6.5) 22 (5.9) 10 (8.4) 
0.04# 0.83 (0.72 to 0.96)** 0.01 
Median length of hospital stay (days) [IQR] 17 [5-46] 17 [5-44] 17 [4-57] 0.976 0.60 (0.37 to 1.00) 0.05 
Admission to stroke unit (n=495)  344 (69.4) 290 (76.9) 54 (45.4) <0.001 4.21 (2.58 to 6.87) <0.001 
 
*Includes all consenting patients and patients who died during admission before consent was sought.  †Includes patients who refused and from whom consent was not sought.  ‡493 
patients included in the logistic regression model.  ¶P-value of the log likelihood ratio statistic (comparing the model with and without the variable).  #Test for trend.  **per unit increase 
in deprivation score. 
LRT = likelihood ratio test; PACS = partial anterior circulation syndrome; LACS = lacunar stroke; POCS = posterior circulation syndrome; TACS = total anterior circulation syndrome; 
Uncertain = uncertain stroke type; TIA = transient ischaemic attack; IQR = interquartile range 
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Table 6.2 Characteristics of participants and non-participants amongst outpatients  
Characteristic 
All patients 
(N = 731) 
n (%) 
Participants* 
(N = 697) 
n (%) 
Non-participants† 




Adjusted OR participants vs 
non-participants (95% CI)‡ 
Adjusted   
p-value 
(LRT)¶ 
Mean age in years (± SD) 70 (± 11) 70 (± 11) 69 (± 12) 0.36 1.02 (0.98 to 1.05) 0.63 
Male  395 (54) 378 (54) 17 (50) 1.00 
Female 336 (46) 319 (46) 17 (50) 0.63 0.88 (0.42 to 1.81) 0.72 
Event type        
 PACS 172 (23.5) 156 (22.4) 16 (47.1) 1.00 
 LACS 110 (15.0) 107(15.4) 3 (8.8) 13.6 (1.01 to 13.2) 
 POCS 55 (7.5)  54 (7.8) 1 (2.9) 5.3 (0.7 to 41.9)** 
 TACS 1 (0.1) 1 (0.1) 0 (0) - 
 Uncertain 23 (3.1) 21 (3.0) 2 (5.9)  1.0 (0.2 to 4.9) 
 TIA / eye attack 370 (50.6) 358 (51.4) 12 (35.3) 
0.03 
3.2 (1.4 to 7.1) 
0.02 
Socio-economic Deprivation score (N = 726)       
 1 (most affluent) 80 (11.0) 78 (11.3) 2 (6.1) 
 2 131 (18.0) 120 (17.3) 11 (33.3) 
 3 141 (19.0) 137 (19.8) 4 (12.1) 
 4 191 (26.3) 182 (26.8) 9 (27.2) 
 5 124 (17.1) 118 (17.0) 6 (18.2) 
 6 41 (5.6) 41 (5.9) 0 (0) 
 7 (least affluent) 18 (2.5) 17 (2.5) 1 (3.0) 
0.04# 1.10 (0.86 to 1.42)†† 0.45 
 
*Includes all consenting patients.  †Includes patients who refused and from whom consent was not sought.  ‡493 patients included in the logistic regression model.  ¶P-value of the log 
likelihood ratio statistic (comparing the model with and without the variable).  #Test for trend.  **POCS and TACS combined for purpose of regression modelling.  ††per unit increase in 
deprivation.   
LRT = likelihood ratio test; PACS = partial anterior circulation syndrome; LACS = lacunar stroke; POCS = posterior circulation syndrome; TACS = total anterior circulation syndrome; 
Uncertain = uncertain stroke type; TIA = transient ischaemic attack. 
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Differences between participants and non-participants were less striking for 
outpatients, among whom the number and proportion of non-participants was small 
(34 / 731 = 5%; Figure 6.2, Table 6.2).  The only statistically significant difference 
(in both univariate and adjusted analyses) between participants and non-participants 
among outpatients was in the distribution of event type (Figure 6.3, Table 6.2), with 
a lower proportion of mild cortical (partial anterior circulation) strokes among 
participants, but a greater proportion of lacunar and TIA patients. 
The number of patients who refused consent (n = 11) was too small to perform any 
meaningful comparison of characteristics with consenters. 
 
Figure 6.3 Distribution of event type by participation, for (a) inpatients and (b) 
outpatients
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6.4.3 Are patients included in the ESS representative of all eligible patients? 
Although there were some differences between participants and non-participants in 
the ESS, the high level of participation meant that, overall, participants were 
representative of all patients eligible for inclusion.  The mean age of patients was 
almost identical, as was the proportion who were male, and there was very little 
difference in the distribution of event type (Table 6.3).  Similarly, the distribution of 
socioeconomic deprivation scores was similar in both groups, and the length of stay 
among inpatients was identical.  The only difference lay in the proportion of patients 
who were admitted to the stroke unit, with a higher proportion of participants having 
had stroke unit care compared with all eligible patients (77% vs 69%; Table 6.3). 
 
Table 6.3 Comparison of characteristics of all eligible patients and all participants in the 
Edinburgh Stroke Study 
Characteristic 
All eligible patients 
(N = 1228) 
n (%) 
All participants 
(N = 1075) 
n (%) 
Mean age in years (± SD) 73.3 (± 12) 73.1 (± 12) 
Male 621 (50.6) 554 (51.5) 
Event type 
  
 PACS 349 (28.4) 298 (27.7) 
 LACS 196 (16.0) 178 (16.6) 
 POCS 136 (11.1) 108 (10.1) 
 TACS 91 (7.4) 73 (6.8) 
 Uncertain type 45 (3.7) 38 (3.5) 
 TIA / eye attack 411 (33.5) 380 (35.4) 
Socioeconomic deprivation score  
  
  1 (most affluent) 126 (10.3) 115 (10.8) 
  2 233 (19.1) 204 (19.1) 
  3 234 (19.2) 208 (19.5) 
  4 309 (25.3) 269 (25.2) 
  5 209 (17.1) 180 (16.8) 
  6 60 (4.9) 54 (5.1) 
  7 (least affluent) 50 (4.1) 39 (3.7) 
Median (IQR) length of hospital stay (inpatients only) 17 (5-46) 17 (5-44) 
Admission to stroke unit (inpatients only) 344 (69) 290 (77) 
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Given the rather large proportion of outpatients included in the ESS the patients in 
our study are not, overall, be entirely representative of the stroke population within 
Edinburgh.  Our study is somewhat over-representative of milder stroke events, and 
under-representative of more severe stroke events.       
6.5 Discussion 
Through comparing a subset of the Edinburgh Stroke Study population with a 
contemporaneous stroke audit not requiring explicit consent, we found that 88% of 
eligible patients identified in the audit participated in the ESS.  Only a very small 
number of patients actually refused consent to be included in the ESS (1% of those 
approached for consent, and < 1% of eligible patients).  The main cause of non-
participation was our inability to seek consent from 9% of eligible patients.  We did 
not routinely record reasons for non-inclusion of patients identified prospectively  
but from whom consent was not sought, but this information was available from our 
administrative records for some patients.  Reasons for non-inclusion reflected the 
practical barriers to seeking consent, such as patients being discharged soon after 
admission before they could be approached for their consent, the difficulties in 
meeting with and obtaining consent from relatives of incapacitated patients, and the 
increased difficulty of obtaining consent from patients admitted to outlying wards, 
which is highlighted by the difference in the proportion of participants and non-
participants admitted to the stroke unit.  Almost all patients approached (99%) gave 
consent to use of their clinical data for research or contact with their family doctor, 
while only slightly fewer consented to questionnaire follow-up or storage of a blood 
sample for research analyses.  Thus, the logistical hurdles associated with the 
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requirement to seek explicit consent, rather than patients’ unwillingness to 
participate, was the main determinant of incomplete participation in the ESS. 
The refusal rate in our study may have been minimised by the use of clear, brief, 
easily readable information leaflets and consent forms, and by consent being sought 
by doctors, on a background of good doctor-patient relationships.  It may also partly 
reflect the patients’ characteristics, including for example their age and cultural 
setting, as well as their perception of the seriousness of their condition and the need 
for research to improve our understanding of and treatments for stroke.   
There is some evidence that the incomplete participation in the ESS, which can 
mainly be explained by the practicalities of the consent process itself, introduced 
potential bias, with important differences between participants and non-participants. 
Participants were more likely than non-participants to be outpatients, and so to have 
milder events, since it was relatively straightforward to seek consent from outpatients 
as a standard part of the clinic procedure, and more difficult to streamline the process 
for inpatients.  Inpatient participants were more likely than non-participants to be 
admitted to a stroke unit, an intervention which leads to better outcomes, as 
demonstrated in randomised controlled trials (Stroke Unit Trialists' Collaboration 
2001), reflecting the practical difficulties of obtaining consent from patients admitted 
to outlying wards in different parts of the hospital.  The smaller proportion of TIA 
patients among inpatient participants reflects the difficulties in obtaining consent 
from patients with very mild events, who are often admitted to hospital for a short 
time only.  The larger proportion of milder (lacunar and partial anterior circulation) 
strokes among inpatient participants compared with non-participants suggests that it 
was easier to obtain consent from patients with milder events, who were likely to be 
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admitted for a long enough duration to be approached for their consent, and then to 
be able to consent for themselves, rather than having to wait for a relative to be 
available.  The larger proportion of inpatients with very severe (total anterior 
circulation) strokes among participants could be explained by their relatively high 
early case fatality (Bamford et al. 1991) coupled with our ability to include in our 
study those patients who died in hospital before consent could be sought.  Although 
there were statistically significant differences in the distribution of events among 
outpatients for participants versus non-participants, these did not follow an easily 
explainable pattern, perhaps because events among outpatients were mostly mild, 
and the number of non-participants (n = 34) was small.   
Although there were some differences in the characteristics of participants and non-
participants, the high level of participation meant that participants (inpatients and 
outpatients combined) were still representative of all eligible patients.  This indicates 
that our study cohort is likely to be very representative of the target population of all 
stroke and TIA patients seen at or admitted to our hospital.  The only potentially 
important difference was the higher proportion of patients admitted from the stroke 
unit among participants compared with all eligible patients, which indicates that we 
have underrepresented patients who were admitted to our hospital but not managed 
in the stroke unit.   
6.5.1 Limitations 
My comparisons with the clinical stroke audit were limited by the data available in 
the audit.  Firstly, the baseline characteristics that I could compare between 
participants and non-participants were restricted to variables collected by both the 
audit and the ESS, using comparable methods and definitions.  Secondly, I was 
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unable to assess whether there were any differences in outcome between participants 
and non-participants, since patients identified by the audit are not routinely followed 
for further events.   
6.5.2 Comparisons with previous studies       
Several other groups have reported on the practical difficulties of obtaining consent 
in various clinical epidemiological settings, important baseline differences between 
consenters and non-consenters, and serious outcome bias as a result of the 
requirement for explicit consent (Al-Shahi et al. 2005; Iversen A et al. 2006; 
McKinney et al. 2005; Tu et al. 2004; Ward et al. 2004).  One other study has 
investigated patient participation in a hospital-based stroke register.  This was a 
multicentre Canadian study, in which the target population was all inpatient 
admissions for stroke (Tu et al. 2004).  The refusal rate (12% of eligible patients) 
was much higher and the overall proportion of eligible patients included (51%) 
considerably lower than in the ESS, even compared with only the inpatients in the 
ESS (76% of whom were included).  These differences could have been due to: the 
added complexities of obtaining consent in a multicentre register compared with a 
single centre study; variation between the studies in the administrative demands of 
the consent process, and the resources available to meet them; research nurses rather 
than doctors seeking consent in the Canadian study; and perhaps cultural differences 
between the Scottish and Canadian populations.  Notwithstanding the differences, the 
Canadian study also demonstrated that the practical difficulties in obtaining consent 
rather than explicit refusal was the main determinant of incomplete participation, and 
found differences between participants and non-participants in baseline 
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characteristics and in-hospital mortality, suggesting that participants had milder 
strokes. 
6.5.3 Conclusion 
Very few patients refused to be included in the Edinburgh Stroke Study, but 
processes integral to the requirement for explicit consent reduced participation, most 
noticeably among patients admitted to hospital.  However, the high level of 
participation meant that there was little difference in most baseline characteristics 
studied, between those eligible for inclusion in the stroke study and those who 
actually participated in the study. 
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C. Analyses of individual patient data, including Edinburgh Stroke 
Study Data 
Chapter 7. Risk factors for lacunar versus non-lacunar ischaemic 
stroke: a pooled individual patient data analysis 
 
7.1 Aim 
In this chapter I will present the results of a collaborative project in which I pooled 
individual patient data from five stroke registers and compared the risk factor 
profiles of patients with lacunar versus non-lacunar ischaemic stroke. 
In my analyses, I aimed to: 
• determine risk factor-ischaemic stroke subtype associations for each stroke 
register individually before pooling the data and adjusting for register; register, 
age and sex; register, age, sex and other risk factors; 
• perform a series of sensitivity analyses to determine the robustness of the 
results of the primary analysis to alteration of the comparison groups, to assess 
how choice of comparison group affects the results; 
• estimate the extent of misclassification of ischaemic stroke subtypes among 
patients included in the two Edinburgh-based stroke registers; 
• update my previous meta-analysis (presented in chapter 3) to include both the 
individual stroke registers analysed here and existing published studies that 
used similar unbiased methods of classifying ischaemic stroke subtypes. 
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7.2 Introduction 
In my systematic review and meta-analysis of published observational studies, I 
found some differences in the risk factor profiles of patients with lacunar compared 
with non-lacunar ischaemic stroke when I considered only those studies that had 
used risk factor-independent methods of classifying ischaemic stroke subtypes.  In 
these studies I found no excess of diabetes, and a slight significant excess of 
hypertension in lacunar versus non-lacunar ischaemic stroke, thus challenging the 
widely held belief that both hypertension and diabetes are more common in lacunar 
than non-lacunar ischaemic stroke.  I did find a higher prevalence of atrial fibrillation 
and carotid stenosis in patients with non-lacunar compared with lacunar ischaemic 
stroke.  A lower prevalence of carotid stenosis among patients with lacunar 
ischaemic stroke might reflect a lower prevalence of systemic atherosclerosis in these 
patients.  A lower prevalence of ischaemic heart disease (IHD), a marker of systemic 
atherosclerosis, among patients with lacunar ischaemic stroke would further support 
the notion of a non-atherothrombotic lacunar arterial pathology.  However, although 
there may have been a trend towards a lower prevalence of IHD among patients with 
lacunar stroke, the confidence interval was compatible with there being no difference 
in the prevalence of this risk factor between patients with lacunar versus non-lacunar 
ischaemic stroke.  
Although I included data from 10 studies (6706 patients) that used a clinical and 
imaging-based ischaemic stroke classification method in my meta-analysis, which 
allowed for reasonable precision, my results were based on univariate analyses for 
each risk factor studied, and not adjusted for the potential confounding effects of age, 
sex and other vascular risk factors.  Furthermore, the definitions of risk factors and of 
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the non-lacunar comparison group varied between studies, and data on several risk 
factors were sparse.      
I was able to overcome these shortcomings by pooling data from the ESS with 
individual patient data from four collaborating prospective stroke registers that 
recruited from predominantly Caucasian populations between 1990 and 2005, and 
that used identical risk factor-independent methods of classifying ischaemic stroke 
subtypes to the ESS, and consistent risk factor definitions.  I performed both 
univariate and multivariable risk factor comparisons between lacunar and non-
lacunar ischaemic stroke, and assessed the effects of varying the lacunar and non-
lacunar comparison groups through a series of pre-defined sensitivity analyses.  I 
also updated my previous systematic review to incorporate the unadjusted data from 
the collaborating stroke registers.   
7.3 Methods 
7.3.1 Obtaining and preparing data from stroke registers 
In addition to the baseline data from the ESS, we obtained individual patient data on 
all patients with stroke from the Lothian Stroke Register (LSR) (Wardlaw et al. 
1998), which recruited from the same target population as the ESS during an earlier 
time period, and three community-based stroke registers in Perth, Australia 
(Jamrozik et al. 1999), and in Lund (Lindgren et al. 1994a) and Orebro (Appelros et 
al. 2003) in Sweden.  Appropriate ethical approval had been sought and obtained for 
each register.  In each of these additional registers a stroke specialist clinician 
assessed patients as soon as possible after the stroke, with prospective recording of 
demographic and clinical details, including exposure to vascular risk factors and 
results of brain imaging and other investigations. 
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After receiving data on requested items from each study, we converted all individual 
patient data to a common format (AH and CLMS), ran a series of data checks for 
completeness and consistency (AH), resolved any queries and inconsistencies with 
the investigators from each study (CLMS) and made corrections where necessary.  
7.3.2 Classification of ischaemic stroke subtypes 
In my analyses I included all patients with a clinically evident stroke demonstrated to 
be ischaemic by the absence of recent intracerebral haemorrhage on CT or MR brain 
imaging, or at autopsy.  As in the ESS, each of the other stroke registers had used the 
OCSP classification (Bamford et al. 1991) to assign a clinical stroke syndrome and 
provided data on the presence and location of any visible relevant infarct(s) on brain 
imaging or at autopsy.  Following the same procedure that we used in the ESS 
(described in detail earlier), we modified the final ischaemic stroke subtype 
classification if an infarct considered relevant to the presenting stroke was present on 
brain imaging or at autopsy, leading to a final classification of TACI, PACI, LACI, 
POCI or uncertain ischaemic subtype.   
7.3.3 Risk factor definitions 
We defined hypertension as a history of treated hypertension prior to the stroke; 
diabetes as previously diagnosed with - or on medication for - type I or type II 
diabetes mellitus; and ischaemic heart disease as a prior history of myocardial 
infarction, angina or coronary revascularisation.  We considered a cardioembolic 
source to be present if a patient had a clear history or post-stroke electrocardiogram 
evidence of paroxysmal or persistent atrial fibrillation.  I dichotomised cigarette 
smoking into current or ex-smoker of ≤12 months, and never or ex-smoker of > 12 
months.  We defined excess alcohol intake in women as > 14 units per week, and in 
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men as > 21 units per week.  We defined carotid stenosis as ≥ 70% stenosis 
(European Carotid Surgery Trial criteria) on any imaging investigation of the 
extracranial neck arteries (predominantly ultrasound, but in some cases, MR, CT or 
digital subtraction angiography).   
7.3.4 Statistical analyses 
I performed statistical analyses using STATA version 8.0 (StataCorp 2003). 
7.3.4.1 Primary analyses 
In the primary analysis I included all patients with a first-ever-in-a-lifetime anterior 
circulation ischaemic stroke, and compared risk factors among patients with a 
lacunar (LACI) versus those with a non-lacunar (PACI or TACI) ischaemic stroke.  
The POCI group comprised a mixture of posterior circulation lacunar and non-
lacunar ischaemic stroke.  Because we could not reliably distinguish between these, I 
excluded all patients with POCI from the primary analysis.  
7.3.4.2 Unadjusted analyses 
I determined the crude association between each risk factor and ischaemic stroke 
subtype, comparing lacunar versus non-lacunar ischaemic stroke.  I obtained study-
specific and Mantel-Haenszel fixed effect pooled odds ratios (ORs) and their 95% 
confidence intervals, assessing heterogeneity between registers using the I2 statistic 
(Higgins & Thompson 2002).  I used Student’s t-test to compare mean ages and the 
χ
2 test to compare proportions of patients who were male.   
7.3.4.3 Adjusted analyses 
I used logistic regression to obtain adjusted ORs, using data from the ESS and LSR 
only, since data was not available on all risk factors in the other three studies (Figure 
7.1).  First, I adjusted risk factor associations for register, and then for register, age 
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and sex.  In a fully adjusted model, I adjusted for register, age, sex, and each of the 
other risk factors under study.   
 
   



















 TIA = transient ischaemic attack; CS = carotid stenosis; ESS = Edinburgh Stroke Study; LSR = Lothian Stroke Register 
 
 
Among patients included in the ESS and LSR, data on most risk factors were present 
for 98-100% of patients.  Data on ipsilateral and contralateral carotid stenosis were 
rather less complete, being present for 91% of patients (94% of lacunar patients and 
89% of non-lacunar patients) in the ESS and 67% of patients (71% of lacunar 
patients and 64% of non-lacunar patients) in the LSR.  Patients for whom data was 
















































































and frequency of other risk factors when compared with patients for whom risk 
factor data was complete.  The one exception was cardioembolic source, which was 
statistically significantly less prevalent among those in whom all risk factor data was 
available compared with those in whom some risk factor data was missing (17% vs 
25%; p < 0.001).  This was related to whether or not data on carotid stenosis had 
been collected, with patients who had a cardioembolic source less likely to have had 
imaging investigation of the extracranial arteries for carotid stenosis.  In my logistic 
regression model I excluded from each adjusted model 652 of the total 2348 patients 
(28%) for whom data was missing for one or more of the included risk factors (which 
left 1696 patients).  Because carotid stenosis was the only variable missing in a 
substantial number of patients, I also repeated my logistic regression analysis but 
excluded ipsilateral and contralateral stenosis from the model, thereby excluding 
only 104 (4%) of the total 2348 patients.  The results from this model were very 
similar to those from the model including the carotid stenosis variables, so I have 
presented the results of the latter model only. 
I investigated interaction between each risk factor and each of age and sex, by 
introducing interaction terms into the model, using the log likelihood ratio test to 
assess for significant interaction.    
7.3.5 Sensitivity analyses 
To test the robustness of the primary analysis results and to determine whether the 
choice of comparison groups has an effect on the results, I repeated the above 
unadjusted and adjusted analyses in four pre-defined sensitivity analyses:  
(1) LACI versus PACI or TACI for all patients with at least one ischaemic stroke, 
whether first-ever-in-a-lifetime or recurrent stroke; 
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(2) LACI versus PACI or TACI among all patients with a first-ever ischaemic stroke, 
excluding those with a potential cardioembolic source; 
(3) LACI versus PACI, TACI or POCI among all patients with a first-ever ischaemic 
stroke; 
(4) small vessel versus large vessel ischaemic stroke among all patients with an 
anterior circulation first-ever ischaemic stroke. 
For the last comparison I devised an algorithm based on the TOAST classification 
(Adams et al. 1993) to assign a presumed aetiological cause of stroke to each patient.  
In addition to the classification based on the clinical syndrome and brain imaging, 
the algorithm took into account the carotid imaging results, and presence or absence 
of a cardioembolic source, but was independent of hypertension, diabetes or any 
other vascular risk factors (Figure 7.2).
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Figure 7.2 Modified TOAST algorithm used to assign aetiological ischaemic stroke subtypes 
 
*LACI = lacunar infarction; PACI = partial anterior circulation infarction; TACI = total anterior circulation infarction; POCI = posterior circulation infarction 
†Ipsilateral internal carotid artery stenosis.  ‡Cardioembolic source defined as history of or post-stroke electrocardiogram (+/- echocardiogram) evidence of atrial 
fibrillation or cardiac valve disease.  #Imaging of extracranial neck arteries not performed.  ¶Appropriate cardiac investigation (electrocardiogram +/- 
echocardiogram) not performed in patients with no known history of atrial fibrillation. 
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7.3.6 Estimating extent of misclassification of ischaemic stroke subtypes 
I estimated the extent of misclassification of ischaemic stroke subtype in the primary 
analysis by calculating the proportion of patients with a visible relevant infarct on 
their brain scan whose final classification placed them in a different comparison 
group (i.e. lacunar or non-lacunar) from their classification based on the clinical 
syndrome alone.  I then applied this proportion to the patients who had no visible 
relevant infarct on brain imaging to estimate the number (and proportion) of patients 
in the analysis who were residually misclassified. 
In a post-hoc analysis, I also repeated my primary analysis among patients with a 
visible relevant infarct only, to assess the effects of excluding all potentially 
misclassified patients. 
7.3.7 Updated meta-analysis to include individual patient data 
I updated my previous meta-analysis to pool unadjusted data from the primary 
analysis of my individual patient data pooling project (using data from all five stroke 
registers) with data extracted from those previously identified published studies that 
had used a similar clinical and imaging-based (but risk factor-independent) method 
for classifying subtypes of ischaemic stroke.  I used Cochrane Review Manager 
(Cochrane Collaboration 2003) to determine study-specific and Mantel Haenszel 




7.4.1 Characteristics of stroke registers included in the pooled individual 
patient data analysis 
Between them, the five registers contributed data on 5101 patients with at least one 
stroke.  Of these, 429 (8%) did not have either brain imaging or autopsy performed 
(or these data were not available) and 414 had had a spontaneous intracerebral 
haemorrhage.  In total there were 4258 patients with a brain imaging-confirmed 
ischaemic stroke, and of these 3593 had a first-ever-in-a-lifetime ischaemic stroke.  
After excluding 638 patients with a POCI and 80 with an uncertain clinical 
syndrome, 2875 patients - 1062 with lacunar and 1813 with non-lacunar ischaemic 
stroke - were included in the primary analyses.  The Lothian Stroke Register and the 
ESS were the largest studies, contributing 1510 and 838 patients respectively to the 
primary analyses, 82% of the total data (Tables 7.1 and 7.2).   
The Lothian stroke register recruited from the same source of patients as the ESS, 
that is inpatient admissions and outpatient clinics at the Western General Hospital, 
during an earlier time period, and the other three registers were community-based. 
The mean age of patients in the five registers ranged from 67 to 76 years.  Patients in 
the hospital-based registers were slightly younger than in the community-based ones, 
and overall lacunar patients were slightly younger than non-lacunar patients (mean 
68 versus 71 years, p < 0.001).  There were approximately equal numbers of men and 
women in the non-lacunar group, but slightly more men (58%) than women in the 
lacunar group (p < 0.001).  The proportion of lacunar and non-lacunar cases was very 
similar in the different registers, with lacunar cases comprising 32% to 42% of 
anterior circulation ischaemic strokes (Table 7.1). 
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recruitment Stroke population  








Gender (% male) 









2002-2005 Consecutive consenting stroke patients 
admitted to or seen in outpatient clinics at 
the Western General Hospital, Edinburgh 
838 
(285 : 553) 
71 ± 13 
(69 ± 12 : 72 ± 13) 
51 





1990-2000 Consecutive patients admitted to or seen in 
outpatient clinics at the Western General 
Hospital, Edinburgh 
1510 
(565 : 945) 
67 ± 13 
(66 ± 12 : 68 ± 14) 
53 




1995-1996 Community-based study based on a 
defined geographical area in the northern 
suburbs of Perth.  Stroke patients were 
identified using multiple methods of 
ascertainment 
126  
(40 : 86) 
76 ± 13 
(77 ± 13 : 76 ± 13) 
52 




1991-1992 Community-based study which registered 
all new stroke patients living in the 
catchment area of Lund University 
Hospital.  Patients were identified using 
multiple methods of ascertainment 
147 
(66 : 81) 
75 ± 11 






1999-2000 Community-based study which registered 
all new stroke cases in Orebro using 
multiple overlapping methods of 
ascertainment 
254 
(106 : 148) 
75 ± 11 
(75 ± 10 : 76 ± 12) 
45 
(48 : 43) 
99 1 
 
*Mean ± standard deviation 
†Type of brain imaging used to determine final ischaemic stroke subtype classification.  Where % does not add up to 100, remainder of patients had an autopsy 
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Table 7.2 Frequency of risk factors among lacunar and non-lacunar patients, by study   
Study‡ 
All studies†  
(N = 2875) ESS (N = 838) LSR (N = 1510) Perth (N = 126) Lund (N = 147) Orebro (N = 254) 
Characteristic* 
Lacunar  
(N = 1062) 
n / N 
Non-
lacunar  
(N = 1813) 
n / N 
Lacunar 
(N = 285) 
n / N (%) 
Non-
lacunar 
(N = 553) 
n / N (%) 
Lacunar 
(N = 565) 
n / N 
Non-
lacunar 
(N = 945) 
n / N 
Lacunar 
(N = 40) 
n / N 
Non-
lacunar 
(N = 86) 
n / N 
Lacunar 
(N = 66) 
n / N 
Non-
lacunar 
(N = 81) 
n / N 
Lacunar 
(N = 106) 
n / N 
Non-
lacunar 
(N = 148) 
n / N 
Median days to brain scan (IQR) 
(N=2845) 
6 (2-21) 2 (1-13) 9 (2-24) 2 (1-13) 12 (2-23) 4 (1-19) 3 (1-6) 2 (0-4) 6 (2-12) 4 (1-7) 12 (2-23) 2 (1-3) 
Ischaemic heart disease  (N=2875) 231 / 1062 
(22) 
550 / 1811 
(30) 
56 / 285 
(20) 
151 / 553 
(27) 
110 / 565 
(19) 
264 / 945 
(28) 
12 / 40 
(30) 
32 / 84   
(38) 
26 / 66  
(39) 
50 / 81 
(62) 
27 / 106 
(25) 
53 / 148 
(36) 
Cardioembolic source  (N=2745) 106 / 1020 
(10) 
445 / 1725 
(26) 
39 / 284 
(14) 
161 / 551 
(29) 
35 / 564    
(6) 
214 / 945 
(23) 
No data 12 / 66  
(18) 
28 / 81 
(35) 
20 / 106 
(19) 
42 / 148 
(28) 
Hypertension (N=2867) 441 / 1062 
(42) 
793 / 1805 
(44) 
135 / 285 
(47) 
287 / 553 
(52) 
222 / 565 
(39) 
381 / 941 
(40) 
26 / 40 
(65) 
51 / 86  
(60) 
14 / 66  
(21) 




50 / 144 
(35) 
Diabetes (N=2872) 136 / 1062 
(13) 
215 / 1810 
(12) 
36 / 285 
(13) 
57 / 553 
(10) 
64 / 565  
(11) 
106 / 945 
(11) 
8 / 40    
(20) 
12 / 86  
(14) 
8 / 66    
(12) 




27 / 145 
(19) 
Ipsilateral ICA stenosis (N=1874) 48 / 721  
(7) 
256 / 1153 
(22) 
12 / 267  
(5) 
94 / 494 
(19) 
30 / 401    
(7) 
150 / 608 
(25) 
No data 6 / 53    
(11) 
12 / 51 
(24) 
No data 
Contralateral ICS stenosis (N=1878) 32 / 722  
(4) 
96 / 1156 
(8) 
12 / 267  
(5) 
31 / 495  
(6) 
18 / 402    
(4) 
62 / 610 
(10) 
No data 2 / 53      
(4) 
3 / 51     
(6) 
No data 
Previous TIA (N=2719) 140 / 993 
(14) 
285 / 1726 
(17) 
48 / 285 
(17) 
101 / 551 
(18) 
74 / 562  
(13) 
139 / 941 
(15) 
6 / 40   
(15) 
17 / 86  
(20) 
No data 12 / 106 
(11) 
28 / 148 
(19) 
Smoking (N=2792) 432 / 1041 
(41) 
563 / 1751 
(32) 
111 / 283 
(39) 
158 / 545 
(29) 
254 / 561 
(45) 
339 / 925 
(37) 
6 / 32    
(19) 
14 / 71  
(20) 
28 / 60  
(47) 
23 / 71   
(32) 
33 / 105 
(31) 
29 / 139 
(21) 
Alcohol excess (N=2267) 142 / 831 
(17) 
187 / 1436 
(13) 
49 / 273 
(18) 
65 / 511 
(13) 
93 / 558  
(17) 
122 / 925 
(13) 
No data No data No data 
 
*N = total number of patients in all studies (ESS, LSR, Perth, Lund and Orebro) with available data for each risk factor 
†Number (percentage) of patients with each risk factor in the lacunar and non-lacunar groups, for all studies 
‡Number (percentage) of patients with each risk factor in the lacunar and non-lacunar groups, by study 
IQR = interquartile range; ESS = Edinburgh Stroke Study; LSR = Lothian Stroke Register 
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In all registers combined, the median time from onset of stroke symptoms to brain 
imaging was 6 days (interquartile range 2-21) among patients with lacunar ischaemic 
stroke and 2 days (interquartile range 1-13) among patients with non-lacunar 
ischaemic stroke (Table 7.2).  All five registers provided data on hypertension, 
diabetes, ischaemic heart disease, and smoking.  For the remaining risk factors, data 
was not available from all registers (Figure 7.1 & Table 7.2). 
7.4.2 Risk factor-ischaemic stroke subtype associations 
For each risk factor, the register-specific univariate ORs (lacunar versus non-lacunar 
ischaemic stroke) were generally very similar across all registers, with very little or 
no between-register heterogeneity, except for cardioembolic source, for which there 
was substantial heterogeneity (Figure 7.3).   
Using only data from the Edinburgh registers, univariate pooled analyses adjusted for 
register and fully adjusted pooled analyses generally yielded very similar results.  A 
history of ischaemic heart disease was less common in lacunar patients, with the 
odds of ischaemic heart disease reduced by about a quarter in lacunar compared with 
non-lacunar patients (fully adjusted OR 0.74; 95% CI 0.57 to 0.96; Figure 7.4).  The 
odds of having a cardioembolic source was also reduced by about two-thirds in 
lacunar compared with non-lacunar patients, which again persisted after fully 
adjusting for confounding factors (OR 0.33; 95% CI 0.24 to 0.47; Figure 7.4).  The 
odds of severe ipsilateral carotid stenosis was reduced by about 80% in lacunar 
compared with non-lacunar patients (OR 0.21; 95% CI 0.15 to 0.30; Figure 7.4).   
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Lacunar  Non-lacunar 
135 / 285 
222 / 565 
26 / 40 
14 / 66 
44 / 106 
287 / 553 
381 / 941 
51 / 86 
24 / 81 
50 / 144 
36 / 285 
64 / 565 
8 / 40 
8 / 66 
20 / 106 
57 / 553 
106 / 945 
12 / 86 
13 / 81 
27 / 145 
56 / 285 
111 / 565 
12 / 40 
26 / 66 
27 / 106 
151 / 553 
264 / 945 
32 / 84 
50 / 81 
53 / 148 
39 / 284 
35 / 564 
12 / 66 
20 / 106 
161 / 551 
214 / 945 
28 / 81 
42 / 149 
OR (95% CI) 
0.83 (0.62 to 1.11) 
0.95 (0.77 to 1.18) 
1.27 (0.58 to 2.79) 
0.64 (0.30 to 1.37) 
1.33 (0.79 to 2.24) 
1.26 (0.81 to 1.96) 
1.01 (0.73 to 1.41) 
1.54 (0.57 to 4.16) 
0.72 (0.28 to 1.87) 
1.02 (0.53 to 1.93) 
0.65 (0.46 to 0.92) 
0.62 (0.48 to 0.80) 
0.70 (0.31 to 1.57) 
0.40 (0.20 to 0.80) 
0.61 (0.35 to 1.07) 
0.39 (0.26 to 0.57) 
0.23 (0.15 to 0.33) 
0.59 (0.32 to 1.09) 
0.42 (0.19 to 0.93) 
0.1 1 10
Risk factor more common 
in lacunar ischaemic stroke 
Risk factor more common 
in non-lacunar ischaemic stroke 
Heterogeneity 





n / N n / N 
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between studies (I2) 
0.1 1 10 
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17 / 86 
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Figure 7.4 Pooled univariate and multivariate odds ratios (lacunar versus non-lacunar) for risk factors (including data from Edinburgh studies only)  
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0.23 (0.16 to 0.33) 
0.24 (0.16 to 0.32) 
0.21 (0.15 to 0.30) 
0.52 (0.34 to 0.80) 
0.51 (0.33 to 0.80) 
0.90 (0.55 to 1.46) 
0.86 (0.65 to 1.14) 
0.85 (0.64 to 1.12) 
0.94 (0.70 to 1.27) 
1.30 (1.06 to 1.59) 
1.09 (0.88 to 1.36) 
1.16 (0.92 to 1.46) 
1.09 (0.83 to 1.44) 
0.81 (0.60 to 1.08) 
0.79 (0.58 to 1.07) 
Risk factor more common in 
non-lacunar ischaemic stroke 
Risk factor more common in 
lacunar ischaemic stroke 
Unadjusted for register Adjusted for age, sex and register Fully adjusted 
89 / 646 166 / 1046 
 
99 / 646 148 / 1046 
273 / 646 375 / 1046 
41 / 646 231 / 1046 







Patients  (%) (%) (n / N) (n / N) 
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OR (95% CI) 
0.1 1 10 
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After adjusting for age, sex and other risk factors, there was no significant difference 
in the frequency of contralateral carotid stenosis (which presumably does not remain 
independently associated with ischaemic stroke subtype because of its close 
correlation with ipsilateral stenosis).  Neither hypertension nor diabetes was 
associated more with either lacunar or non-lacunar ischaemic stroke, with the lack of 
association persisting after adjustment for age, sex and other risk factors (OR 1.04; 
95% CI 0.84 to 1.29 and OR 1.23; 95% CI 0.89 to 1.70, respectively; Figure 7.4).  
Similarly, prior TIA and excess alcohol were not associated more with either lacunar 
or non-lacunar ischaemic stroke.  Smoking appeared to be more common in patients 
with lacunar compared with non-lacunar ischaemic stroke but this association did not 
persist in the fully adjusted model (Figure 7.4).     
There was no evidence of interaction by age or sex for each of the risk factor-
ischaemic stroke subtype associations. 
7.4.3 Sensitivity analyses 
In the first three planned sensitivity analyses, I obtained very similar results to the 
primary analyses (Table 7.3).  The results were unaffected by inclusion of both 
recurrent and first-ever strokes; inclusion of patients with posterior circulation 
ischaemic stroke in the non-lacunar comparison group; or exclusion of patients with 
a cardioembolic source from both comparison groups.   
When I compared patients whose ischaemic stroke was attributed to small versus 
large vessel disease, having applied my modified TOAST algorithm, I did find some 
apparent differences from the results of the primary analysis: contralateral carotid 
artery stenosis was much more common in ischaemic strokes attributed to large 
vessel disease in both unadjusted and adjusted analyses, but this was presumably 
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because of a correlation with ipsilateral stenosis which was not adjusted for due to its 
inclusion in the TOAST subtype definitions; smoking also appeared commoner in 
large vessel disease (Table 7.3).  However, the analysis of TOAST subtypes was 
based on a smaller number of patients which reduced precision of the results as 
demonstrated by the relatively wide confidence intervals for all estimates.  These 
analyses included a smaller number of patients from the ESS and LSR than in the 
other analyses because an aetiological classification could not be assigned to every 
patient, with the cause of stroke in a rather large proportion of patients remaining 
undetermined (Table 7.4).  Where we classified patients as having an ischaemic 
stroke of undetermined aetiology, we categorised them further as having had 
complete or incomplete investigation (Figure 7.2).  Thus, where patients had 
undergone imaging of the extracranial neck arteries to determine presence of internal 
carotid artery stenosis, and ECG or ECHO to determine presence of atrial fibrillation 
(the main source of cardiac emboli in stroke patients), but were found not to have 
severe stenosis or cardiac sources of emboli, we classified them as having had a 
stroke of “undetermined aetiology - complete investigation”.  We considered patients 
in whom cardiac investigations or imaging of the extracranial neck arteries were not 
performed as having had an ischaemic stroke of “undetermined aetiology -
incomplete investigation”.  More patients in the LSR than the ESS were categorised 
as having an undetermined stroke subtype due to incomplete investigation, largely 
because fewer patients in the LSR had carotid doppler ultrasound of the extracranial 
neck arteries (Table 7.4). 
I also re-classified patients using this same method, but defined severe stenosis as 
presence of an ipsilateral carotid stenosis ≥ 50% instead of ≥ 70%.  After re-
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classifying patients, the proportion of patients in the small vessel disease category 
was slightly lower, as some patients with 50-69% carotid artery stenosis were classed 
as having multiple aetiologies.  The proportion of patients in the large vessel disease 
category increased, as patients with 50-69% carotid artery stenosis previously classed 
as having an undetermined cause of stroke despite complete investigation were re-
classified as having large vessel disease.  However, the proportion of patients 
classified as having an undetermined cause despite complete investigation was still 
relatively high (23%), and only marginally lower than when I used a severe carotid 
stenosis definition of ≥ 70% ipsilateral carotid stenosis (27%).  When I then repeated 
my primary analyses using my modified TOAST algorithm which incorporated this 
less strict definition of severe carotid stenosis, I obtained very similar results to those 
in the primary analysis and in my first modified TOAST classification sensitivity 













Table 7.3 Sensitivity analyses: unadjusted and adjusted odds ratios*  
Risk factor Analysis 
Total patients 
in analyses 
 OR (95% CI) 
 Adjusted for 
register 





All strokes included  
POCI included  
Cardioembolic excluded  






0.67 (0.53 to 0.85) 
0.63 (0.51 to 0.78) 
0.70 (0.56 to 0.87) 
0.74 (0.57 to 0.96) 
0.64 (0.44 to 0.95) 
0.74 (0.57 to 0.96) 
0.71 (0.56 to 0.89) 
0.76 (0.60 to 0.96) 
0.76 (0.58 to 1.01) 




All strokes included  






0.33 (0.23 to 0.44) 
0.36 (0.28 to 0.48) 
0.35 (0.26 to 0.48) 
- 
0.33 (0.24 to 0.47) 
0.40 (0.30 to 0.53) 
0.38 (0.27 to 0.52) 
- 
Hypertension Primary 
All strokes included  
POCI included 
Cardioembolic excluded  






0.90 (0.74 to 1.10) 
0.88 (0.74 to 1.06) 
0.90 (0.75 to 1.09) 
0.93 (0.74 to 1.15) 
0.77 (0.56 to 1.06) 
1.04 (0.84 to 1.29) 
1.02 (0.84 to 1.24) 
0.99 (0.81 to 1.21) 
1.03 (0.81 to 1.29) 
0.86 (0.60 to 1.23) 
Diabetes Primary 
All strokes included 
POCI included  







1.21 (0.90 to 1.64) 
1.17 (0.89 to 1.53) 
1.22 (0.92 to 1.62) 
1.24 (0.89 to 1.73) 
1.41 (0.82 to 2.44) 
1.23 (0.89 to 1.70) 
1.23 (0.92 to 1.64) 
1.24 (0.92 to 1.67) 
1.20 (0.84 to 1.70) 




All strokes included  
POCI included  







0.23 (0.16 to 0.33) 
0.26 (0.20 to 0.36) 
0.35 (0.25 to 0.49) 
0.20 (0.14 to 0.29) 
- 
0.21 (0.14 to 0.30) 
0.24 (0.17 to 0.33) 
0.31 (0.21 to 0.44) 





All strokes included  
POCI included  
Cardioembolic excluded  






0.52 (0.34 to 0.80) 
0.57 (0.39 to 0.83) 
0.70 (0.46 to 1.08) 
0.49 (0.31 to 0.78) 
0.11 (0.06 to 0.19) 
0.90 (0.55 to 1.46) 
1.00 (0.66 to 1.52) 
1.09 (0.68 to 1.75) 
0.89 (0.53 to 1.49) 
0.12 (0.07 to 0.22) 
Previous TIA Primary 
All strokes included  
POCI included  
Cardioembolic excluded  






0.86 (0.65 to 1.14) 
0.77 (0.60 to 1.00) 
0.89 (0.68 to 1.16) 
0.89 (0.66 to 1.20) 
0.68 (0.44 to 1.05) 
0.94 (0.70 to 1.27) 
0.81 (0.62 to 1.06) 
0.95 (0.72 to 1.25) 
0.98 (0.71 to 1.34) 
0.71 (0.44 to 1.14) 
Smoking Primary 
All strokes included  
POCI included  
Cardioembolic excluded  






1.30 (1.06 to 1.59) 
1.37 (1.14 to 1.65) 
1.41 (1.16 to 1.70) 
1.09 (0.88 to 1.49) 
0.67 (0.49 to 0.93) 
1.16 (0.92 to 1.46) 
1.20 (0.97 to 1.48) 
1.31 (1.06 to 1.62) 
1.12 (0.88 to 1.43) 




All strokes included  
POCI included  
Cardioembolic excluded  






1.09 (0.83 to 1.44) 
1.05 (0.82 to 1.36) 
1.00 (0.77 to 1.29) 
1.11 (0.83 to 1.49) 
1.25 (0.79 to 1.97) 
0.79 (0.58 to 1.07) 
0.74 (0.56 to 0.98) 
0.75 (0.57 to 1.00) 
0.84 (0.61 to 1.15) 
1.25 (0.74 to 2.11) 
 
*Lacunar versus non-lacunar ischaemic stroke patients are compared in all analyses other than that of TOAST subtypes, where I 
compared patients with small versus large vessel disease (hence the fewer number of patients included in this latter analysis) 
†Adjusted for age, sex, and all other risk factors included in the analysis 
‡Cardioembolic source and ipsilateral carotid stenosis were included in modified TOAST definitions, so these variables were 
not analysed   
POCI = posterior circulation ischaemic stroke; ICA = internal carotid artery; TIA = transient ischaemic attack; OR = odds ratio; 
CI = confidence interval 
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Table 7.4 Aetiological classification of ischaemic stroke subtypes according to clinical and imaging-based classification 
Aetiological classification according to Modified TOAST classification* 
Study 














ESS Lacunar 222 (78) 0 (0) 0 (0) 44 (15) 0 (0) 19 (7) 285 (100) 
 Non-lacunar 0 (0) 79 (14) 120 (22) 15 (3) 279 (50) 60 (11) 553 (100) 
 Total 222 (26) 79 (9) 120 (14) 59 (7) 279 (33) 79 (9) 838 (100) 
         
LSR Lacunar  350 (62) 0 (0) 0 (0) 50 (9) 0 (0) 165 (29) 565 (100) 
 Non-lacunar 0 (0) 134 (14) 99 (10) 16 (2) 359 (38) 337 (36) 945 (100) 
 Total 350 (23) 134 (9) 99 (7) 66 (4) 359 (24) 502 (33) 1510 (100) 
         
ESS + LSR Lacunar 572 (67) 0 (0) 0 (0) 94 (11) 0 (0) 184 (22) 850 (100) 
 Non-lacunar 0 (0) 213 (14) 219 (9) 31 (2) 638 (43) 397 (27) 1498 (100) 
 Total 572 (24) 213 (9) 219 (9) 125 (5) 638 (27) 581 (25) 2348 (100) 
 
*Patients with an uncertain ischaemic stroke syndrome or an unusual cause of stroke such as arterial dissection have already been removed 
ESS = Edinburgh Stroke Study; LSR = Lothian Stroke Register 
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7.4.4 Misclassification of ischaemic stroke subtypes  
In the primary analysis population, 1806 patients had a visible relevant infarct on 
their scan, and 343 of these (19%) were allocated to a different comparison group 
than would have been the case based on their clinical syndrome alone.  Applying the 
proportion misclassified (343 / 1806 [19%]) to the 1039 patients with no visible 
relevant infarct on their brain scan gave 197 patients who remained potentially 
misclassified.  Therefore 197 / 2845 (7%) patients may have been misclassified in 
the whole primary analysis population.  The proportion of patients misclassified was 
similar in each comparison group.  When I repeated the primary analyses including 
only patients with a visible relevant infarct on brain imaging, I found very similar 
results to the primary analysis. 
7.4.5 Updated meta-analysis 
In my previous systematic review and meta-analysis, I identified 10 published 
studies that had used a clinical syndrome and imaging-based method of classifying 
ischaemic stroke subtypes that was independent of the patient’s risk factors (Boiten 
et al. 1991; Hajat et al. 2001; Lodder et al. 1990; Mead et al. 1999b; Norrving & 
Cronqvist 1989; Sacco et al. 2006; Somay et al. 2006; Tegeler et al. 1991; Toni et al. 
1995), and three studies that relied on clinical syndrome, not modified by brain 
imaging (Lindgren et al. 1994b; Mead et al. 1998; Pittock et al. 2003).  One study 
overlaps with the Lund register in my pooled individual patient data analysis and was 
therefore excluded from my updated meta-analysis (Lindgren et al. 1994b).  
Although this overlapping study previously reported results based on ischaemic 
stroke subtypes having been categorised using a clinical syndrome (not modified by 
brain imaging findings) classification method, it should be remembered that in the 
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Lund register included in my pooled individual patient data analysis the clinical 
symptoms and the site and size of any visible relevant infarcts on brain imaging was 
taken into account when we assigned the subtype classification.     
Figure 7.5 shows, for each risk factor, the ORs for lacunar versus non-lacunar 
ischaemic stroke from my previous meta-analysis, from my unadjusted primary 
analysis of the collaborative individual patient dataset (including data from all five 
stroke registers), and from my updated meta-analysis incorporating the collaborative 
data.  These three estimates were generally similar for all risk factors.  The most 
consistent findings were a lower frequency among patients with lacunar ischaemic 
stroke of ischaemic heart disease (updated meta-analysis OR: 0.76, 95% CI 0.68 to 
0.85), cardioembolic source (OR: 0.40, 95% CI 0.35 to 0.46), and carotid stenosis 
(OR for ipsilateral stenosis: 0.23, 95% CI 0.19 to 0.29; and for contralateral stenosis: 
0.29, 95% CI 0.21 to 0.41); and no difference in the prevalence of diabetes or prior 
TIA.  The updated meta-analysis showed a slight excess of hypertension among 
patients with lacunar ischaemic stroke (OR 1.12, 95% CI 1.02 to 1.24).  It also 
suggested that smoking and excess alcohol consumption were more common in 
lacunar ischaemic stroke, but these results may be subject to residual confounding 
since they were not significant in fully adjusted analyses of the data from the two 
Edinburgh stroke registers.  There was moderate heterogeneity between studies in 
my updated meta-analysis (due to variation between the results of published studies 
and not the collaborative registers) for each of ischaemic heart disease, 
cardioembolic source, ipsilateral stenosis, previous TIA and smoking. 
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Figure 7.5 Unadjusted ORs in the previous review, the individual patient data analysis, and the updated meta-analysis 
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Figure 7.5 continued 
Lacunar Non-lacunar 
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Analyses based on this large collaborative individual patient dataset revealed 
important differences in the risk factor profiles among patients with lacunar as 
compared with non-lacunar ischaemic stroke.  There was a striking similarity 
between unadjusted and adjusted analyses of data from the Edinburgh stroke 
registers (which contributed 82% of the patients included in the entire collaborative 
dataset) and demonstrable robustness to a series of sensitivity analyses for most risk 
factors, providing methodological justification for the updated meta-analysis of 
unadjusted results from published studies.  The individual patient data results were 
largely confirmed by the updated meta-analysis, and the overall evidence supports 
the notion of a distinct non-atherosclerotic arteriopathy causing many - perhaps most 
- lacunar ischaemic strokes.  
Presence of a cardioembolic source and carotid artery stenosis were consistently less 
common in patients with lacunar than with non-lacunar ischaemic stroke, confirming 
that emboli from the heart or proximal arteries are much less likely to cause lacunar 
ischaemic stroke.  My new clearly established finding that a history of ischaemic 
heart disease, a marker of systemic atherosclerosis, is less common in lacunar than 
non-lacunar patients provides further support for a distinct non-atherosclerotic 
lacunar arteriopathy.  The results of my previous systematic review and meta-
analysis where I included data from only those studies free from classification bias 
indicated that there was no difference in the frequency of diabetes.  This finding has 
been confirmed and strengthened by these new - and now more robust - results.  The 
results of my systematic review indicated that there may be a marginal excess of 
hypertension among lacunar as compared with non-lacunar patients when only 
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studies free from classification bias are analysed.  However, in my individual patient 
data analysis hypertension is clearly equally common in patients with lacunar and 
non-lacunar ischaemic stroke.  I also found no convincing, consistent differences in 
the frequency of each of previous TIA, smoking, or excess alcohol between lacunar 
and non-lacunar ischaemic stroke subtypes.     
7.5.1 Strengths 
There are considerable strengths to my collaborative individual patient data analyses 
and their inclusion in my updated meta-analyses.  First, these analyses benefited 
from the methodological similarities between the included registers; the large 
numbers of patients, allowing more reliable detection of moderate differences in risk 
factor frequencies; and the opportunity to adjust for potential confounding factors. 
Second, their inclusion in the updated meta-analysis almost doubles the existing 
published data from studies using risk-factor free ischaemic stroke subtype 
classification methods on hypertension and diabetes, and more than doubles the 
existing data for many other risk factors analysed.  Third, although adjustment for 
potential confounders made little difference to the results for most risk factors, it did 
suggest that confounding by other risk factors might explain the results for smoking 
and alcohol excess.  Thus in my updated meta-analysis, smoking, alcohol excess and 
contralateral carotid stenosis appeared to be more common in lacunar ischaemic 
stroke, but my individual patient data adjusted analyses suggest that this may be due 
to confounding (and in the case of contralateral carotid stenosis, almost certainly due 
to a strong correlation with ipsilateral stenosis).  Fourth, a series of sensitivity 
analyses in which I varied the lacunar and non-lacunar comparison groups did not 
substantially alter the overall or register-specific results.  This suggests that the 
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observed heterogeneity between studies for some risk factor-stroke subtype 
associations in my updated meta-analysis is due less to variability in the non-lacunar 
comparison group or the inclusion of recurrent strokes and more to differences in risk 
factor definitions, the populations of patients studied, or other unidentified study 
characteristics.                     
7.5.2 Limitations 
Although three of the five registers included in my individual patient data analysis 
were community-based, the two phases of the Edinburgh hospital-based register 
contributed the majority of the data.  There is evidence that the distribution of, and 
risk factors for, ischaemic stroke subtypes differ between hospitalised and non-
hospitalised patients (Schulz & Rothwell 2003).  However, the hospital-based 
register patients in the present study were recruited from both hospital admissions 
and outpatient clinics, making them more representative.  Furthermore, although 
community-based studies should avoid spurious risk factor-stroke subtype 
associations arising from selection bias, accurate classification of pathological stroke 
types and subtypes requires early specialist clinical assessment, appropriately timed 
brain imaging and other investigations, which would essentially confine analyses 
from community-based stroke registers to those patients having some sort of 
hospital-based assessment.  
Although a classification method based on the clinical syndrome and brain imaging 
findings is probably the least biased method of assigning ischaemic stroke subtypes 
when investigating risk factor-stroke subtype associations, any classification system 
will result in some misclassification of ischaemic stroke subtypes.  On the basis of 
the clinical syndrome alone, around 10-20% of small cortical ischaemic strokes tend 
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to be misclassified as lacunar and vice versa (Mead et al. 1999a), and in my 
collaborative individual patient dataset, I estimated that misclassification may have 
occurred in up to about 7% of the total number of patients included in our primary 
analysis.  The effects are difficult to predict, but since the proportion of misclassified 
patients in the two compared groups of patients was similar, this would probably 
have caused a dilution of any true associations between risk factors and ischaemic 
stroke subtype.  However, it seems unlikely that a strong association between, for 
example, hypertension and lacunar as compared with non-lacunar ischaemic stroke 
would be completely obscured by this, and it is reassuring that my analyses confined 
to patients with a visible relevant infarct on brain imaging produced similar results to 
the primary analysis, with the OR estimates in the same directions but with less 
precision due to inclusion of fewer patients. 
It is also important to consider the potential for imprecise measurement and 
misclassification of the risk factors themselves.  Ideally, data for risk factor 
comparisons between ischaemic stroke subtypes would come from large, population-
based, prospective studies with detailed collection of risk factors at baseline; repeat 
risk factor measurements over time in subsets of subjects to permit adjustment for 
regression dilution bias; and rigorous follow-up over many years with careful 
subtyping of stroke outcomes, accruing in sufficient numbers for adequately powered 
comparisons between ischaemic subtypes.  However, in practice, while analyses of 
pooled data from prospective studies have been highly informative about the nature 
of the relationship between several risk factors (such as blood pressure and blood 
cholesterol) and stroke in general, and – to some extent – the main pathological types 
of ischaemic and haemorrhagic stroke, the level of detail required for adequate 
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distinction between ischaemic stroke subtypes has rarely been available in 
prospective studies to date (Prospective Studies Collaboration 2007; Prospective 
Studies Collaboration 2002; Asia Pacific Cohort Studies Collaboration 2003).  There 
are data from two small prospective studies, including about 300 (Tanizaki et al. 
2000) and 500 (Ohira et al. 2006) stroke outcome events each, but they used 
potentially biased risk factor-dependent or imaging-based methods for classifying 
subtypes of ischaemic stroke.  All the studies that I analysed used prospective 
methods to identify and subtype patients with stroke (in a hospital or community-
based setting), but ascertained exposure to risk factors retrospectively, and so 
necessarily crudely.  Taking blood pressure as an example, a simple dichotomy into 
those with or without hypertension loses valuable information on the nature of the 
relationship with stroke risk over a range of usual blood pressure, and any dichotomy 
based on retrospective information will necessarily be imprecise, whether it is based 
on a measure of pre-stroke blood pressure, a history of receiving treatment for 
hypertension, or post-stroke blood pressure (which may of course be influenced by 
the stroke itself).   Furthermore, a definition based on a history of treated 
hypertension will of course have failed to identify those patients with previously 
undiagnosed hypertension.  I could not measure misclassification of risk factor 
status, and although its effect on my results is difficult to predict, it seems most likely 
to have occurred to a similar extent in both comparison groups, and so to have been 
non-differential and to have diluted estimates of association.  The implication is that, 
although my analyses were based on large numbers of patients, I may have failed to 
detect some risk factor-ischaemic stroke subtype associations, but there are simply 
not yet the robust prospective data to check whether this is the case.   
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I was unable to assess the relationship between raised cholesterol and lacunar versus 
non-lacunar ischaemic stroke in my dataset, since data on pre-stroke cholesterol 
levels were unavailable.  As demonstrated in my systematic review and in a recent 
study (Amarenco et al. 2006), the current evidence suggests no definite association 
between cholesterol level and ischaemic stroke subtype. 
7.5.3 Comparisons with other studies 
In an earlier meta-analysis of four population-based studies, risk factor-stroke 
subtype associations were broadly similar to those from my individual patient data 
analyses, but ischaemic heart disease was not assessed (Schulz & Rothwell 2003). 
This meta-analysis found hypertension to be more frequent in lacunar as compared 
with non-lacunar ischaemic stroke, but this result could be attributed to a single large 
study that used strict application of the TOAST criteria with the reliance on risk 
factors to define subtypes and so potential for bias in addressing risk factor-stroke 
subtype associations. 
In a recently published study that compared risk factor prevalence in stroke patients 
with presumed small vessel versus large vessel disease, hypertension appeared much 
more common in patients with small vessel disease (Khan et al. 2007).  However, 
there are a number of important differences between this study and the studies 
included in my individual patient data analysis.  First, the comparison groups in this 
study were not strictly consecutive and contemporaneous, with some of the patients 
included in the small vessel disease group recruited from centres different from those 
which recruited the large vessel disease group.  Second, this study included post-
stroke raised blood pressure in the definition of hypertension, whereas in the studies 
included in my individual patient data analysis hypertension was defined as a history 
 188 
of treated hypertension prior to stroke onset.  Third, and perhaps because of the 
differences in definitions, the proportion of patients classed as having hypertension 
was markedly higher in both the lacunar and non-lacunar comparison groups than in 
the studies included in our individual patient analysis.  This high prevalence of 
hypertension inevitably leads to a more extreme OR than if the prevalence had been 
slightly lower in both groups, and this should be remembered when the OR is 
interpreted as a risk ratio.  And finally, the method of classifying ischaemic stroke 
subtypes was different, with the authors using a modified TOAST classification to 
assign ischaemic stroke subtypes, excluding hypertension and diabetes from the 
definitions, but taking into account cardiac sources of emboli and degree of carotid 
stenosis.  Interestingly, however, when I applied my own, similar, modified TOAST 
algorithm to the patients in our study and compared risk factor prevalence in those 
with small versus large vessel disease I obtained almost identical results to my 
primary analysis.     
7.5.4 Conclusion 
I confirmed in a large methodologically robust individual patient dataset, and in an 
updated meta-analysis including both this individual patient data and data from 
published studies free from classification bias, that a cardioembolic source and 
severe carotid stenosis are infrequently found in patients with lacunar ischaemic 
stroke and are much less prevalent than in patients with non-lacunar ischaemic 
stroke.  This suggests that emboli from the heart or proximal arteries are likely to be 
the cause of only a minority of lacunar ischaemic strokes.  Furthermore, my newly 
clearly established finding that the prevalence of previous ischaemic heart disease is 
also lower in patients with lacunar compared with non-lacunar ischaemic strokes, 
 189 
provides further evidence against in situ atherosclerosis underlying most lacunar 
strokes.   
In my individual patient analyses, hypertension and diabetes were consistently 
equally common in lacunar and non-lacunar ischaemic stroke, providing evidence 
against the still widely held belief that these risk factors are more prevalent in 
lacunar ischaemic stroke.  When I combined the unadjusted individual data with data 
from published studies that used similar methods of classifying ischaemic stroke 
subtypes, there remained a suggestion that hypertension may be only marginally 
more common in patients with lacunar ischaemic stroke.  The epidemiological 
evidence does not therefore support the view that hypertension is substantially more 
common in patients with lacunar ischaemic stroke.   
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Chapter 8. Do differences between ischaemic stroke subtypes in 
recurrent stroke and myocardial infarction support a distinct lacunar 
arteriopathy?: analysis of Edinburgh Stroke Study data 
 
8.1 Aim 
In this penultimate chapter, I report the results of my analyses where I addressed the 
final objective of my thesis, which was to compare risks of myocardial infarction and 
recurrent stroke, and recurrent stroke subtype patterns between ischaemic stroke 
subtypes, in patients followed up in the Edinburgh Stroke Study. 
8.2 Introduction 
Differences in the risk and patterns of vascular outcomes between lacunar and non-
lacunar ischaemic stroke may reflect fundamentally different underlying pathologies.  
In the previous chapter, I demonstrated that patients with lacunar ischaemic stroke 
have a lower frequency of carotid stenosis and cardioembolic source than those with 
non-lacunar ischaemic stroke - suggesting that most lacunar ischaemic stroke is not 
caused by thromboemboli - and a lower frequency of prior ischaemic heart disease (a 
marker of systemic atherothrombosis), providing indirect evidence for an arterial 
pathology that is distinct from large artery atherothrombotic disease.  If lacunar 
stroke is indeed mainly caused by a distinct non-atherothrombotic arterial pathology, 
then we would also expect a lower early recurrent stroke rate after lacunar compared 
with non-lacunar ischaemic stroke (because of a lower frequency of active sources of 
emboli); a tendency for recurrent stroke subtypes to breed true; and a lower risk of 
MI among patients with lacunar compared with non-lacunar ischaemic stroke.  From 
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my systematic review and meta-analysis of published data, I found that, although 
existing studies have suggested a lower early recurrence rate among patients with 
lacunar ischaemic stroke and a tendency for recurrent stroke subtypes to breed true, 
the reliability of the results was limited by small numbers of patients, and variable, 
sometimes biased definitions of recurrent strokes.  Also, brain imaging rates were 
low among patients following their recurrent stroke with no reports of the use of 
diffusion weighted magnetic resonance imaging (DW MRI), which is particularly 
helpful in differentiating new from old lesions, especially when they are small or 
when patients present late (Keir et al. 2004).  Several cohort studies have assessed 
the incidence of MI after ischaemic stroke, which is reported to be about 2% per 
year, but only one has reported the risk of MI in lacunar and non-lacunar ischaemic 
stroke patients separately, and it included only 6 MIs (Landi et al. 1992).  In the ESS, 
we aimed to address and overcome many of the methodological shortcomings of 
these previous studies.     
8.3 Methods 
I described the recruitment of patients, collection of baseline data, method of follow-
up and ascertainment of outcome events in chapter 5, and will therefore reiterate only 
the salient methods here before describing the statistical analyses.   
8.3.1 Study population 
In my analyses I included all patients with a clinically evident stroke demonstrated to 
be ischaemic by the absence of recent intracerebral haemorrhage on CT or MR brain 
imaging, and who had been included in the follow-up component of the ESS.   
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8.3.2 Baseline and recurrent stroke data collection 
Briefly, similar data were collected for the index and subsequent recurrent stroke, 
including data on: clinical features of stroke; primary prevention treatment at stroke 
onset; risk factor history; results of clinical investigations including brain imaging 
findings; clinical stroke syndrome using the OCSP classification (Bamford et al. 
1991); and final stroke subtype, based on clinical stroke syndrome modified by brain 
imaging findings to give a final classification of LACI, PACI, TACI, POCI or 
uncertain subtype.   
8.3.3 Ascertainment and definition of outcome events 
We followed patients for a minimum of one year and a maximum of four years, 
using multiple overlapping methods to ascertain death, recurrent stroke and MI.  
These methods included contact with GPs, patients, and the General Registry Office 
for Scotland, and, where necessary, review of hospital and GP medical records and 
autopsy reports.    
We defined recurrent stroke using the same definition as for the index stroke, with 
the added criterion that there had to be a period of clinical stability for at least 24 
hours between the index and recurrent stroke, and intercurrent illness, cerebral 
oedema and haemorrhagic transformation had to be excluded as potential causes of 
any neurological worsening.  Where there were insufficient clinical details about a 
potential recurrent stroke, and no brain imaging was performed, we considered the 
event as a possible recurrent stroke only.  Most patients with a suspected recurrent 
stroke were assessed as an inpatient or outpatient by a stroke specialist.  For patients 
with a suspected MI, or those unable to attend a face-to-face clinical assessment for 
suspected recurrent stroke, we confirmed occurrence of the event by independent 
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review of all relevant medical records and results of investigations.  Where possible, 
we obtained CT and/or advanced MR brain imaging with T2, gradient echo, fluid-
attenuated inversion recovery and diffusion weighted (DW) imaging sequences in 
patients with a suspected recurrent stroke, and in particular performed DW MRI if 
CT revealed no visible relevant lesion.     
We diagnosed definite MI where there was either: (1) autopsy evidence of acute MI, 
or (2) evidence of two of the following: symptoms of ischaemia (e.g. chest pain); 
enzyme changes indicative of MI (generally raised troponin); ECG changes 
suggestive of new ischaemia (new ST-T changes or left bundle branch block).  We 
assigned a probable MI when the patient died suddenly and unexpectedly, without 
evidence of a non-cardiac cause and with no subsequent autopsy examination. 
8.3.4 Statistical analyses 
I performed statistical analyses using STATA version 8.0 (StataCorp 2003). 
8.3.4.1 Descriptive analyses 
In my primary analysis I compared baseline characteristics of patients with a first-
ever-in-a-lifetime lacunar versus non-lacunar anterior circulation ischaemic stroke 
(i.e. patients with LACI versus PACI or TACI) using the χ2 test for dichotomous 
variables, Student’s t-test for normally distributed continuous variables, the Mann 
Whitney U-test for non-normally distributed continuous variables and the χ2 test for 
trend for ordered categorical variables.  I calculated the median length of follow-up 
as the median observation time (time from entry into study to date of death or date 
censored).    
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8.3.4.2 Assessment and quantification of follow-up completeness 
I determined the proportion of patients included in the primary analysis (i.e. lacunar 
and non-lacunar patients) who were completely followed up by each method, 
calculating the proportion of patients: 
• who had died and for whom we had received cause of death information from 
the GRO; 
• whose GP was contacted to inform them of their inclusion in the study; 
• whose GP completed postal forms in the GP survey at the end of the follow-
up period; 
• who returned all postal questionnaires.  
To determine a minimum estimate of completeness of follow-up, I quantified 
completeness of follow-up using a method modified from Clark et al. 2002.  For 
each patient, I determined the percentage of completeness of follow-up by 
determining the ratio of the observed follow-up time to the potential follow-up time: 
  
I then applied the following equation to obtain an overall follow-up completeness 
index (C) for all patients (Clark et al. 2002):     
                   
   
observed follow-up time 
potential follow-up time 
% completeness =  * 100 
ti = observed, possibly censored, survival time for the ith participant 
ti
* = ith participants follow-up time; n = number of participants 





For the purposes of this analysis, I considered recurrent stroke as the primary 
outcome of interest.  I defined the potential follow-up time as the time from entry of 
the patient into follow-up to the end point of the study or the date patients were 
censored (the date of recurrent stroke if it occurred, or date of death).  I defined 
observed follow-up as the time from entry of the patient into follow-up to the date 
patients were censored (date of recurrent stroke if it occurred, or date of death), or 
the date of last contact with each patient.  I defined last contact date as: the end point 
of the study if a patient had returned all postal questionnaires; the date the last postal 
questionnaire was completed if subsequent questionnaires were not returned; the date 
of clinical assessment of baseline stroke if no questionnaires were returned and there 
was no further direct contact between one of our clinical stroke specialists and the 
patient, or the date that a patient was last reviewed by a stroke specialist if there was 
further direct contact.  To identify any difference in completeness of follow-up 
between the comparison groups included in my primary analysis, I compared the 
proportion of patients with 100% complete follow-up among patients with lacunar 
and non-lacunar ischaemic stroke using the χ2 test.  Since completeness of follow-up 
is likely to be affected by the number of outcome events I also compared 
completeness of follow-up between my comparison groups having excluded patients 
who experienced a recurrent stroke or died.  
8.3.4.3 Survival analysis 
I used survival analysis techniques to determine the survival patterns for each of 
death, recurrent stroke and MI among patients with anterior circulation lacunar and 
non-lacunar ischaemic stroke, censoring patients at time of their non-fatal event or 
death, or at the end of the follow-up period, and compared reverse Kaplan Meier 
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survival (i.e. cumulative incidence) curves using the log-rank test.  I used Cox 
regression to obtain unadjusted and age and sex-adjusted hazard ratios for death and 
for recurrent stroke (lacunar versus non-lacunar) for the entire follow-up period and 
for pre-defined time periods: 0-1 year and 1-4 years; 0-1 month and 1 month-4 years; 
and (for recurrence only) 0-1 week and 1 week-4 years.  I was unable to adjust 
recurrent stroke hazard ratios at one month and one week for age and sex due to low 
numbers of recurrent events in the early period.  I assessed for violation of the 
proportional hazards assumption by plotting log cumulative hazard against time for 
dichotomous variables, and by plotting Schoenfeld residuals for continuous 
variables.  The proportional hazards assumption was not violated for each of stroke 
subtype, gender and age in the analyses of death and recurrent stroke (Appendix 12a 
and 12b).  I obtained unadjusted rate ratios for MI, comparing patients with lacunar 
versus non-lacunar ischaemic stroke.  It was not possible to adjust the MI risk 
comparison for confounding factors using multivariable survival analysis techniques 
because the proportional hazards assumption was violated, with the survival curves 
for lacunar and non-lacunar patients overlapping multiple times (Appendix 12c).  As 
an alternative method of controlling for prior IHD, which is likely to be the most 
important confounding factor in this case, I repeated the univariate analysis but 
excluded patients with previous IHD (see footnotes to Table 8.1 for definition). 
8.3.4.4 Sensitivity analyses 
To control for the effect of stroke severity on the rates of death in lacunar compared 
with non-lacunar ischaemic stroke, I performed a sensitivity analysis where I 
compared patients with lacunar versus mild cortical (PACI) stroke.   
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To test the robustness of the primary analysis results and to determine whether the 
choice of comparison groups has an effect on the results I repeated the above 
analyses of rates of recurrent stroke and MI in a series of pre-defined sensitivity 
analyses, altering the comparison group each time: 
(1) I compared risks of MI and recurrent stroke in patients with lacunar stroke 
compared with mild cortical stroke (i.e. PACI) to compare vascular outcome rates in 
patients with similar stroke severity  
(2) I applied my modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) 
algorithm (as described in the previous chapter; Figure 7.1) to assign an aetiological 
stroke classification to each patient and compared patients with presumed small 
vessel versus large vessel disease (thus excluding patients with a presumed 
cardioembolic stroke or stroke of an undetermined cause) 
(3) I repeated the MI analyses but included patients with definite MI only   
8.3.5 Analysis of recurrent stroke subtype patterns 
I analysed recurrent stroke subtype patterns by calculating unadjusted odds ratios for 
a lacunar or a non-lacunar recurrence following a lacunar versus non-lacunar stroke 
at baseline.  I used logistic regression analysis to adjust these odds ratios for potential 
confounding by age, sex and antiplatelet or anticoagulant therapy at onset of 
recurrent stroke.  I adjusted for treatment because this may differ according to 
baseline stroke subtype, and may also influence the type of ischaemic recurrent 
stroke (e.g. warfarin treatment for AF may be more commonly used in patients with 
non-lacunar ischaemic stroke, and may particularly reduce the risk of cardioembolic 
ischaemic stroke).   
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Inclusion of recurrences that occurred during the early period might bias analyses of 
recurrent stroke subtype patterns since these early recurrences may be more likely to 
be of the same subtype as the index stroke as a result of further thrombus or emboli 
from unstable atherosclerotic plaque in carotid arteries, for example, and not 
necessarily because stroke subtypes breed true to type in the longer term.  I therefore 
performed a sensitivity analysis where I repeated the above analyses but excluded all 
recurrent events occurring within the first 30 days post-stroke.   
8.3.6 Updated meta-analysis of recurrent stroke subtype patterns 
I updated my meta-analysis of data from studies reporting patterns of recurrent stroke 
subtypes among patients with lacunar versus non-lacunar ischaemic stroke, to 
include data from the ESS.  I determined fixed-effect study-specific and summary 
odds ratios of having a lacunar recurrence (for lacunar versus non-lacunar ischaemic 
stroke at baseline) and a non-lacunar recurrence (for lacunar versus non-lacunar 
ischaemic stroke at baseline), with their accompanying 95% confidence intervals 
using Cochrane Review Manager.  I assessed heterogeneity between studies using 
the I2 statistic (Higgins & Thompson 2002).   
8.3.7 Estimation of ischaemic stroke subtype misclassification 
I estimated the extent of misclassification of ischaemic stroke subtypes by 
calculating the proportion of patients with a visible relevant infarct on their brain 
scan whose final classification placed them in a different comparison group (i.e. 
lacunar or non-lacunar) from their classification based on the clinical syndrome 
alone.  I then applied this proportion to the patients who had no visible relevant 
infarct on brain imaging to estimate the extent of residual misclassification among 
both baseline and recurrent ischaemic stroke subtypes.   
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8.4 Results 
8.4.1 Baseline characteristics of patients 
Of 1413 stroke patients recruited into the ESS and eligible for inclusion in follow-up, 
1368 (97%) were followed up (Figure 8.1).  As presented previously, just 14 patients 
(1%) who gave their consent for their data to be collected for research purposes did 
not consent to the follow-up component of the study. 
  
Figure 8.1 Flow diagram of Edinburgh Stroke Patients included in analyses  
 
 
1435 stroke patients 
recruited to the ESS 
1413 patients  
eligible for follow-up 
22 non-EH postcode residents were 
ineligible for follow-up  
1368 stroke patients  
included in follow-up 
Eligible patients not followed up: 
14 did not consent to follow-up 
31 patients omitted from follow-up in error 
1230 ischaemic stroke patients 
Excluded from analyses: 
88 patients with ICH 
30 with an uncertain pathological type of 
stroke (i.e. patients with no brain imaging) 
Excluded from analyses: 
1 patient aged <18 
221 with a prior stroke 
19 patients with unusual cause of stroke (e.g. 
arterial dissection, monogenic disorders etc) 
1008 first-ever-in-a-lifetime 
ischaemic stroke patients 
included in analyses 
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Of the 1368 patients followed up, 1230 had had an ischaemic stroke.  After 
excluding one patient aged less than 18, 19 patients whose stroke was known to have 
been due to an unusual cause, and patients with a previous history of a symptomatic 
stroke, this left 1008 patients who had had a first-ever-in-a-lifetime stroke, all of 
whom underwent brain imaging.  Of these, 809 patients had an anterior circulation 
ischaemic stroke (282 were lacunar and 527 were non-lacunar) and were followed up 
for a median of 2.4 (interquartile range 1.7 to 3.2) years, giving a total follow-up 
time of 1726 person-years.  
Patients with lacunar ischaemic stroke were slightly younger than those with non-
lacunar ischaemic stroke (mean 69 vs 73 years; p < 0.001) and there were more men 
in the lacunar compared with the non-lacunar group (60% vs 47%; p = 0.001; Table 
8.1).  The delay from onset of stroke symptoms to clinical assessment was slightly 
longer for patients with lacunar than non-lacunar ischaemic stroke (median 12 vs 7 
days; p < 0.001), with the delay to assessment reflecting the inclusion of patients 
who were assessed in outpatient clinics.  More patients with lacunar than non-lacunar 
ischaemic stroke were assessed in outpatients, hence the slightly longer time to 
clinical assessment in the former group.   
Among patients who had CT brain imaging only (and not MR brain imaging), a 
greater proportion of lacunar than non-lacunar cases was scanned more than 7 days 
after symptom onset (51% vs 41%; p = 0.02), but few patients in both groups were 
scanned at more than one month post-stroke (12% vs 9%; p = 0.22).  More than one 
quarter of lacunar patients and about one fifth of non-lacunar patients had MRI at 
baseline, with no significant difference in time between symptom onset and MR 
brain scan (Table 8.1). 
 201 
Table 8.1 Baseline characteristics of lacunar and non-lacunar anterior circulation ischaemic 








(527) p value 
Demographics     
   Age (mean years  ± SD) 72 (±12) 69 (±12) 73 (±12) <0.001 
   Male (%) 418 (52) 168 (60) 250 (47) 0.001 
Clinical risk factors     
   Hypertension* (%) 414 (51) 135 / 282 (48) 279 / 527 (53) 0.17 
   Diabetes mellitus† (%) 91 (11) 38 / 282 (13) 53 / 527 (10) 0.14 
   Previous TIA (%) 141 (17) 47 / 282 (17) 94 / 525 (18) 0.53 
   Previous IHD‡ (%) 203 (25) 56 / 282 (20) 147 / 527 (28) 0.01 
   Atrial fibrillation¶ (%) 177 (22) 34 / 281 (12) 143 / 527 (27) < 0.001 
   Ipsilateral carotid stenosis# (%) 106 (14) 13 / 271 (5) 93 / 479 (18) < 0.001 
   Contralateral carotid stenosis# (%) 43 (5) 12 / 271 (4) 31 / 482 (6) 0.26 
Clinical assessment     
    Independent in ADL pre-stroke     766 (95) 274 / 282 (97) 492 / 525 (93) <0.01 
    NIHSS (median [IQR]) 1 (0-4) 1 (0-3) 2 (0-7) < 0.001 
    Time to assessment 
    (median days [IQR]) 
9 (2-20) 12 (4-22) 7 (1-19) < 0.001 
Brain imaging     
 CT (%) 662 (81) 217 / 282 (78) 445 / 527 (84) 0.01 
   Median days from onset to CT  
   (IQR) 
4 (1-18) 7 (1-19) 3 (1-17) 0.001 
   Scanned > 7 days post-stroke (%)** 276 / 619 (45) 105 / 206 (51) 171 / 413 (41)  
   Scanned > 30 days post-stroke (%)** 62 / 619 (10)  25 / 206 (12) 37 / 413 (9)  
 MRI (%) 189 (23) 76 / 282 (27) 113 / 527 (21) 0.17 
   Median days from onset to MRI 
   (IQR) 
19 (4-35) 21 (14-22) 18 (1-38) 0.13 
 
*History of treated hypertension 
†previously diagnosed with or on medication for diabetes mellitus  
‡history of myocardial infarction (including ECG evidence of silent myocardial infarction), angina or coronary 
revascularisation 
¶history, or post-stroke electrocardiogram evidence, of paroxysmal or persistent atrial fibrillation 
#severe carotid stenosis defined as ≥ 70% internal carotid artery stenosis (ECST criteria) 
**including patients who had CT brain imaging only 
TIA = transient ischaemic attack; IHD = ischaemic heart disease; ADL = activities of daily living; NIHSS = 
National Institute of Health Stroke Score; IQR = interquartile range; CT = computed tomography; MRI = 
magnetic resonance imaging 
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8.4.2 Completeness of follow-up 
There were no patient withdrawals from the study, and no patient was entirely lost to 
follow-up.  Five patients withdrew from the postal questionnaire follow-up aspect of 
the study, but were still followed up by other methods.  The estimated completeness 
of each follow-up method is detailed in Table 8.2.  It was not possible to determine 
whether contact cards were always given to patients or whether study stickers were 
always added to patients’ notes.  Patient response to postal questionnaires was good, 
with 72% returning all questionnaires sent to them and 88% returning at least the 
first (6-month) questionnaire. 
 
Table 8.2 Completeness of follow-up 
Follow-up method Details Completeness of follow-up method 
General Registry 
Office for Scotland 
 
All patients were flagged at the 
General Registry Office, to obtain 
notification and cause of death 
Data on 1367 (100%) patients 
provided to the GRO for flagging 
purposes 
Cause of death data received from 
GRO for 338 / 356 (95%) patients 
known to have died 
GP contact Letters sent to GP when patient 
entered into the study, requesting that 
they inform us of further vascular 
events and/or death 
Letters sent to GPs of all  
1367 patients (100%) 
 
GP survey: at end of study, 
questionnaires sent to GPs of all 
living patients to enquire about the 
occurrence of further vascular events 
during the entire course of the study  
Form returned by GP for  
792 / 1014  patients  
(78% of living patients) 
 
Contact cards Patients were given a study contact 
card and asked to contact the study 
team if they had another stroke or an 
MI 
Inestimable 
Postal questionnaire Patients still alive at 6 months, 1 year 
(and annually thereafter) were sent a 
postal questionnaire  
882 / 1217 (72%) patients returned 
all questionnaires sent to them 
 
ESS Stickers Study stickers were placed on the 
front of hospital medical records and 
were provided to GPs to place on the 
front of primary care medical records 
Inestimable 
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The completeness of follow-up - as measured by postal questionnaire response - was 
84%.  This is a minimum estimate of overall completeness of follow-up, because it 
does not take into account our other methods of follow-up which were not analysable 
by this method of estimating completeness.  Slightly more patients with non-lacunar 
than lacunar ischaemic stroke had 100% complete follow-up (86% vs 81%, p = 0.05; 
Figure 8.2a).  However, this is probably explained by the increased number of 
outcome events (and thus more patients with 100% follow-up) in the non-lacunar 
group, because when I excluded patients who had had a recurrent stroke or died, 
there was very little difference in the proportion of patients who were completely 
followed up (77% vs 75%, p = 0.51; Figure 8.2b). 
 
Figure 8.2 Proportion of lacunar and non-lacunar patients with complete (100%) follow-up 
by postal questionnaire: (a) including all patients and (b) excluding patients who had had a 
recurrent stroke or died 
 



























81 % 86 % 75 % 77 % 
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8.4.3 Death 
Among all 809 patients with anterior circulation ischaemic stroke, 191 (24%) died 
during follow-up.  Of these, 127 (66%) were deaths due to a vascular cause.  
Specifically, deaths were due to stroke (77 [40%]); cardiac causes (35 [18%]), cancer 
(32 [17%]), chest infection (12 [6%]), chronic obstructive pulmonary disease (5 
[3%]), ischaemic bowel (4 [2%]), other causes such as sepsis, liver failure, vascular 
dementia etc (21 [11%]), and unknown cause (5 [13%]).      
Of the 191 deaths, 38 (13%) were among patients with lacunar ischaemic stroke and 
153 (29%) were among patients with non-lacunar ischaemic stroke (Table 8.3).   
Death was due to a vascular cause in 19 of the 38 (50%) lacunar patients, and 108 of 
the 153 (71%) non-lacunar patients.   
 
Table 8.3 Outcome events among lacunar and non-lacunar anterior circulation ischaemic 
stroke patients 













Death 191 (24) 38 (13) 153 (29) 101 (23) 
Recurrent stroke 109 (13) 36 (13) 73 (14) 64 (14) 
Myocardial infarction     
   All 33 (4) 8 (3) 25 (5) 21 (5) 
      -  Fatal 11 (1) 1 (0.4) 10 (2) 7 (2) 
      -  Non-fatal 22 (3) 7 (2) 15 (3) 14 (3) 
 




Over the entire follow-up period, risk of death was significantly lower in the lacunar 
than in the non-lacunar ischaemic stroke group (unadjusted HR 0.41, 95% CI 0.29 to 
0.58), as demonstrated in the reverse Kaplan Meier survival plot (Figure 8.3; log 
rank p < 0.001).  After adjusting for age and sex the difference in risk of death 
attenuated only very slightly, with the rate of death in lacunar patients about 50% 
lower than in non-lacunar patients (adjusted HR 0.46, 95% CI 0.33 to 0.66).  The 
difference in risk of death was most prominent during the early (one-month) post-
stroke period (Figure 8.3 & Figure 8.4), although there was still a trend towards a 
lower risk of death among patients with lacunar compared with non-lacunar 
ischaemic stroke in the longer term, even after I accounted for stroke severity in a 
sensitivity analysis where I compared patients with lacunar versus mild cortical 
ischaemic stroke (PACI) (Figure 8.4). 
 
Figure 8.3 Plot of cumulative probability of death, among lacunar and non-lacunar 
ischaemic stroke patients 
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Unadjusted HR*: 0.41, 95% CI 0.29 to 0.58 
Adjusted HR*: 0.46, 95% CI 0.33 to 0.66 
( 
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Figure 8.4 Age and sex-adjusted hazard ratios for death, for the entire follow-up period and 
for pre-defined time periods, in primary and sensitivity analyses 
 
*unadjusted hazard ratio 
HR = hazard ratio; CI = confidence interval; PACI = partial anterior circulation infarction 
 
8.4.4 Recurrent stroke 
Among patients included in the primary analysis, 109 (13%) had at least one 
recurrent stroke during follow up (Table 8.3).  Thirty-six (13%) patients with a 
lacunar ischaemic stroke at baseline had a recurrent stroke and 73 (14%) patients 
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with a non-lacunar ischaemic stroke at baseline had a recurrent stroke (9 [11%] 
among patients with a TACI and 64 [14%] among patients with a PACI). 
 
Figure 8.5 Plot of cumulative probability of recurrent stroke, among patients with lacunar 
and non-lacunar ischaemic stroke 
 
*Cox regression 
HR = hazard ratio; CI = confidence interval 
 
 
Over the entire follow-up period, there was no statistically significant difference in 
rate of recurrence between patients with lacunar versus non-lacunar ischaemic stroke 
(unadjusted HR 0.81, 95% CI 0.55 to 1.21), with the Kaplan Meier reverse survival 
plots very similar for both groups (log rank p value = 0.32; Figure 8.5).  This lack of 
difference remained after adjusting for age and sex (adjusted HR 0.88, 95% CI 0.59 
to 1.31).  There was a non-significant trend towards a lower rate of recurrent stroke 
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Unadjusted HR* 0.81, 95% CI 0.55 to 1.21    
Adjusted HR* 0.88, 95% CI 0.59 to 1.31    
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0.55, 95% CI 0.18 to 1.70), with no evidence of any difference thereafter (Figure 
8.6).  This difference in recurrence rate was greater when I examined the very early 
(i.e. first week) period (unadjusted HR 0.31, 95% CI 0.04 to 2.53), but precision was 
limited by small numbers of early recurrences (at one week 1 patient in the lacunar 
group had a recurrence versus 7 in the non-lacunar group).  However, due to the 
delay between onset and clinical assessment, we probably underestimated the early 
stroke recurrence risk, particularly among patients with non-lacunar stroke at 
baseline, and hence underestimated the extent of the reduced early recurrence risk 
among patients with lacunar as compared with non-lacunar stroke.  After I excluded 
the first week post-stroke, there was no clear difference in the rate of recurrence 
thereafter (age and sex-adjusted HR 0.93, 95% CI 0.62 to 1.41; Figure 8.6). 
The results of my sensitivity analyses were very similar to the results of my primary 
analysis.  When I compared risk of recurrence in patients with lacunar versus mild 
cortical ischaemic stroke (i.e. PACI), I found very similar results to those in the 
primary analysis when I analysed the entire follow-up period (adjusted HR 0.88, 
95% CI 0.58 to 1.32), the one month period (unadjusted HR 0.52, 95% CI 0.17 to 
1.60), and the one week period (unadjusted HR 0.29, 95% CI 0.03 to 2.40), although 
again, low numbers of very early recurrences limited the precision of effect estimates 
in the acute period (Figure 8.6).  When I compared risk of recurrence in patients with 
presumed small vessel versus large vessel disease, I found no significant difference 
in risk of recurrence during the entire follow-up period once I adjusted for 
confounding by age and sex (adjusted HR 0.56, 95% CI 0.30 to 1.05; p = 0.07), and 
no difference at one month, although numbers of outcome events (n = 5) were low 
once patients were classified according to presumed aetiological cause.  There were 
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no very early recurrent strokes among patients with presumed small vessel disease, 
which prohibited analysis of the one-week period. 
 
Figure 8.6 Age and sex-adjusted hazard ratios (lacunar versus non-lacunar ischaemic stroke) 
for recurrence risk during the entire follow-up period, and at specific time periods, in 
primary and sensitivity analyses 
 
*Unadjusted for age and sex 
HR = hazard ratio; CI = confidence interval; PACI = partial anterior circulation infarction 
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8.4.5 Myocardial infarction 
Twenty-five (5%) patients with a non-lacunar ischaemic stroke at baseline 
subsequently had an MI compared with 8 (3%) patients with a lacunar ischaemic 
stroke at baseline (Table 8.3).  Although the Kaplan Meier plot suggested a reduced 
risk of MI following lacunar compared with non-lacunar ischaemic stroke (Figure 
8.7), this was not statistically significant (log rank p value = 0.10; rate ratio 0.51, 
95% CI 0.23 to 1.14).   
 
Figure 8.7 Plot of cumulative probability of MI, among patients with lacunar and non-
lacunar ischaemic stroke 
 
When I limited my analysis to patients without a prior history of IHD, the association 
between lacunar stroke and a reduced rate of MI became more extreme, and reached 
statistical significance albeit with poor precision due to reduced numbers of patients 
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RR = rate ratio; CI = confidence  interval; MI = myocardial infarction 
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sensitivity analyses, where I compared MI risk in patients with: small versus large 
vessel disease; lacunar stroke versus PACI; and where I included definite MIs only.  
Effect estimates became less precise however, due to inclusion of fewer patients 
(Figure 8.8). 
 
Figure 8.8 Rate ratios of myocardial infarction, comparing lacunar with non-lacunar patients 
in the primary analysis, and varying the comparison groups in sensitivity analyses 
 
MI = myocardial infarction; IHD = ischaemic heart disease; SVD = small vessel disease; LVD = large vessel 
disease; PACI = partial anterior circulation infarction 
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8.4.6 Recurrent stroke subtype patterns 
Brain imaging was available to confirm the main pathological type of recurrent 
stroke (ischaemic or haemorrhagic) and to help with assigning an ischaemic subtype 
in 93% of patients with a recurrent stroke, and one patient had autopsy but no brain 
imaging.  Of the patients with brain imaging, 64% had CT imaging and 54% had 
advanced MR imaging including diffusion weighted sequences (Table 8.4).  We 
assigned a pathological subtype (TACI, PACI, LACI, POCI) in 97 of 98 cases of 
recurrent ischaemic stroke.  Over three quarters of patients with recurrent ischaemic 
stroke had a visible relevant infarct on brain imaging (Table 8.5).  Among patients 
with PACI and lacunar ischaemic stroke (between which there is the greatest degree 
of clinical subtype misclassification), three quarters and two thirds, respectively, had 
a visible relevant infarct on brain imaging. 
 
Table 8.4 Brain imaging characteristics of patients with recurrent stroke following anterior 
circulation ischaemic stroke at baseline 
Brain imaging 
All patients 
(N = 109) 
Lacunar 
ischaemic stroke  
(N = 36) 
Non-lacunar 
ischaemic stroke  
(N = 73) 
CT or MR imaging 101 (93) 35 (97) 66 (90) 
CT imaging 70 (64) 22 (61) 48 (66) 
     Median days to CT imaging* (IQR) 2 (1-4) 4 (1-5) 1 (0-4) 
MR imaging 59 (54) 23 (64) 36 (50) 
     Median days to MR imaging* (IQR) 20 (9-32) 18 (5-31) 21 (1-33) 
CT and MR imaging 28 (26) 10 (28) 18 (25) 
 
* Time from onset of symptoms to imaging.  CT = computed tomography; MR = magnetic resonance; 




Table 8.5 Brain imaging characteristics of all patients with recurrent ischaemic stroke 
Brain imaging performed 
Recurrent stroke 
subtype CT (%) MR (%) CT and MR (%) 
Visible relevant 
infarct on CT and / or 
MR imaging (%) 
LACI (n = 24) 11 (46) 17 (71) 4 (17) 16 (67) 
TACI (n = 14) 14 (100) 2 (14) 2 (14) 14 (100) 
PACI (n = 47) 33 (70) 31 (66) 17 (36) 36 (77) 
POCI (n = 12) 9 (75) 8 (67) 5 (42) 9 (75) 
All (n = 97) 67 (69) 58 (60) 29 (30) 75 (77) 
CT = computed tomography; MR = magnetic resonance; LACI = lacunar infarction; TACI = total 
anterior circulation infarction; PACI = partial anterior circulation infarction; POCI = posterior 
circulation infarction 
 
Overall, the distributions of recurrent subtypes following lacunar versus non-lacunar 
ischaemic stroke subtypes were significantly different (χ2 test: p = 0.001; Figure 8.9). 
 
Figure 8.9 Recurrent stroke subtype patterns, according to type of baseline ischaemic stroke 
 
The risk of a lacunar recurrence was six times greater following a lacunar than a non-
lacunar ischaemic stroke at baseline (OR 6.50, 95% CI 2.43 to 17.52).  This 
association attenuated only slightly and remained statistically significant after 
adjusting for age, sex and whether patients were on antiplatelet or anticoagulant 
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therapy at the time of their recurrent stroke (OR 5.39, 95% CI 1.79 to 16.2).   The 
risk of a non-lacunar recurrence was reduced by more than 70% among patients with 
lacunar compared with non-lacunar stroke at baseline (OR 0.24, 95% CI 0.10 to 
0.57), with little change after adjusting for age, sex, and antiplatelet and 
anticoagulant therapy at stroke onset (adjusted OR 0.27, 95% CI 0.11 to 0.67). 
When I repeated these analyses in a sensitivity analysis including only those patients 
who had a recurrent stroke after the acute period (> 30 days post-stroke), I found 
very similar results to those in the primary analysis, with the risk of a lacunar 
recurrence about 5 times greater following a lacunar compared with a non-lacunar 
ischaemic stroke at baseline (adjusted OR 4.97, 95% CI 1.51 to 16.4), and a lower 
risk of a non-lacunar recurrence following lacunar as compared with non-lacunar 
ischaemic stroke (adjusted OR 0.36, 95% CI 0.14 to 0.96).     
8.4.7 Meta-analysis of recurrent stroke subtype patterns  
In my previous systematic review and meta-analysis of outcome studies, I identified 
four studies that reported on patterns of recurrent stroke subtypes following lacunar 
and non-lacunar ischaemic stroke (De Jong et al. 2004; Hata et al. 2005; Hillen et al. 
2003; Nadeau et al. 1993).  After combining data from these studies with unadjusted 
data from the Edinburgh Stroke Study, I found a six-fold increase in the odds of a 
lacunar recurrence following a lacunar compared with a non-lacunar ischaemic 
stroke at baseline (OR 6.83, 95% CI 4.18 to 11.18; Figure 8.10).  There was however 
substantial heterogeneity between studies (I2 = 77%) which could largely be 
explained by the results of one study in which the proportion of recurrences that were 
lacunar following non-lacunar ischaemic stroke at baseline was much higher (23%) 
than in the other three studies (3% to 4%) and in the ESS (11%) (Hillen et al. 2003).  
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Similarly, the odds of a non-lacunar recurrence among patients with a lacunar versus 
non-lacunar stroke at baseline was significantly lower (OR 0.21, 95% CI 0.14 to 
0.32; Figure 8.10), with substantial heterogeneity again explained by the results of 
one study (Hillen et al. 2003).  One notable difference between this study and the 
others is the definition of recurrent stroke used.  In the former, recurrences that 
occurred within 21 days of the index stroke and in the same part of the brain as the 
first stroke were excluded.  This may have biased the results, leading to an 
underestimation in this study of the extent to which recurrent stroke subtypes may 
breed true.  Brain imaging rates among index and recurrent strokes were similar to 
those in the other included studies (but lower than in the ESS), but there may be 
other unidentified methodological differences in this study which may explain this 
different recurrent stroke subtype pattern, such as quality of clinical assessment; time 
from stroke onset to assessment; time from stroke onset to brain imaging and type of 
brain scan.  A combination of these may have led to greater misclassification of 
ischaemic stroke subtypes.  
 216 
Figure 8.10 Meta-analysis of (a) risk of lacunar recurrence and (b) risk of non-lacunar 





In (a), n = number of patients with a lacunar recurrence and N = total number of either lacunar or non-lacunar 
patients who had a recurrence.   
In (b), n = number of patients with a non-lacunar recurrence and N = total number of either lacunar or non-
lacunar patients who had a recurrence. 
Open diamond represents the pooled summary estimate.  OR = odds ratio; CI = confidence interval; ESS = 
Edinburgh Stroke Study.   
1Hata et al. 2005; 2Hillen at al. 2003; 3de Jong et al. 2004; 4Nadeau et al. 1993  
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8.4.8 Misclassification of baseline and ischaemic stroke subtypes 
In my primary analysis 509 / 809 patients had a visible relevant infarct on their scan, 
64 of whom were allocated to a different comparison group than would have been 
the case based on their clinical syndrome alone.  Applying the proportion 
misclassified (64 / 509) to the 300 patients with no visible relevant infarct on their 
brain scan gave an estimated 42 / 809 (5%) patients residually misclassified at 
baseline.  Slightly fewer – 4 / 97 (4%) – recurrent strokes were potentially 
misclassified.  Among baseline and recurrent strokes, the degree of misclassification 
was similar in the lacunar and non-lacunar comparison groups.     
8.5 Discussion 
My analyses of data from the Edinburgh Stroke Study revealed no difference in the 
long-term risk of recurrent stroke between patients with lacunar compared with non-
lacunar ischaemic stroke.  However, the very early risk of recurrence was almost 
certainly lower in patients with lacunar stroke, confirming results of previous studies 
(Lovett et al. 2004) and probably reflecting a lower prevalence of active 
thromboemboli early after lacunar compared with non-lacunar ischaemic stroke.  I 
also confirmed that recurrent stroke subtypes do tend to breed true, even after 
adjusting for potentially confounding effects of age, gender and secondary stroke 
prevention treatment at onset of recurrent stroke, which had not been accounted for 
in my systematic review and meta-analysis, or in previous individual studies.  And 
when I examined recurrent stroke subtype patterns after having excluded any 
recurrences that occurred in the first month, I found very similar results to those in 
my primary analysis, which indicates that in the long term, after presumed healing of 
any unstable atherosclerotic plaques, recurrent stroke subtypes still appear to breed 
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true.  The similarity between adjusted and unadjusted results provides 
methodological justification for my meta-analysis of unadjusted data from published 
studies, the results of which confirm and strengthen the findings from the Edinburgh 
Stroke Study.  Finally, I observed a lower MI risk following lacunar versus non-
lacunar ischaemic stroke, in keeping with my previous findings of a lower prevalence 
of IHD among patients with lacunar as compared with non-lacunar ischaemic stroke.    
8.5.1 Study strengths 
The Edinburgh Stroke Study and my analysis of outcome events benefit from a 
number of methodological strengths.  First we recruited a large study population at 
baseline, allowing us to collect a relatively large number of outcome events.  In 
particular, we identified over five times as many MI events as reported in the only 
previous published study of MI risk among both lacunar and non-lacunar ischaemic 
stroke subtypes (Landi et al. 1992).   
Second, an important feature of our study is the high proportion of patients who had 
brain imaging following baseline and recurrent strokes (100% and 93% respectively).  
Where reported in previous studies, the proportion of patients with recurrent stroke in 
whom brain imaging was performed was much lower (40-65%), with no study 
reporting the use of DW MR imaging.  The extensive use of brain imaging 
(particularly DW MRI) in our study allowed us to classify recurrent stroke subtypes 
with a higher degree of accuracy than in previous similar studies, thereby reducing 
misclassification of ischaemic stroke subtypes.  However, some misclassification of 
stroke subtypes is inevitable, since not all lesions are visible on brain imaging.  I 
estimated the extent of misclassification to be low in patients included in my primary 
analyses, and given that the proportion of misclassified patients in both comparison 
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groups was similar, I am unlikely to have overestimated - but may have 
underestimated – any true differences in outcome.  
Third, we used an unbiased definition of recurrent stroke since we did not 
automatically exclude those patients with an early recurrence in the same territory of 
the brain as the index events, as many previous studies have done.  We therefore 
limited underestimation of the early risk of recurrence (Coull & Rothwell 2004) and 
potential bias in determining recurrent stroke subtype patterns.  Clinicians were not 
specifically blinded to the subtype of the index stroke when classifying the subtype 
of the recurrent stroke, to allow them to distinguish between residual neurological 
signs due to the index stroke and new neurological signs due to the recurrent stroke.  
Knowledge of the nature of the index event may influence assignment of the 
recurrent subtype, particularly when there is uncertainty as to the subtype of 
recurrence, but we were able to minimise this potential bias in our study through our 
extensive use of brain imaging.   
Finally, we used multiple overlapping follow-up methods to maximise ascertainment 
of outcome events.  My analysis of the completeness of follow-up was, however, 
complicated by this use of multiple overlapping methods.  Ideally, I would have 
analysed success of follow-up using a capture-recapture analysis approach, but I was 
unable to do this because we did not routinely record the route(s) by which we 
identified a recurrent event.  Although we had not routinely recorded the last date of 
contact with each patient, I was able to modify the approach by Clark et al. to 
estimate the minimum completeness of follow-up by determining the completeness 
of follow-up by postal questionnaire.  It is important to note that the calculated 
completeness is a minimum estimate of follow-up completeness, because it does not 
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account for all methods of follow-up used.  However, the advantage of this analysis 
is that I was able to investigate whether follow-up completeness differed between 
patients with lacunar and non-lacunar ischaemic stroke, and hence address whether 
any difference in outcome between these groups was biased by incomplete follow-up 
contact.  It is reassuring that completeness of follow-up was high, and was similar in 
the comparison groups included in my primary analysis.  However, this analysis does 
not of course reveal to what extent events may have been missed due to lack of 
reporting of events by patients, their GPs and others.   
8.5.2 Study limitations 
The Edinburgh Stroke Study and my analyses of outcome do have a few limitations.  
Although we used multiple overlapping methods of follow-up, we may have under-
ascertained vascular events.  Despite our definition of recurrent stroke, the early 
recurrence rates were quite low in comparison to those of similar previous studies, 
suggesting that we may have under-ascertained recurrences, particularly during the 
early period (Lovett et al. 2004).  This may partly reflect our recruitment of patients 
several days (median 9) after stroke onset, effectively excluding from our first-ever 
stroke cohort some patients who had already had a very early recurrence.  Although 
time to recruitment of patients with lacunar stroke was somewhat longer (median 12 
days) than for those with non-lacunar stroke (median 7 days), the delay to 
recruitment would have caused in particular an underestimate of the very high 
recurrence rate in the first few days after non-lacunar (mainly large artery) ischaemic 
stroke, so diminishing the early excess of recurrences detected by our study among 
those with non-lacunar versus lacunar strokes.  In addition, we may have been more 
likely to have missed some recurrent stroke or MI events occurring among patients 
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with a severe stroke at baseline, where ascertainment of further events may have 
been complicated by patients’ co-morbidities, or where patients or doctors may have 
been less likely to report possible further events to our stroke study team.  However, 
the results of my primary analysis were unchanged in a sensitivity analysis 
comparing lacunar patients with mild cortical (PACI) patients for risks of recurrence 
and MI.  We are far less likely to have incorrectly included false positive outcome 
events, since for all outcomes we either assessed patients face-to-face or thoroughly 
reviewed their medical notes.  Furthermore, it is also reassuring that the incidence of 
MI in our study is comparable to the incidence of MI in ischaemic stroke patients in 
previous published studies (Touze et al. 2005).   
Second, although this is the largest study of the risk of MI among different ischaemic 
stroke subtypes to date, the relatively low incidence of MI still limited the reliability 
and precision of comparisons between lacunar and non-lacunar patients, and 
prevented full adjustment for potential confounders.   
Third, in my primary analyses I may have included a small number of patients in the 
lacunar group whose stroke may have been caused by thromboemboli rather than 
small vessel disease (since more than one potential aetiology is present in some 
patients).  However the results of my primary analyses remained unchanged in a 
sensitivity analysis where I compared stroke subtypes according to their presumed 
aetiological cause.   
Finally, there was substantial heterogeneity between studies in my meta-analysis of 
recurrent stroke subtypes, but this could be explained by the results of one study 
(Hillen et al. 2003) in which the definition of recurrent stroke may have biased the 
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results and led to underestimation of the degree to which recurrent stroke subtypes 
breed true  
8.5.3 Conclusion 
In conclusion, my findings considerably strengthen the existing evidence for a lower 
risk of stroke recurrence early after lacunar ischaemic stroke, reflecting the lower 
prevalence of active thromboemboli early after lacunar versus non-lacunar stroke.  
My novel finding of a lower risk of MI following lacunar as compared with non-
lacunar ischaemic stroke provides further epidemiological evidence to suggest that 
many lacunar ischaemic strokes may be caused by a distinct, non-atherothrombotic 
arteriopathy.  Because this last finding was based on relatively small numbers of MI 
events (albeit a much larger number than previously published), it would be very 
helpful to confirm these results with a pooled analysis of data from stroke cohorts 
similar to the Edinburgh Stroke Study, with well characterised baseline ischaemic 
stroke subtypes and follow-up for MI.   
Finally, data on recurrent stroke subtype patterns in the Edinburgh Stroke Study 
suggest that recurrent stroke subtypes tend to breed true to type, adding further 
support to the notion of a distinct lacunar arteriopathy.     
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D. Summary and Conclusions 
Chapter 9. Conclusions and implications for further research 
 
9.1 Summary of the epidemiological evidence for a distinct lacunar 
arteriopathy 
My comparisons of the epidemiology of ischaemic stroke subtypes revealed 
differences in the risk factor profiles and risks of recurrent vascular events between 
patients with lacunar as compared with non-lacunar ischaemic stroke which suggest 
that many (and perhaps most) lacunar ischaemic strokes are caused by a distinct, 
non-atherothrombotic small vessel disease.   
9.1.1 Risk factor profiles 
In my systematic literature review of studies of the risk factor profiles of ischaemic 
stroke subtypes, I found evidence of classification bias in many studies, where 
systematic error was introduced through the use of ischaemic stroke subtype 
classification methods in which risk factors are included in the definitions of stroke 
subtypes.  For some risk factors this led to overestimation of the assciation with 
ischaemic stroke subtype, and for others it resulted in an apparently stronger 
association with lacunar compared with non-lacunar ischaemic stroke which was not 
apparent in studies that used risk factor-independent classification methods. 
In my analyses of individual patient data pooled from the Edinburgh Stroke Study 
and from other similar stroke registers, I was able to overcome both the 
methodological shortcomings of most previous studies of risk factor-stroke subtype 
associations and the limitations of my meta-analyses of these existing published 
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studies.  In this large pooled data project I confirmed that atrial fibrillation (AF) and 
severe carotid stenosis are found relatively infrequently in patients with lacunar 
ischaemic stroke, and are much less prevalent than in patients with non-lacunar 
ischaemic stroke.  This strongly suggests that emboli from the heart or proximal 
arteries are likely to be the cause of only a minority of lacunar strokes, especially 
given the fact that where sources of emboli such as AF are present, they may be 
incidental (i.e. not causal) in some patients.  The probable non-causal role of carotid 
artery stenosis has been demonstrated in studies comparing the severity of internal 
carotid artery stenosis on the symptomatic (ipsilateral) side versus the asymptomatic 
(contralateral) side within the same patient.  Most studies found no difference in 
severity of carotid stenosis in the symptomatic versus non-symptomatic side in 
patients with lacunar ischaemic stroke, indicating that carotid stenosis may be 
coincidental (Mead et al. 2002).   
Interestingly, the likelihood of emboli reaching the small peforating arteries 
supplying the deep parts of the brain has been investigated in an experimental study, 
in which the authors injected varying sizes of agarose emboli into the internal carotid 
arteries of nine monkeys.  They found that although very small embolic particles 
could enter deep penetrating arteries in the brain, they did so infrequently, with up to 
just 6% of embolic particles entering the lenticulostriate arteries and the remainder 
entering cortical arteries (Macdonald et al. 1995).   
My findings also suggest that prior ischaemic heart disease (IHD), for which the 
relationship with ischaemic stroke subtype was far less clear in previous published 
studies, is also less common among patients with lacunar than non-lacunar ischaemic 
stroke.  If we consider IHD, and indeed carotid artery stenosis, to be markers of 
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systemic atherosclerosis, these results further suggest that a non-atherosclerotic 
arteriopathy may underlie many lacunar strokes.  Further evidence supporting this 
concept comes from studies of intracranial artery blood flow velocity, blood flow 
reversal and vessel stenosis or occlusion.  One study reported a lower frequency of 
some or all of these abnormalities (as determined by transcranial doppler 
investigation) in the middle and anterior cerebral arteries of patients with lacunar 
ischaemic stroke compared with patients with total or partial anterior circulation 
infarction (Mead et al. 2000).  Although some of these abnormalities may be due to 
downstream effects of internal carotid artery stenosis (which, as I reported in this 
thesis, is more common in patients with non-lacunar than lacunar ischaemic stroke) 
rather than intracranial large artery stenosis, these findings do suggest that 
intracranial large artery atherosclerosis seems to be less common among patients 
with lacunar ischaemic stroke.  Given the lower frequency of carotid, cardiac and 
intracranial large artery stenosis among lacunar compared with non-lacunar patients, 
it seems unlikely that lacunar ischaemic stroke is largely caused by atherosclerosis in 
the small penetrating arteries.    
In contrast to widespread belief, I found that diabetes does not appear to be more 
important in the aetiology of lacunar ischemic stroke than in other types of ischaemic 
stroke.  In my combined individual patient data analysis I also found no differences 
in the prevalence of prior hypertension between patients with lacunar versus non-
lacunar stroke, although, when I combined these data with those from similar 
published studies, prior hypertension was marginally more common in patients with 
lacunar stroke.  Thus the epidemiological evidence does not support the view that 
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hypertension is substantially more important in the aetiology of lacunar relative to 
non-lacunar ischaemic stroke 
9.1.2 Risks and patterns of vascular outcomes 
In my systematic review of studies reporting on risks of death and recurrent vascular 
events among patients with different ischaemic stroke subtypes I found that risk of 
death was higher among patients with lacunar compared with non-lacunar ischaemic 
stroke in the short term, with the difference attenuating, but persisting, in the long 
term.  On further investigation of this using data from the ESS, I found that this 
difference in risk of death is far greater at one month post-stroke than at later time 
periods, and, at all time periods, is at least partly explained by stroke severity.  Thus, 
differences in risk of death between stroke subtypes do not greatly inform on 
differences in underlying arterial pathologies.   
In my systematic review and meta-analyses, recurrent stroke risk appeared to be 
lower among patients with lacunar stroke in the first month post-stroke, with no 
difference in risk thereafter.  Similarly, in the ESS there was a trend towards a lower 
recurrence risk following lacunar compared with non-lacunar stroke in the first 
month, with no apparent difference thereafter.  Given the lower prevalence of 
embolic sources in lacunar patients, this probably reflects the lower prevalence of 
active thromboemboli early after lacunar compared with non-lacunar ischaemic 
stroke.     
When reviewing the published literature, I found few studies presenting data on 
recurrent stroke subtype patterns, and sparse data on risk of myocardial infarction 
(MI) following different ischaemic stroke subtypes.  Our data on recurrent stroke 
subtype patterns and MI risk in the Edinburgh Stroke Study therefore make a 
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significant additional contribution to existing published data.  My results suggested a 
trend towards a reduced rate of MI following lacunar compared with non-lacunar 
ischaemic stroke, which is in keeping with my findings of a lower prevalence of IHD 
in lacunar patients, and provides further support for a non-atherothrombotic lacunar 
arteriopathy underlying many lacunar strokes.   
Recurrent stroke subtype patterns have only been reported in a handful of published 
studies and have had some important limitations.  In the ESS our careful 
characterisation of both baseline and recurrent stroke subtypes and rigorous follow-
up of patients means that our study is the most methodologically robust study in 
which recurrent stroke subtype patterns have been analysed to date.  We observed 
that recurrent ischaemic strokes were more likely to be of the same subtype (lacunar 
or non-lacunar) as the index event, a finding which was largely in agreement with 
results of existing studies, adding substantial support to the notion that recurrent 
stroke subtypes breed true to type and providing additional epidemiological evidence 
for a distinct lacunar arteriopathy. 
9.2 Implications for, and direction of, future research 
9.2.1 The need for accurate classification of ischaemic stroke subtypes 
The results of my comparisons of the risk factor profiles of lacunar versus non-
lacunar ischaemic stroke have implications for the way in which patients with 
lacunar ischaemic stroke in particular are classified.  First, the epidemiological 
evidence indicates that clinicians should not be guided by the presence or absence of 
hypertension and diabetes when classifying ischaemic stroke subtypes. 
Second, my investigation of the effect of stroke subtype classification method on 
comparisons of risk factor profiles of different ischaemic stroke subtypes reveals the 
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impact that the classification system can have on the results of research studies.  The 
resulting bias which I demonstrated in my meta-analyses in chapter three highlight 
the important point that in research studies, the classification method used should be 
appropriate to the research question being addressed.  The issue of how best to 
classify ischaemic stroke subtypes is therefore clearly an important one, particularly 
in clinical research, and should be given careful consideration.   
Accurate and unbiased classification of ischaemic stroke subtypes is not only 
relevant to observational studies such as those analysed and discussed in this thesis.     
There is an increasing interest at present in the role of genetic factors in the 
pathogenesis of ischaemic stroke and its subtypes.  The most efficient and frequently 
used approach to study this is the genetic association study, where the frequencies of 
DNA sequence variants (allelic polymorphisms or the different genotypes they give 
rise to) are compared between cases and controls.  Although there is a rapidly 
growing interest in the field of stroke genetics, the findings to date have been 
disappointing with few replicable and robust associations identified.  This may be 
partly explained by poor study methodology.  For example, existing studies may 
have been too small, leading to false-positive or false-negative results (Dichgans & 
Markus, 2005).  Furthermore, and most pertinent to this discussion, patients need to 
be well characterised or “phenotyped” in terms of the ischaemic stroke subtype.  
Poorly characterised ischaemic stroke subtypes may contribute to the failure to 
identify and reproduce true genetic associations (Dichgans & Markus, 2005).     
Another research area to which the classification of ischaemic stroke subtypes is 
particularly relevant is that of randomised controlled clinical trials.  With the 
growing understanding of the complexity of the causes of ischaemic stroke and the 
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recognition that ischaemic stroke subtypes are likely to differ in their underlying 
arterial pathologies, there is a need to determine the effectiveness of current 
thrombolytic and anti-thrombotic therapies in patients with lacunar ischaemic stroke, 
and to tailor treatment regimes to optimise their effect in patients with lacunar 
ischaemic stroke (Benavente & Hart 2004) . The use of these treatments is currently 
based on clinical trials that either failed to distinguish between ischaemic stroke 
subtypes, or were statistically under-powered to detect differences in treatment effect 
between stroke subtypes.  There is also a growing interest in the development of 
therapies that are more targeted to treating and/or preventing specific stroke subtypes 
(Aslanyan et al. 2007).  Future clinical trials need to be as well powered as possible 
to detect differences in treatment effect between these subtypes.  Just as importantly, 
they should also be designed to distinguish accurately between ischaemic stroke 
subtypes, thereby reducing ischaemic stroke subtype misclassification which may 
otherwise contribute to the failure to detect important differences in treatment effect 
between groups of patients.     
9.2.2 Improving on existing ischaemic stroke subtype classification methods 
There is a need to improve upon the accuracy of the classification of ischaemic 
stroke subtypes.  While the nature of stroke makes it impossible to accurately 
diagnose and categorise every patient with this disorder, there may be ways of 
further developing existing classification methods, to minimise this misclassification. 
Some researchers favour the use of an aetiological classification, which they consider 
to be more informative and more accurate than the OCSP classification (Dichgans & 
Markus, 2005).  However, it must be recognised that the most frequently used 
aetiological classification – the TOAST classification – does have some major 
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limitations, including the need for extensive investigations (which may limit its use 
in particular centres where certain clinical investigations are not available or 
routinely used); variation in the interpretation and application of the classification; 
and the large proportion of patients who are placed in the “undetermined cause” 
category (even with complete investigation).  The latter limitation is currently being 
addressed by one group who, through a modified, extended version of the original 
TOAST classification, are attempting to reduce the proportion of patients who are 
labelled as having an undetermined cause (Ay H et al. 2005; Ay H et al. 2007).  The 
performance of this classification, particularly within different clinical settings, 
remains to be established.   
An alternative classification approach worthy of further development and assessment 
is one which combines the clinical and imaging-based classification system with an 
aetiological component, such as the algorithm described in chapter 7, which I 
devised for the purpose of retrospectively assigning an aetiological classification to 
patients in the ESS.  In such an approach, the clinical and imaging-based 
classification would form the basic classification level, after which the classification 
becomes more aetiologically refined, with the incorporation of findings from 
additional investigations.  Such a multilevel approach would allow most stroke 
patients to be classified as accurately as possible in the majority of clinical settings, 
but would incorporate an option for increasing the degree of refinement where 
suitable investigations are available and performed, perhaps for the purposes of 
specific research studies. 
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9.2.3 Minimising ischaemic stroke subtype misclassification 
In all classification methods there will inevitably be some degree of 
misclassification.  The OCSP classification is easily and quickly applied in all 
clinical settings,  predicts death, disability and recurrent stroke, and, as demonstrated 
in this thesis, does relate to a large extent to the underlying aetiology.  It therefore 
remains a very useful method of classifying ischaemic stroke subtypes, and is 
especially useful in settings where clinical investigations such as brain imaging or 
echocardiography, or even more advanced investigations such as DW MR brain 
imaging, are less readily available.  However, there is a need to minimise 
misclassification between ischaemic stroke subtypes and particularly between 
lacunar and small cortical ischaemic stroke.  One method of reducing this 
misclassification is to perform advanced DW MR imaging rather than CT brain 
imaging in patients with lacunar or mild cortical ischaemic stroke or when patients 
present late.  In the acute period, CT imaging is known to be less sensitive than 
diffusion weighted (DW) MR imaging for small acute infarcts (Lansberg et al. 
2000), and conventional MR imaging has been shown to be less sensitive than 
conventional MR imaging with DW sequences when applied several weeks after the 
stroke event (Kier et al. 2004).  The use of MR imaging with DW sequences is 
therefore likely to reduce misclassification between stroke subtypes.  However, the 
extent to which CT brain imaging (which is far less expensive and more accessible 
than MR imaging) underestimates the degree of misclassification between lacunar 
and mild cortical ischaemic stroke relative to DW MR imaging needs to be 
investigated.  No study has yet compared CT brain imaging with DW MR imaging 
performed at the same time (as near as possible) to assess ischaemic stroke subtype 
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misclassification.  Such a study would be helpful in determining how far 
misclassification of ischaemic stroke subtypes can be reduced through the use of 
advanced DW MR imaging. 
9.2.4 Effects of ischaemic stroke subtype misclassification 
In my analyses of individual patient data, the degree of misclassification of 
ischaemic stroke subtypes was similar among patients with lacunar and non-lacunar 
ischaemic stroke, and, assuming that this misclassification is independent of risk 
factor status (which seems likely),will have probably led to an underestimation of 
risk factor-stroke subtype associations, moving the odds ratio estimates closer to the 
null (Copeland et al. 1977).  It is therefore possible that we may have slightly 
underestimated the true odds ratios for some risk factor-stroke subtype associations.  
It may be possible to adjust effect estimates for this misclassification of covariates 
(Thomas et al. 1993) but unfortunately the investigation and applicability of such 
methods to my risk factor-ischaemic stroke subtype associations was beyond the 
scope of my thesis.  However, it would be interesting to investigate such statistical 
approaches in future analyses of these data.   
9.2.5 Classification of risk factors 
One of the limitations of the collaborative individual data project where I compared 
the risk factor profiles of patients with lacunar versus non-lacunar ischaemic stroke is 
the way in which some risk factors were defined.  There will certainly have been 
some misclassification of prior hypertension and diabetes mellitus in particular, 
partly because they were ascertained retrospectively (after the stroke event occurred).  
We may have misclassified patients who actually had undiagnosed hypertension and 
diabetes as not having these risk factors.  Also, given that hypertension and diabetes 
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mellitus can both be subcategorised further, our definitions may have been too broad, 
thereby obscuring any associations between subgroups of these exposures and 
ischaemic stroke subtypes.  For example, the severity and duration of exposure to 
raised blood pressure, extreme fluctuations in blood pressure, and whether a patient 
has Type I or Type II diabetes mellitus and their duration of exposure to diabetes 
may each be important.   
Presence of undiagnosed hypertension may be detected by measuring post-stroke 
blood pressure, but the reliability of these measurements as indicators of pre-stroke 
hypertension is questionable given that the stroke itself often affects blood pressure.  
Duration of exposure to hypertension is much harder to determine without having 
obtained repeat blood pressure measurements in healthy subjects followed 
prospectively for the occurrence of stroke.  Severity and/or duration of hypertension 
may be reflected in the presence or absence of left ventricular hypertrophy - 
detectable by electrocardiogram or echocardiogram, with differing degrees of 
sensitivity - although it should be remembered that factors other than raised blood 
pressure can cause left ventricular hypertrophy (Dunn & Pfeffer 1999).  These data 
are available in some of the patients in the Edinburgh Stroke Study and could be 
included in further sensitivity analyses of the effect of differing definitions of 
hypertension on associations between risk factors and ischaemic stroke subtypes.   
Given the continuous log linear relationship between increasing blood pressure and 
stroke (Prospective Studies Collaboration 2002), we will also have lost information 
by dichotomising patients as being hypertensive or not (Altman & Royston, 2006), 
and it would almost certainly be more informative to analyse blood pressure as a 
continuous variable.  However, this can only be done reliably in prospective studies 
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of healthy subjects where blood pressure has been measured at baseline (with repeat 
measurements in a subset of subjects to allow adjustment for regression dilution bias) 
prior to the occurrence of stroke outcomes.  The relationship between subgroups of 
diabetes and specific ischaemic stroke subtypes might be investigated in more depth 
in future projects which take advantage of the existence of the Scotland-wide clinical 
stroke audit (in which details of stroke events are collected) and diabetes registers.   
In the longer term, useful data on the relationship between blood pressure, other risk 
factors and different ischaemic stroke subtypes may be obtained from new, large 
prospective studies such as the UK BioBank project.  In the latter study, extensive 
baseline data and blood samples on 500,000 middle-aged people are being collected 
with plans to follow up for outcome events for most common disease including 
stroke over the next few decades (Elliott et al. 2008).  Such studies will be very 
informative about risk factor-ischaemic stroke subtype relationships, provided that 
sufficient details of the subtype of ischaemic strokes that occur are collected.  
9.2.6 Myocardial infarction following lacunar ischaemic stroke 
Despite making a substantial contribution to the existing published data on MI risk 
across different ischaemic stroke subtypes, the number of MI events in our study was 
still too low to allow appropriate adjustment for potential confounding factors and to 
draw definite conclusions about the relationship between risk of MI and lacunar 
compared with non-lacunar ischaemic stroke.  My results need to be confirmed in a 
meta-analysis of individual patient data from the Edinburgh Stroke Study and other 
studies that have similarly collected data on well characterised ischaemic stroke 
subtypes and MI during follow-up.   
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9.2.7 Two subtypes of small vessel disease? 
An interesting hypothesis has been presented which proposes that patients who 
present with a lacunar ischaemic stroke and who have a single lacunar infarct on 
brain imaging represent a discrete clinical subgroup from those patients who present 
with a lacunar ischaemic stroke but have multiple, usually asymptomatic, lacunar 
infarcts on brain imaging, the view being that these two groups of patients reflect two 
distinct arterial pathologies (Boiten et al. 1993).  There is some epidemiological 
evidence to support this theory. Hypertension and diabetes have been reported in a 
few studies as being more common in lacunar ischaemic stroke patients who have 
multiple, usually asymptomatic, lacunar infarcts on brain imaging than lacunar 
ischaemic strokes patients with a single lacunar infarct on brain imaging (Boiten et 
al. 1993; Mast et al. 1995; Machizuki et al. 1997).  And there is evidence of 
differences in outcome in terms of death, recurrent stroke and disability between 
these two groups of patients (De Jong et al. 2002).  However, these findings are 
based on results from just a few small studies which largely used CT brain imaging 
to identify lacunar infarcts, and did not include a control group of non-lacunar stroke 
patients.   
One study also reported that leukoaraiosis is statistically significantly more common 
among patients with multiple asymptomatic lacunar infarcts than in patients without 
asymptomatic lacunar infarcts (Boiten et al. 1993).  A related finding is that 
hypertension may be more common in patients with lacunar ischaemic stroke and 
white matter hyperintensities (leukoaraiosis) on brain imaging, than in patients with 
lacunar ischaemic stroke without leukoaraiosis (Khan et al. 2007).  The relationship 
between the underlying arteriopathy of lacunar ischaemic stroke and leukoaraiosis 
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remains unclear.  It has been proposed that a cerebral small vessel endothelial 
dysfunction may contribute to the development of both these conditions (Wardlaw et 
al. 2003).  Alternatively, it has been proposed that isolated lacunar infarction in 
patients without leukoaraiosis may result from atheroma in the small perforating 
arteries, whilst small vessel endothelial dysfunction might be responsible for multiple 
small lacunar infarcts and leukoaraiosis (Markus, 2008).     
The identification of and discrimination between subgroups of ischaemic stroke 
subtypes may be especially useful in the refinement of ischaemic stroke phenotypes 
for the purposes of maximising insight into the underlying arterial pathologies at the 
molecular and genetic level, and is certainly worthy of further investigation.  The 
existing epidemiological evidence supporting the notion of two small vessel disease 
subtypes stems largely from a small number of observational studies comparing the 
clinical features and risk factors of patients with lacunar ischaemic stroke with and 
without asymptomatic lacunar infarcts.  Many of these studies have relied on CT 
brain imaging in the identification of lacunar infarcts (and white matter 
hyperintensities), included small numbers of patients, and did not always include a 
cortical stroke control group.  This area could be explored further using baseline and 
follow-up data from patients who had DW MRI in the Edinburgh Stroke Study, to 
determine whether different types of lacunar ischaemic stroke can be distinguished.  
Detailed imaging data (such as presence of asymptomatic lacunar infarcts) was not 
recorded at the time of data collection for the Edinburgh Stroke Study, but has since 
been collected retrospectively for patients who underwent MRI.  It might also be 
appropriate to combine our data from other studies of stroke patients that have 
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similarly used MRI, to increase numbers of patients and power to detect moderate 
differences in risk factor prevalence and outcome. 
9.3 A multi-disciplinary approach to the study of lacunar ischaemic stroke 
The difficulties inherent in studying the aetiology of lacunar ischaemic stroke makes 
identification of the nature of the underlying small vessel arteriopathy very 
challenging.  My investigation of the epidemiological differences of ischaemic stroke 
subtypes has been highly informative and makes an important contribution to our 
understanding of lacunar stroke pathology.  It complements other approaches to 
studying the arteriopathy of lacunar stroke and highlights ways to improve the 
methodology of future research.  That research should continue to be multi-
disciplinary if we are to make further progress in understanding the arteriopathy of 
lacunar stroke.  Interesting findings are currently being generated through advanced 
brain imaging research, with the early results proving very promising.  This research 
uses cutting-edge brain imaging techniques to investigate the permeability of arteries 
in the brain, and recent results do indicate a possible role of increased blood-brain-
barrier “leakiness” (perhaps as a result of endothelial dysfunction) in patients with 
lacunar compared with non-lacunar ischaemic stroke (Wardlaw et al., 2009). 
Although genetic studies have identified associations between factors connected with 
endothelial function and lacunar ischaemic stroke, few of these have been robust, 
replicable assocations (Markus, 2008).  Furthermore the complex interaction between 
environmental and genetic factors adds to the difficulty of identifying genetic factors 
important to the aetiology of lacunar stroke.  It remains to be seen whether large 
multicentre collaborative efforts, with improved methodology, will prove to be more 
successful. 
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Finally, although autopsy studies of lacunar stroke are fraught with a number of 
drawbacks, there is perhaps a need for modern day pathological autopsy studies 
which, in combination with the improved collection of clinical data and advanced 
brain imaging now available, may prove more fruitful than the pathological studies 
from 40-50 years ago.  This would, however, require a renewed enthusiasm for the 
value of such studies, and a reversal of the current decline in autopsy rates.  
9.4 Conclusion 
My comparisons of the epidemiology of different ischaemic stroke subtypes suggest 
that a distinct, non-atherothrombotic arteriopathy may underlie many lacunar 
ischaemic strokes.  These findings support other lines of evidence for a distinct 
lacunar arteriopathy, and highlight the need for further research into lacunar 
ischaemic stroke to identify the main pathological abnormality and its molecular 
mechanism.  Lacunar ischaemic stroke is a particularly complex condition to study, 
not least because it can be caused by multiple pathologies which are not necessarily 
mutually exclusive within a single patient, and which share common multifactorial 
determinants.  This complexity means that a multi-disciplinary approach, including 
epidemiological, pathological, molecular, genetic and brain imaging studies, is 
needed to identify the precise nature of the vascular pathology underlying most 















Any of:  
  Pure motor stroke          The relevant deficit should involve at least      
  Pure sensory stroke        two contiguous areas out of three of the  
  Sensorimotor stroke       whole of the face, arm and leg* 
   Ataxic hemiparesis 
 
There should be no: 
  visual field deficit 
  new disturbances of higher cerebral function 
  signs of brainstem disturbance† 
Small vessel disease 






  Motor / sensory deficit plus hemianopia 
  Motor / sensory deficit plus new higher cerebral 
  dysfunction 
  New higher cerebral dysfunction plus hemianopia 
  New higher cerebral dysfunction alone 
  Pure motor / sensory deficit less extensive than for 
  lacunar syndromes (e.g. monoparesis (such as hand 
  weakness)) 
1. Cardioembolism         
2. Atherothrombosis 
(large vessel disease) 






  Hemiplegia or severe hemiparesis 
  Hemianopia 
  New disturbance of higher cerebral function (e.g. 
  dysphasia) 
  + / - sensory deficit  
1. Cardioembolism         
2. Atherothrombosis 
(large vessel disease) 





  Ipsilateral cranial nerve (III-XII) palsy with 
  contralateral motor and/or sensory deficit 
  Bilateral motor and/or sensory deficit 
  Disorder of conjugate eye movement 
  Cerebellar dysfunction without ipsilateral long tract 
  deficit 
  Isolated hemianopia or cortical blindness 
(disorders of higher cerebral function may also be present, e.g. 
aphasia) 
 
1. Cardioembolism         
2. Atherothrombosis 
(large vessel disease) 
3. Small vessel disease 
 
*i.e. face and arm, arm and leg or all three 
†Some brainstem syndromes may be caused by lacunar infarcts (e.g. in the pons or the cerebellum) 
 
(modified from Warlow et al. 2008) 
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Appendix 2  Description of TOAST classification 
Category Description 
Large artery atherosclerosis • Clinical findings include cortical, cerebellar, or brain 
stem dysfunction and on brain imaging cortical, 
cerebellar, brain stem or subcortical lesions >1.5cm are 
considered to be of potential large artery atherosclerotic 
origin.   
• Diagnosis requires supportive evidence by duplex 
imaging or arteriography of >50% stenosis of an 
appropriate intracranial or extracranial artery. 
• Potential sources of cardiogenic embolism, such as AF 
should be excluded, and history of TIAs in the same 
vascular territory supports the clinical diagnosis. 
 
Cardioembolism • Clinical and brain imaging findings are similar to those 
described for large artery atherosclerosis.   
• At least 1 cardiac source of embolism, such as AF, must 
be identified.  Previous TIAs in >1 vascular territory 
supports the diagnosis.   
• Potential large artery atherosclerotic sources of 
thrombosis or embolism should be absent.   
 
Lacunar • Clinical findings of one of the lacunar syndromes should 
be present.  Brain imaging should be normal or show a 
relevant brain stem or subcortical hemispheric lesion of 
diameter <1.5cm.   
• A history of diabetes mellitus or hypertension supports 
the diagnosis.   
• Potential cardiac sources of embolism, such as AF, 
should be absent, and the large extracranial arteries 
should not demonstrate >50% stenosis. 
 
Undetermined aetiology Includes patients with ≥2 potential causes of stroke (eg, AF and 
>50% stenosis of extracranial arteries), patients with no 
identifiable cause of stroke following complete or incomplete 
investigation. 
 
Other determined aetiology:  
 
Includes patients with rare causes of stroke (eg, 
nonatherosclerotic vasculopathies and haematologic disorders). 
 
AF = atrial fibrillation; TIA = transient ischaemic attack 
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Appendix 3  MedLine literature search strategy 
 
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or 
exp brain ischemia/ or exp carotid artery diseases/ or exp cerebrovascular 
accident/ or exp dementia, vascular/ or exp hypoxia-ischemia, brain/ or exp 
intracranial arterial diseases/ or exp “intracranial embolism and thrombosis”/ 
or exp intracranial hemorrhages/ or exp vasospasm, intracranial/ 
2. (Stroke$ or cerebrovasc$ or cerebral vasc$).tw. 
3. 1 or 2 
4. lacun$.tw. 
5. ((lacunar or small or subcortical or silent) adj5 (infarct$ or stroke)).tw. 
6. (small vessel adj5 (stroke$ or occlusion or disease)).tw. 
7. 4 or 5 or 6 
8. 3 and 7 





Appendix 4  Embase literature search strategy 
 
1. cerebrovascular disease/ or cerebral artery disease/ or cerebrovascular 
accident/ or stroke/ or exp carotid artery disease/ or exp brain infarction/ or 
exp brain ischemia/ or exp occlusive cerebrovascular disease  
2. (Stroke$ or cerebrovasc$ or cerebral vasc$).tw. 
3. 1 or 2 
4. lacun$.tw. 
5. ((lacunar or small or subcortical or silent) adj5 (infarct$ or stroke)).tw. 
6. (small vessel adj5 (stroke$ or occlusion or disease)).tw. 
7. 4 or 5 or 6 
8. 3 and 7 
9. 9 limit 8 to human 
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Appendix 5  Patient information leaflet 
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The study is being funded by the Wellcome Trust, a 
medical research charity, and has been approved by 
the Lothian Research Ethics Committee.  The results 
of this research will eventually be published in scientific 
journals read by doctors with an interest in stroke.  
 
If you have any questions about the study, please feel 
free to contact our study administrator (Miss Caroline 
Jackson, Department of Clinical Neurosciences, 
Western General Hospital, Edinburgh, EH4 2XU, 
telephone 0131- 537 2875) who will arrange for one of 
the study medical staff to get in touch with you. 
 
If you would like to speak to somebody who is not 
involved in this research but knows about the study, 
you are welcome to contact Dr Richard Davenport, 
Consultant Neurologist at the Western General 
Hospital (Department of Clinical Neurosciences, 
Western General Hospital, Edinburgh, EH4 2XU, 




















PATIENT INFORMATION LEAFLET 
INPATIENT STROKE SERVICE 
You are being invited to take part in a research study.  
This information leaflet explains why the research is 
being done and what it will involve.  Please take time 
to read it carefully and to discuss it with friends, 
relatives and your GP if you wish.  Ask us if there is 
anything that is not clear or if you would like more 
information.  Take time to decide whether or not you 
wish to take part. 
 
It is up to you to decide whether or not to take part.  If 
you do decide to take part you will be given this 
information sheet to keep and be asked to sign a 
consent form.  If you decide to take part you are still 
free to withdraw from the study at any time without 
having to give a reason and without it affecting your 
future care.       
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The Edinburgh Stroke Study is aiming to identify 
everyone who has a stroke or TIA (mini-stroke) and is 
referred to hospital in Edinburgh. It will provide very 
valuable information that will help us to find better 
treatments for stroke and to improve our services for 
patients. The study will eventually include several 
thousand local people. 
The medical staff in this hospital will be collecting 
some basic information and medical details about you.  
This information will be kept in your medical notes as 
well as on a computer database, and will be kept safe 
and confidential.  Collecting this information enables us 
to care for and advise you, as well as to monitor and 
improve our services for you and for other patients.  
The doctors and other medical staff caring for you will 
also be arranging for some tests to help confirm the 
diagnosis and to find out why you may have had a 
stroke or TIA. This information can be helpful in 
choosing the best treatment for you and in reducing 
your risk of further strokes. The tests may include a 
blood test, a heart tracing (ECG), and an ultrasound 
scan of your heart and blood vessels as well as a brain 
scan.  
We would like to ask your permission to use the 
information collected about you (along with the 
information about hundreds of other patients) for 
research purposes, to help us to address some of the 
many unanswered questions about the causes and 
consequences of strokes and TIAs.   
We would also like to ask your permission to store 
some of the blood we take so that we can test it in the 
future to identify possible genetic and environmental 
causes of stroke which have not yet been discovered.   
To help us find out more about your illness, we would 
also like to ask your permission to contact your GP, to 
look at your medical records, and to link the 
information collected in this study to other NHS 
information on your health care held confidentially by 
NHS Scotland. This will give us important information 
about any past and future illnesses which may be 
related to your current problems.  
We would also like to be in touch with you regularly to 
find out how you are getting on. This will normally 
involve us contacting you by post or telephone in the 
next few months and then every year and you filling in 
a questionnaire about your health. The questionnaire 
would only take a few minutes of your time. We may 
invite you to attend for a further follow-up visit (or, if 
you prefer, one of the study medical staff could visit 
you at home) so that we can make a more detailed 
assessment of how you are getting on. We might also 
contact you to invite you to participate in related 
research studies. 
Any information you give us will of course be treated 
as confidential and will only be available to the medical 




Appendix 6  Patient consent form 
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PATIENT’S CONSENT FORM 
 
The Edinburgh Stroke Study has been explained to me and I have read the information 
leaflet about it.  I have had time to consider the study and have had all my questions about 
it answered.   
                YES       NO 
                   (please tick) 
 
I give my consent for the information collected  
about me to be used for research purposes.      
 
I give my consent for my usual general practitioner    
to be contacted about the study, for my medical records to be  
examined, and for the information collected in this study to be  
linked to other NHS information on my health care held  
confidentially by NHS Scotland.        
 
I give my consent for a sample of my blood  
to be stored so that it can be tested in the  
future for possible genetic and other causes  
of stroke which have not yet been discovered.      
 
I give my consent to be contacted in the future  
about how I am getting on, and to be invited to  
attend for follow-up assessments or to participate 
in related research studies.        
 
I understand that I am free to withdraw at any time from any part of the study, without 




Place patient sticker 
here 
The Lothian University 
Hospital NHS Trust 
Western General Hospital 
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Appendix 7  Inpatient data collection form
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Lothian Stroke Care Audit / ESS Form – Clinical Inpatient Information 
 
 Date of admission :  ____/____/____ 
 Date of assessment : ____/____/____ 
 
Time of assessment:  ____:____ 
 
Consultant in charge : __________________________ 
 
Final diagnosis and status (Please tick all that apply) 
Cerebral1 Stroke (not SAH)  Transient ischaemic attack Subarachnoid haemorrhage 
Eye1 Retinal artery occlusion  Transient monocular blindness  
Other Possibly cerebrovascular2  Details: ____________________________________________ 
 Definitely non-cerebrovascular Details: ____________________________________________ 
Casemix assessment 
Was the patient independent in ADL3 before event ? [__] Are they oriented in time, place and person ? [__] 
Was the patient living alone at the time of event ? [__] Can the patient lift both arms off the bed ? [__] 
Can the patient talk4 ? [__] Able to walk without help from another person ? [__] 
NIH stroke scale score (0-42; please complete scoring sheet on back page and see supplementary notes 
attached ) [______] 
 
Clinical assessment –presenting event(s) presenting event(s), past history  & related signs 
Date of onset of symptoms (or best estimate)  ____/____/____ Prior stroke (before presenting event(s)) ? [__] 
Time of onset of symptoms (enter ? if unknown)
5
 Prior TIA (before presenting event(s)) ? [__] 
On aspirin at onset ?  [__] History of ischaemic heart disease6 ? [__] 
On other antiplatelet drug at onset ?  [__] History of treated hypertension ? [__] 
On warfarin at onset?  [__] History of diabetes mellitus ? [__] 
Side of brain/eye lesion (please circle)   
 Right  /   Left  /    Cerebellar or brainstem  /   Bilateral  /   Uncertain   
Peripheral arterial disease7 ? [__] 
Blood pressure at time of assessment [______/______] Cardiac failure8 ?  [__] 
Height (cm)  [________] or half - armspan5 (cm)  [________] 
Clear history of atrial fibrillation ?  [__] 
Weight (to nearest kg) [________] 
(paroxysmal or persistent) 
 
 
                                                 
1 Use these categories for definite or probable (>50% certain) cerebrovascular diagnoses 
2 Use if presentation could have cerebrovascular cause but < 50% certain and give details (e.g. lone vertigo) 
3 Independent in walking, dressing, washing, feeding, and toileting,  not necessarily bathing, shopping or climbing stairs 
4 Able to utter understandable words even if quiet or slurred 
5 Mid-sternal notch to tip of middle finger with (non-paretic) arm outstretched at right angles to body and palm facing forward 
6 MI (including ECG evidence of silent MI) / angina /CABG/coronary angioplasty or stent etc. 
7 History of claudication / rest pain / peripheral arterial intervention, or definite signs (absent foot pulses / femoral arterial bruit) 
8 Definite clinical signs of heart failure or taking at least two drugs for its treatment (eg. ACE-inhibitor and loop diuretic) 





Wider boxes are for numbers 
Please use ? for unknown 
Dates: please use ?? for unknown, and 
complete what you can (e.g. ??/12/1980) 
 
Address label 
Chi No. Sex 






Clinical assessment - social and family history 
Cigarette smoker ? (please circle) :  Never     /     Ex>12 m  /     Current or ex<12 m      /     Unknown 
 If current or ex <12 m cigarette smoker, cigarettes / day ? [_______] 
Alcohol intake (units/week)  [_______] 
1st degree relative with stroke / TIA ? [__] 
(please circle all that apply) : 
Mother    /    Father    /    Sibling(s)    /    Child(ren) 
 If yes, how many 1st degree relatives in total? (please circle) : 1    /   2    /    >2 
1st degree relative with IHD / PAD9 ? [__] 
(please circle all that apply): 
Mother    /    Father    /    Sibling(s)    /    Child(ren) 
 If yes, how many 1st degree relatives in total? (please circle) : 1    /   2    /    >2 
 
Edinburgh Stroke Study information / consent 
(if full consent already available following a previous event, simply write “CONSENT OBTAINED ALREADY” across this box) 
Patient / relatives given info pack with consent form? [__] 
 
Consent for ESS:     Patient    /     Relative     /     Witnessed    /    Waiver   /    Refused   /   None yet 
(please circle- see patient information sheet and consent forms 
for details)  
Consent date: ____/____/____ 
Use of data for research purposes    [__] 
Blood for research [__] 
Contact GP / examine medical records  [__] Follow-up [__] 
 
Clinical classification of stroke / TIA syndrome10 
(please circle): LACS  /  PACS  /  POCS  /  TACS  /  Eye
11  /  Uncertain    
 
Other risk factors or unusual cause of stroke or TIA ?  [__] (circle any options that apply and give 
details) 
coronary catheterisation   /   carotid endarterectomy  /   cardiac valve disease   /   haematological illness  /   
hereditary e.g. CADASIL  /  arterial dissection   /   coagulopathy   /   other 
Details : _____________________________________________________________________________ 
 
Clinical prediction of dependency at six months (clinician's 'gut feeling' : 0-6 on Oxford Handicap scale
12
 ) 
 [_______]  
Assessing clinician (please circle)  
 MSD   /   RIL   /   PAGS   /   CPW   /   CLMS   /   BW   /   VC   /   Other  (please initial) :  ________________ 
                                                 
9 ischaemic heart disease / peripheral arterial disease 
10 Based on clinical assessment before results of imaging or other investigations 
11 Use for transient monocular blindness / retinal artery occlusion 
12 Oxford Handicap Scale:  0 = no symptoms;  
1 = minor symptoms which do not interfere with lifestyle;  
2 = some restriction to lifestyle but look after themselves;  
3 = significant restriction to lifestyle, preventing total independence;  
4 = severe handicap preventing independent existence but not requiring constant attention;  
5 = severe handicap, totally dependent, requiring attention night and day 




Admission blood tests Taken ?  
(please tick) 
Date taken: Result (leave blank if not yet known) 
FBC  ____/____/____ Haemoglobin (g/l)                            [                  ]  
   Haematocrit (ratio) [0              ] 
   White cell count (x109/l) [                ] 
   Platelets (x109/l)                               [                  ] 
ESR   ____/____/____ (mm/hour)                                        [                  ] 
U&E 
 ____/____/____ 
Urea (mmol/l)                                  [                ] 
    Creatinine (µmol/l) [                  ] 
Glucose  ____/____/____ (mmol/l)    [                ] 
Lipids  ____/____/____ Total cholesterol (mmol/l)  [                ] 
   HDL cholesterol (mmol/l) [                ] 
Research  ____/____/____  
 
Brain imaging and final classification  
CT done ? [__] Date :   ____/____/____ Evidence of new haemorrhage on CT/MRI13 ? [__] 
MRI done ? [__] Date :   ____/____/____ Visible relevant infarct on CT/MRI ?  [__] 
Final syndrome classification : 
(using all clinical and imaging information) 
LACS  /  PACS  /  POCS  /  TACS  /  Uncertain  / Eye14 
 
Cardiac investigations  
ECG since event available ?  [__] AF on ECG ?             [__] 
 
LVH on ECG15 ? [__] 
Echocardiogram done?(please circle):  None  /  TTE no contrast  /  TTE+contrast  /  TOE no contrast  /  TOE+contrast 
Date of first echocardiogram :   ____/____/____ LVH on echo ? [__] 
 
Carotid imaging  
Carotid Duplex examination performed ? [__] Date of 1st Duplex ____/____/____ 
2nd Carotid Duplex performed ? [__] Date of 2nd Duplex ____/____/____ 
MR Angiography performed ? [__] Date of MRA ____/____/____ 
CT Angiography performed ? [__] Date of CTA ____/____/____ 
Conventional Angiography performed ? [__] Date of angiography ____/____/____ 
Carotid imaging results  Right  Left 
ICA % stenosis on Duplex16 ?  [_____________]  [_____________] 
Post-stenotic collapse (equivalent on Duplex) ?                                  [__]                                  [__] 
Plaque instability / irregularity (on Duplex or MRA) ? 
                                 [__]                                  [__] 
                                                                                                                                                                                     





Wider boxes are for numbers 
Please use ? for unknown 
Dates: please use ?? for unknown, and 
complete what you can (e.g. ??/12/1980) 
 
13 Include harmorrhagic transformation of infarct but NOT petechial haemorrhage / microbleeds 
14 Use for transient monocular blindness / retinal artery occlusion 
15 Don’t rely on automatic report.  Use voltage criteria – sum of S wave in V1 or V2 + R wave in V5 or V6 ≥ 3.5 mV (35 mm) 
16 Record discrete figure or range. If >1 result, record most severe. If result ‘normal’ record 0%; if ‘minor atheroma’ record 30%. 
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NIH Stroke Scale (Please circle the most appropriate response for each section. See supplementary notes 
attached. If untestable please state reason. Add the scores for each item to get the total, and do not count 
untestable items) 








Alert – keenly responsive 
Drowsy – arousable by minor stimulation to obey, answer, or respond 
Stuporous – requires repeated stimulation to attend, or is obtunded and requires strong or painful stimulation to make movements (not 
stereotyped) 






Answers both correctly 







Obeys both correctly 
Obeys one correctly 
Incorrect 





Partial gaze palsy – gaze is abnormal in one or both eyes, no forced deviation/total gaze paresis  
Forced deviation – or total gaze paresis not overcome by oculocephalic maneouvre 





No visual loss 
Partial hemianopia or visual inattention 
Complete hemianopia 
Bilateral hemianopia – including cortical blindness 






Minor -  flattened nasolabial fold, asymmetry on smiling 
Partial – total or near total paralysis of lower face 
Complete -  absent facial movement in upper and lower face on one or both sides 








No drift – holds limb at 90 degrees for full 10 seconds 
Drift -  drifts down but does not hit bed 
Some effort against gravity 
No effort against gravity 
No movement 
Untestable (only for amputation or shoulder joint fusion – please state which) 








No drift – holds limb at 90 degrees for full 10 seconds 
Drift -  drifts down but does not hit bed 
Some effort against gravity 
No effort against gravity 
No movement 
Untestable (only for amputation or shoulder joint fusion – please state which) 








No drift – holds limb at 45 degrees for full 5 seconds 
Drift -  drifts down but does not hit bed 
Some effort against gravity 
No effort against gravity 
No movement 
Untestable (only for amputation or hip joint fusion – please state which) 








No drift – holds limb at 45 degrees for full 5 seconds 
Drift -  drifts down but does not hit bed 
Some effort against gravity 
No effort against gravity 
No movement 
Untestable (only for amputation or hip joint fusion – please state which) 






Present in 1 limb 
Present in 2 or more limbs 






Partial loss - patient feels pinprick is less sharp or is dull on affected side 










Mild to moderate dysphasia - obvious loss of fluency or comprehension, without significant limitation in ideas expressed or form of 
expression. Conversation about provided material difficult or impossible but examiner can identify items from patient's response. 
Severe dysphasia - all communication is through fragmentary expression; great need for inference, questioning, and guessing by the 
listener who carries burden of communication. Examiner cannot identify items provided from patient response. 







Mild to moderate dysarthria - patient slurs some words, can be understood with some difficulty. 
Unintelligible or worse - speech is so slurred as to be unintelligible (absence of or out of proportion to dysphasia) or is mute/anarthric 







Partial neglect - Visual, tactile, auditory, spatial, or personal inattention or extinction to bilateral simultaneous stimulation in one of the 
sensory modalities 
Complete neglect - Profound hemi-inattention (e.g. does not recognise own hand or orients to only one side of space) or hemi-inattention 
to more than one sensary modality (e.g. visual + tactile). 





Wider boxes are for numbers 
Please use ? for unknown 
Dates: please use ?? for unknown, and 
complete what you can (e.g. ??/12/1980) 
 
Patient is asked to close & open eyes, grip & release normal hand 
Patient is asked to state the month & his/her age. No credit for partly correct answers. 
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LOTHIAN STROKE CARE AUDIT / REGISTRATION FORM – Outpatients 
 
 GP Initials___________ GP Surname___________________ 
 GP Postcode ________ GP Phone ___________________ 
 Date of assessment ____/____/____ 
 Responsible consultant _____________    Unit : WGH 
 Date of referral ____/____/____ From GP ? [__] 
 Date referral received ____/____/____ 
 Date of first appointment offered ____/____/____ 
 
Final diagnosis (of  presenting event(s)) (Please tick all that apply) 
Cerebral1 Stroke (not SAH)                          Transient ischaemic attack  
Subarachnoid haemorrhage  
Eye1 Retinal artery occlusion               
Transient monocular blindness    
     
 
Other 
Possibly cerebrovascular2            Details: ____________________________________________ 
 
Definitely non-cerebrovascular   
Details: ____________________________________________ 
Complete remainder of form only if definite / probable cerebrovascular diagnosis within last 6 months 
Casemix assessment (complete for STROKE PATIENTS ONLY - refers to most recent event) 
Was the patient independent in ADL3 before event ? [__] Are they oriented in time, place and person ? [__] 
Was the patient living alone at the time of event ? [__] Can the patient lift both arms off the bed ? [__] 
Can the patient talk4 ? [__] Able to walk without help from another person ? [__] 
NIH stroke scale score (0-42; please complete attached scoring sheet) [_____] 
 
Clinical assessment – presenting event(s), past history  & related signs 
Date of most recent stroke / TIA / eye attack ____/____/____ 
(or best estimate) 
Prior stroke - before presenting event(s) ? [__] 
Number of TIAs (not strokes) in the last 3 months [______] Prior TIA - before presenting event(s) ? [__] 
Any stroke symptoms lasting > 7 days5 ? [__] History of ischaemic heart disease6 ? [__] 
Side of brain/eye lesion (please circle)   
 Right  /   Left  /    Cerebellar or brainstem  /   Bilateral  /   Uncertain   
History of treated hypertension ? [__] 
Have there been carotid and vertebral events ? [__] History of diabetes mellitus ? [__] 
Residual neurological signs from presenting event(s) ?  [__] Peripheral arterial disease7 ? [__] 
Any symptomatic neck bruit ?  [__] Cardiac failure8 ?  [__] 
Blood pressure [______/______] Clear history of atrial fibrillation ?  [__] 
Height (cm)  [________]  
Weight (to nearest kg) [________]  
 
Clinical assessment - social and family history 
                                                 
1 Use these categories for definite or probable (>50% probability) cerebrovascular diagnoses within last 6 months 
2 Use and give details: if < 50% probability cerebrovascular cause (e.g. lone vertigo); or if presenting event(s) not within last 6/12 
3 Independent in walking, dressing, washing, feeding, and toileting,  not necessarily bathing, shopping or climbing stairs 
4 Able to utter understandable words even if quiet or slurred 
5 Only count focal neurological symptoms. If too soon to be sure, please code as unassessable 
6 MI (including ECG evidence of silent MI) / angina /CABG/coronary angioplasty or stent etc. 
7 History of claudication / rest pain / peripheral arterial intervention, or definite signs (absent foot pulses / femoral arterial bruit) 
8 Definite clinical signs of heart failure or taking at least two drugs for its treatment (eg. ACE-inhibitor and loop diuretic) 
 
Address label 
Chi No. Sex 
 





Cigarette smoker ? (please circle) :  Never   /   Ex>12 m /   Current or ex<12 m   /   Pipe or cigars only   /   Unknown 
 If current or ex <12 m cigarette smoker, cigarettes / day ? [_______] 
Alcohol intake (units/week)  [_______] 
1st degree relative with stroke / TIA ? [__] 
(please circle all that apply) : 
Mother    /    Father    /    Sibling(s)    /    Child(ren) 
 If yes, how many ? (please circle) : 1    /   2    /    >2 
1st degree relative with IHD / PAD9 ? [__] 
(please circle all that apply): 
Mother    /    Father    /    Sibling(s)    /    Child(ren) 
 If yes, how many ? (please circle) : 1    /   2    /    >2 
 
Data to audit use of 2
ary
 preventative drugs 
(for each column, please tick all that apply or confirm NONE at foot) 
 
Use of following drugs : 
At time of 
event for 
which referred 





But record if 
patient known 
not to tolerate 
Aspirin     
Dipyridamole (Persantin/Asasantin)     
Clopidogrel (Plavix)     
Warfarin     
ACE inhibitor     
Diuretic     
Other antihypertensive     
Statin / lipid lowering agent     
NONE    n/a 
 
Edinburgh Stroke Study consent  
(if full consent already available following a previous event, simply write “CONSENT OBTAINED ALREADY” across this box) 
Consent obtained for ESS ? (please circle - see patient  Patient     /      Relative     /      Witnessed     /    None 
information sheet and consent forms for details) 
Consent date : ____/____/____ 
 Use of data for research purposes [__] 
Blood for research [__] 















Wider boxes are for numbers 
Please use ? for unknown 
Dates: please use ?? for unknown, and complete what 





                                                 
9 ischaemic heart disease / peripheral arterial disease 
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Blood tests Done prior 





Result (leave blank if not yet known) 
FBC   ____/____/___ Haemoglobin (g/l)  [                  ] 
   
    Haematocrit (ratio) [0              ] 
    White cell count (x109/l) [                ] 
    Platelets (x109/l)  [                  ] 
ESR    ____/____/___ (mm/hour) [                  ] 
U&E 
  ____/____/___ 
Urea (mmol/l) [                ] 
    Creatinine (µmol/l) [                  ] 
Glucose   ____/____/___ (mmol/l)    [                ] 
Lipids   ____/____/___ Total cholesterol (mmol/l)   [                ] 
    HDL cholesterol (mmol/l) [                ] 
Research10   ____/____/___  
NONE11    
 
Clinical classification 
of presenting stroke / TIA syndrome12 (please circle) 
LACS  /  PACS  /  POCS  /  TACS  /  Eye13  / Uncertain    
 
Other risk factors or unusual cause of stroke or TIA ?       [__] (circle any options that apply and give details) 
coronary catheterisation   /   carotid endarterectomy  /   cardiac valve disease   /   haematological illness   
/   hereditary e.g. CADASIL  /  arterial dissection   /   coagulopathy   /   other 
Details : __________________________________________________________________________________ 
 
 
Clinical prediction of outcome (clinician's 'gut feeling')  
Probability of stroke (%) at one year [________] at five years [________] 
Probability of vascular event (%)  
(stroke, MI or vascular death) 
at one year [________] at five years [________] 
Dependency (for STROKE PATIENTS 
ONLY) 
(0-6 on Oxford Handicap scale
14
) 
at six months [________]  
Assessing clinician (please circle) MSD   /   RIL   /   PAGS   /   CPW   /   CLMS   /   BW   /  
Other  (please initial) :  _________________ 
                                                 
10 For research bloods, please fill completely: two normal 2.7 ml EDTA tubes (red top). Label with hospital patient stickies. Research 
samples should be kept in the ice box provided and will be sent to the Wellcome Trust Clinical Research Facility at the end of the 
clinic. 
11 Tick this box if no blood tests done since referral event(s) 
12 Based on clinical assessment before results of imaging / other tests. If patient presents with TIA and stroke, classify the stroke. 
13 Use for transient monocular blindness / retinal artery occlusion 
14 Oxford Handicap Scale:  0 = no symptoms;  
1 = minor symptoms which do not interfere with lifestyle;  
2 = some restriction to lifestyle but look after themselves;  
3 = significant restriction to lifestyle, preventing total independence;  
4 = severe handicap preventing independent existence but not requiring constant attention;  
5 = severe handicap, totally dependent, requiring attention night and day 
6 = dead 





Wider boxes are for numbers 
Please use ? for unknown 
Dates: please use ?? for unknown, and 














Cardiac investigations  
ECG since event available ?  [__] 
AF on ECG ? [__] 
 
LVH on ECG ?                                   [__] 
Echocardiogram done ?(please circle):  None  /  TTE no contrast  /  TTE+contrast  /  TOE no contrast  /  
TOE+contrast 
Date of first echocardiogram : ____/____/____ 
Patent foramen ovale on echo?  [__] 
 
LVH on echo ?                                   [__] 
 
Data to audit carotid intervention service 
 
Carotid Duplex examination performed ? [__] Date of 1st Duplex ____/____/____ 
2nd Carotid Duplex performed ? [__] Date of 2nd Duplex ____/____/____ 
MR Angiography performed ? [__] Date of MRA ____/____/____ 
CT Angiography performed ? [__] Date of CTA ____/____/____ 
Conventional Angiography performed ? [__] Date of angiography ____/____/____ 
Referred to vascular surgeons/interventional radiologist ? [__] Date referred ____/____/____ 
If not referred, why ? (please circle reason):   patient choice   /   clinically not worthwhile (doctors decision) 
 mutual agreement /    not appropriate (no severe stenosis) 
If referred – intervention considered (please circle):     surgery   /   angioplasty ± stent 
 Seen by surgeon / radiologist ?  [__] Date seen ____/____/____ 
 Intervention performed ? [__]  
If yes Side (please circle) Right   /   Left   /   Both Date of (first) procedure ____/____/____ 
Stroke within 30 days of intervention ? [__] 
 
 Other complication(s) of intervention ? [__] (please specify) _____________________ 
 Reviewed in NV clinic after intervention ? [__] Date reviewed ____/____/____ 
 
Carotid imaging results  Right  Left 
ICA % stenosis on 1st Duplex15 ?  [_____________]  [_____________] 
Post-stenotic collapse (equivalent on Duplex) ?  [__]  [__] 
Plaque instability / irregularity (on Duplex or MRA) ?  [__]  [__] 
 
 
14 Include harmorrhagic transformation of infarct but NOT petechial haemorrhage / microbleeds 
15 Use for transient monocular blindness / retinal artery occlusion 
16 Don’t rely on automatic report.  Use voltage criteria – sum of S wave in V1 or V2 + R wave in V5 or V6 ≥ 3.5 mV (35 mm) 
17 Record discrete figure or range. If >1 result, record most severe. If result ‘normal’ record 0%; if ‘minor atheroma’ record 30%. 





Wider boxes are for numbers 
Please use ? for unknown 
Dates: please use ?? for unknown, and 
complete what you can (e.g. ??/12/1980) 
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«TITL» «INIT» «SURNAME» Department of Clinical Neurosciences 
«ADDRESS_1» University of Edinburgh 
«ADDRESS_2» Bramwell Dott Building 
«ADDRESS_3» Western General Hospital 
 Crewe Road 
 Edinburgh 
«Date» EH4 2XU 
 Tel: 0131 537 2875 
 Fax: 0131 332 5150 
 E-mail: ess@skull.dcn.ed.ac.uk 
 Web: www.dcn.ed.ac.uk/ess  
Dear «TITL» «SURNAME»  
 
You were seen at the Western General Hospital on «EXAM_D» and we 
would now be very interested to find out how you are getting on. 
 
We would be grateful if you or someone who knows you well could complete 
and return the questionnaire in the envelope enclosed.  No stamp is required. 
Should you have any problems completing the questionnaire, please do not 
hesitate to contact Miss Caroline Jackson on 0131 537 2875. 
All information received will be kept strictly confidential. 
 
Many thanks for your help 
 
Yours sincerely 
Dr Martin Dennis   Dr Cathie Sudlow 
Consultant Physician  Specialist Registrar in Neurology 
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YES       NO 
 
              (Please tick one box) 
 
 





           YES      NO 
 
                (Please tick one box) 
 





           YES      NO 
3. How do you live now?         (Please tick one box) 
          
On my own         
 
With my partner or relatives        
   
 
 
           YES      NO 
4. Where do you live now?         (Please tick one box) 
  
 In my own home or my relative’s home 
  
 In a residential home 
 





 YES       NO 
 
5. Have you had any FURTHER weakness or      (Please tick one box) 
numbness in your legs or arms or have you had  
any NEW problems with your vision or speech  
since «LAST_SEEN»? 
If YES, did you attend your GP or hospital? 
 
       
Date attended:   ……../……./…….. 
 
 
           YES     NO 
 
             (Please tick one box) 
6. Has a doctor told you that you have had a  
stroke or ‘shock’ since «LAST_SEEN»? 
 
 
If YES, who told you?……………………………………… 
 
 
When? (approximately) Date:  ……../……../…….. 
 
 
           YES     NO 
 
             (Please tick one box) 
       
7. Have you had any chest pains since «LAST_SEEN»? 
 
If YES, did you attend your GP or hospital? 
 
Date attended: ……/……/…… 
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   YES      NO 
 
            (Please tick one box) 
8. Has any doctor told you that you have had a  
heart attack since «LAST_SEEN»?       
 
If YES, who told you?……………………………………… 
 




9. Tick the ONE box next to the sentence which best describes your 
present state. 
          
 I have no symptoms at all. 
  
 I have a few symptoms but these do not interfere with 
 my everyday life.  
        
 I have symptoms which have caused some changes 
 in my life but I am still able to look after myself.    
   
 I have symptoms which have significantly changed my 
 life and I need some help in looking after myself. 
 
 I have quite severe symptoms which mean I need to  
 have help from other people but I am not as bad as 
 to need attention day and night. 
 
 I have major symptoms which handicap me and I need  
 constant attention day and night. 
 
 




Thank you for completing the questionnaire.  Please now return it in the 
pre-paid envelope enclosed. 
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Appendix 10   (a) Study contact card given to patients and (b) Study 
sticker provided to General Practitioners and placed on the front of 















Please let us know as soon as possible 
if this patient may have had a further 
stroke or a MI. 
Dr Cathie Sudlow / Dr Martin Dennis 
Department of Clinical Neurosciences 
Western General Hospital 
Tel: 0131 537 2875 





This Patient is 
enrolled in the 
Edinburgh 
Stroke Study 
Thank you for joining the 
Edinburgh Stroke Study 
 
How to contact us: 
Telephone: 0131 5372875 
 
 
  Fax: 0131 332 5150 
  E-mail: ess@skull.dcn.ed.ac.uk 
Edinburgh Stroke Study, Dept of Clinical 
Neurosciences, Bramwell Dott Building, Western 
General Hospital, Edinburgh EH4 2XU 
If, at any time in the future, you have: 
• new weakness or numbness in your 
legs or arms; or 
• new problems with vision or speech 
you might have had another stroke.  You 
should:  
• seek medical help straight away 
• please let the Edinburgh Stroke Study 
know as soon as possible. 
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Date of birth: «DOB» 
«ADDR_1» «ADDR_2» «ADDR_3» 
 
 
If the patient is no longer registered at your practice, please tick this box.             
You do not need to complete the rest of the form.  Please return the form  
to us using the enclosed freepost envelope. 
 
1. As far as you know, has the patient had any further strokes since they were seen by the stroke team at 
the Western General Hospital on *insert date of assessment* ?  
   
Yes  If Yes, how many strokes? ___    No   If No, go to question 2   
 
Date(s) of further stroke(s): 1: __/__/____       2: __/__/____     3: __/__/____        
   
Was the patient ever admitted to hospital with a further stroke? Yes  No 
 
If yes, which hospital? (please tick all that apply) 
  
Royal Infirmary of Edinburgh 
  
 Western General Hospital 
 
 Other (please give details) ___________________________________________ 
 
2. As far as you know, has the patient had a myocardial infarction (MI) since they were seen by the 
stroke team at the Western General Hospital on *insert date of assessment*? 
 
Yes           If Yes, how many MIs ? ___       No  If No, form now complete for return 
 
Date(s) of MI(s)  1: __/__/____ 2: __/__/____ 3: __/__/____ 
 
Was the patient ever admitted to hospital with a MI?  Yes  No 
 
If yes, which hospital? (please tick all that apply) 
  
 Royal Infirmary of Edinburgh 
 
 Western General Hospital  
 
 Other (please give details) _____________________________________________ 
 
 
Thank you very much for taking the time to complete the form.  If you have any questions, please contact 
Caroline Jackson (tel: 0131 - 537 2875, email: caroline.jackson@ed.ac.uk).   
 
Please return the form to us using the freepost envelope enclosed. 
 
(Edinburgh Stroke Study, Division of Clinical Neurosciences, Bramwell Dott Building, Western General Hospital, 
Edinburgh, EH4 2XU) 
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Appendix 12   (a) Assessment of the proportional hazards assumption 
for variables included in the Cox regression model comparing risk of 
death in lacunar versus non-lacunar patients 
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 Appendix 12 (b) Assessment of the proportional hazards assumption 
for variables included in the Cox regression model comparing risk of 
recurrent stroke in lacunar versus non-lacunar patients 
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Appendix 12 (c) Assessment of the proportional hazards assumption 
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